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ABSTRACT
One of the major ways employed by eukaryotic cells to control gene expression is by 
the action of the regulatory sequences known as enhancers and repressors. An 
understanding of the spatial and temporal activation of these sequences would help 
our understanding of gene control. Because polymorphisms in these control regions 
have been associated with disease a way to rapidly identify if these polymorphisms 
were affecting gene expression would be a useful diagnostic tool.
This thesis describes the development of a chick-based model to attempt to rapidly 
identify when and where enhancers are being activated. Using the ECR Browser, 
putative enhancer sequences are identified by cross-species comparison of the 
genomes to expose evolutionary conserved regions. By cloning an ECR, so identified, 
into a suitable reporter vector and transfecting cells in-ovo, the activation of the 
enhancer by the cell can be detected. Following a successful proof-of-concept run 
using the Hb9 gene, LSAMP, was selected as the first gene to investigate because of 
its role in development and its implication in mental health disorders and cancer. A 
number of ECRs were examined and six of these were shown to be enhancers 
proving that the system functioned.
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Abbreviation Expansion of Term
AMP Ampicillin
AMPr Ampicillin resistant
BLAST Basic local alignment search tool
BLAT BLAST-like alignment tool
Bp/bp base pair/base pairs
bpm Beats per minute
CEPU-1 Cerebellum-Purkinje (chick homolog of
NTM)
DAPI 4,6-diamidino-2-phenylindol
DMEM Dulbecco's Modified Eagle Medium
DMSO Dimethyl sulphoxide
DNA Deoxyribonucleic acid
dNTP Deoxyribonucleotides
DSM Diagnostic and Statistical Manual of Mental
Disorders
dT Deoxythymidinetriphosphate
E Embryonic day, number of days following 
start of incubation.
EBI European Bioinformatics Institute
ECM Extra-cellular matrix
VI
ECR Evolutionary Conserved Region
ECRx:pl229 LSAMP enhancer sequence ECRx (where x =
1,2 or 3) and pl229 plasmid construct
EDTA Ethylenediaminetetraacetic acid
GFP Green fluorescent protein
GIF General transcription factor
GWAS Genome-wide association study
GxEy:pl229 LSAMP enhancer sequence GxEy (where x = 
group number and y = ECR number within 
that group) and pl229 plasmid construct
Hb9 Homeo box-HB9 (Note: Official name MNX1)
Hb9:pl229 Hb9 enhancer sequence and pl229 plasmid
construct
Hox Homeobox
Inr Initiator
IPTG Isopropyl 3-D-l-thiogalactopyranoside
IRES Internal ribosome entry site
KAN Kanamycin
KANr Kanamycin resistant
Kb Kilo bases
LAMP Protein encoded for by the LSAMP gene.
LB Lysogeny broth
LSAMP Limbic system-associated membrane protein
gene
M Molar
MCS Multiple Cloning Site
mg Milligram
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ml millilitre
mM millimolar
MNX1 Motor neuron and pancreas homeobox 1 
(a/k/a Hb9)
mRNA Messenger RNA
NaCI Sodium Chloride
ng nanogram
nm Nanomolar
NTM Neurotrimin
O.D. Optical Density
OBCAM Opiate-binding cell adhesion molecule
OCT medium Optimal Cutting Temperature medium
Bright Cryo-M-Bed medium
p!229 A non-commercial reporter vector based on 
a pBluescript backbone.
PCR Polymerase chain-reaction
pCRII A propriety plasmid used in Invitrogen's
TORO TA cloning kit
PI Post-injection
PVC Polyvinyl chloride
RCAS Replication-Competent ASLV long terminal 
repeat (LTR) with a Splice acceptor
RE Restriction enzyme
SAP Shrimp alkaline phosphatase
SOC Super Optimal Broth
STET Sodium, Tris-CI,EDTA,TRITON X100
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SyG
Ta
TAE
Tris (a pH buffer)
SYBR Green I nucleic acid stain 
Annealing temperature
Tris acetate EDTA buffer 
Tris(hydroxymethyl)aminomethane
TSS Transcription Start Site
UTR
V
Untranslated region 
volts
X-gal bromo-chloro-indolyl-galactopyranoside
A
Mg
Ml
Wave length
microgram
microlitre
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Chapter 1 - Introduction
1.1 Transcription initiation is an important point at which gene 
expression is regulated.
The central dogma of molecular biology as defined by Crick was that DNA makes RNA makes 
Protein (Crick, 1958, Crick, 1970). This process whereby the genetic information held in the 
form of DNA ultimately makes protein must first go through the transcription of the DNA 
into RNA. Because each cell in an organism has the same complement of genes the control 
of what genes are transcribed at a given time in a cell must be under exquisite control. The 
transcription step is probably the most important control point in this process because it is 
the most efficient place to moderate the process, in eukaryotic cells the transcription that 
eventually results in protein and peptides is performed by RNA Polymerase II (Polll). This 
requires that a plethora of basal transcription machinery assembles on the promoter region 
upstream of the gene's transcription start site (TSS) in what is known as the pre-initiation 
complex (PIC). Once this PIC has formed transcription can occur at a basal level but the rate 
of transcription starts is greatly increased by the receipt of a signal by DNA. However 
because the DNA is held in the form of chromatin, i.e. DNA wrapped around histone cores, 
access to the nucleotides is not always possible and the histone core needs to be displaced 
or its grip on the nucleotides needs to be loosened in order for the signal to be effective. 
Access to the DNA is implemented by a number of stimuli but mainly by molecules known as 
Transcription Factors (TFs). These TFs bind to regions of DNA known as 'enhancers'. 
Enhancers are regions of DNA to which multiple TFs bind and increase the transcription start 
rate (Banerji et al., 1981). The mechanism behind this seems to be that the transcription 
factors on the enhancer sequences recruit enzymes such as histone acetyltransferase (HAT) 
to the targeted DNA domain. HATs acetylate lysine residues in the N-terminal tail function as 
part of gene regulation (Sadoul et al., 2008) possibly providing binding sites for specific 
protein-protein interaction domains (Dhalluin et al., 1999). Certain transcription factors
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interact with those at the promoter (Maston et al., 2006, Malik and Roeder, 2010) resulting 
in the formation of a chromatin loop that physically brings together the enhancer and 
promoter sequences (Schoenfelder et ah, 2010, Dekker et ah, 2002). Conversely repressor 
sequences contain TFBS that recruit enzymes such as histone de-acetylase (HDAC) that have 
the opposite effect.
1.2 Transcription Factor Binding Sites are short regions of DNA to 
which Transcription Factors bind.
The Transcription Factor Binding Sites (TFBS), to which the TFs bind, are typically in the 
range of 6-12 bp although the actual binding specificity is typically conferred by 4-6 of these 
bp. The TFBSs for any given TF are usually degenerate (Zhang et al., 2006) and defined by a 
consensus sequence in which some locations are more highly conserved than others. 
Therefore a particular TF can bind to sites that contain differing nucleotides although there 
would typically be a relatively well conserved central motif. Examples of degenerate binding 
sequences for two common TFs, TATA Binding Protein (TBP) and murine GATA1 are shown 
below (Figure 1) showing pictorially and by frequency matrix the relative occurrence of the 
nucleotides in the binding sites.
Heterodimers and homodimers are often formed by the TFs resulting in the binding sites 
consisting of two half sites.
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A1
A2
2-
A [61 16 352 3 354 268 360 222 155 56 83 82 82 68 77 ]
£__[145 46 0 10 0 0 3 2 44 135 147 127 118 107 101 ]
S__1.152 18 2 2 5 0 20 44 157 150 128 128 128 139 140 ]
T [ 31 309 35 374 30 121 6 121 33 48 31 52 61 75 71 ]
B1
B2
123456789 10 11
&__[,1423 708 2782 0 4000 27 3887 3550 799 1432 1487 ]
£__i 560 1633 31 0 0 29 0 4 681 897 829 ]
£__[,1242 1235 10 4000 0 109 6 383 2296 1360 1099 ]
T__l 775 424 1177 0 0 3835 107 63 224 311 585 ]
Figure 1 Transcription factor Binding Sites of (TATA Binding Protein) TBP and mouse 
GATA1.
(Al) Pictogram of the TBP TFBS motif. The letters on the top of each position represent the 
TBP consensus. The height of each position reflects the information content at that 
position with the relative height of a letter in each position reflects the frequency of 
observing the nucleotide.
(A2) Frequency Matrix of TBP underlying model showing the DNA pattern. The cell 
numbers indicate the number of sequences having base x in column y.
(Bl) Pictogram of the GATA1 TFBS motif in mouse. The letters on the top of each position 
represent the GATA1 consensus. The height of each position reflects the information 
content at that position with the relative height of a letter in each position reflects the 
frequency of observing the nucleotide.
(A2) Frequency Matrix of GATA1 underlying model showing the DNA pattern. The cell 
numbers indicate the number of sequences having base x in column y.
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1.3 Identifying DNA regulatory sequences is difficult
Identifying enhancers or repressors by analysing DNA sequences is difficult. This is because 
of their small size and degeneracy, they have few identifiable motifs, they may be located 
upstream, downstream or within the transcription unit, can function in either orientation, 
and may be tens to hundreds of kilobases away from the gene that they control (Banerji et 
al., 1981), and may even reside on a different chromosomes (Lomvardas et al., 2006, Geyer 
et al., 1990). For example, an enhancer of tyrosine kinase was located at a distance of 212 
kbp from the gene {Haupt et al., 2010), one for Myf5 was found between 50 kbp and 95 kbp 
upstream (Hadchouel et al., 2000)and one for human (3 -globin was identified at 260 kbp 
from the gene's TSS {Porcu et al., 1997). One method of identifying enhancers is by finding 
the binding sites for the p300 protein. The p300 protein interacts with numerous TFs and 
increases the expression of their target genes (Vo and Goodman, 2001, Kasper et al., 2006). 
The ChIP-Seq method can be used to analyse the binding of the P300 protein to DNA and 
help identify enhancers (Visel et al., 2009).
1.4 Many non-coding Evolutionary Conserved Regions function as 
transcriptional control regions.
A method of identifying putative cis regulatory elements is by locating regions of non-coding 
DNA that are conserved over evolution across many species. These are known as 
Evolutionary Conserved Regions (ECRs). It was presumed that as these regions are 
conserved across evolutionary time they must have a function and it is now generally 
accepted that one of the functions of ECRs is to act as enhancers and repressors of gene 
expression (Pennacchio et al., 2006, Woolfe et al., 2005). Finding ECRs has been made much 
easier by the introduction of the databases of such regions and tools to interrogate them 
such as at University of California at Santa Cruz (Kent et al., 2002, Lindblad-Toh et al., 2011, 
Pennacchio et al., 2006, Woolfe et al., 2005) and the ECR Browser (Ovcharenko et al., 2004).
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The ECR Browser has been previously used in a number of projects such as investigation into 
distal regulatory elements of Fs/ir expression (Hermann et al., 2007), comparative study of 
the insulin gene promoters (Hay and Docherty, 2006) and continues to be employed, for 
example into mouse Elf5 regulation (Pearton et al., 2011). The ECR Browser is a tool for 
visualising evolutionary relationships between genomes (Ovcharenko et al., 2004) and was 
used in this thesis. In this tool one organism is set as the 'base' and the other selected 
organisms, the 'targets', are compared against this.
The comparison criteria used to identify such ultra-conserved regions typically consists of 
length of sequence and percentage similarity between the sequence of the base organism 
and that of the target(s). What is reported as being an ECR will vary depending on how 
these parameters are set, if set too stringently ECRs will be missed and if the parameters are 
not sufficiently stringent there will be too many false positives.
The evolutionary distance between the organisms being compared greatly affects the 
results. If there is too great a difference between the two sequences being compared few or 
no ECRs will be identified, conversely if there is too small a difference between the 
organisms too many regions will tend to be flagged as ECRs.
Having identified a region of DNA as being a potential enhancer it must be tested for 
function. Although great strides have recently been made in deciphering genomes and 
bioinformatics-based methods of interpreting the instructions encoded in the genome, and 
in identifying variations associated with disease have improved, they still need to be proven 
in a living model. This model may be in vivo or in vitro. In vivo is preferable as there is 
minimal disruption to the cells being examined and the ceils can develop within the whole 
animal and so be subjected to the normal range of growth factors and signals from many 
cells and the general developmental environment.
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1.5 Model Organisms are non-human species that are studied to 
understand biological functions.
When studying human development and disorders probably the best organism to use would 
be human however due to a number of reasons, such as ethics, complexity of humans and 
development time this is not typically practicable. To ameliorate some of these problems 
model organisms are used. These are typically more simple organisms than the one being 
studied and their selection and suitability is based on a number of criteria, for example how 
long they take to regenerate, fecundity, the accessibility to tissues, organs and/or DNA, ease 
of manipulation, cost, existing knowledge of the organism and similarity to the target 
organism. Many organisms are used, from the simplest organisms such as yeast and bacteria 
through D. melanogaster and on to the more complex animals such as fish, avians, rodents 
and primates. Evolution is regarded as a process where populations are altered over time 
and may divide into separate branches, join together or become extinct. Thanks to the 
development of phylogeny (Woese et al., 1990, Doolittle, 1999), the study of evolutionary 
relationship between organisms through molecular and morphological methods, the 
evolutionary distance between the entire or even part of an organism can be calculated. This 
may be visualized in as a phylogenetic tree, a graphic representation of the order in which 
evolutionary events are assumed to have occurred. Figure 2 indicates the evolutionary 
distance between the isoforms of LSAMP in the selected organisms with the length of the 
lines indicating the evolutionary distance. As can be seen, of the organisms included in the
7
comparison, Zebrafish is the most evolutionary distant from human and Pig is the closest.
— XENOPUS 
r-PIG
^HUMAN 
'-COW
— RAT
— MOUSE
— CHICK
— ZEBRAFISH
Figure 2. Phylogenetic tree showing relative evolutionary distance of LSAMP between the 
organisms shown. The line-length indicates the relative distance. Produced by ClustalW 
(Larkin et a!., 2007).
The ability to use such a wide range of organisms is because all living organisms are 
descendants from a common ancestor and the genetic material and metabolic pathways of 
these have been conserved, to a greater or lesser degree, over evolutionary time. During 
the work described here chicken will be used as the model organism.
1.5.1 Mouse as an experimental model: Advantages and 
Disadvantages.
Using mouse as an experimental model imparts a number of advantages to the investigator. 
It is a well-established practice, with well documented techniques (Cold Spring Harbor 
Protocols, 2006, Lawson, 2000, Nagy, 2003) (Wassarman and Soriano, 2010, Hedrich, 2012) 
and a fully characterised genome (Mouse Genome Sequencing et al., 2002, Church et al., 
2009).
Although it varies between species, birds and mammals have brains that are between six 
and ten times as big as the brains of reptiles of the same body size (Northcutt, 2002). 
Chicken-type birds and rodents have comparatively the smaller brains (Nieuwenhuys et al.,
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1998). All human homologous brain areas and cell types are present (Bier and McGinnis, 
2004). Reverse genetic engineering by gene knock-out (Capecchi et al., 2007) and site 
directed mutagenesis techniques are available (Thomas and Capecchi, 1987). Chimeric 
embryos construction is possible (Tam and Rossant, 2003) and a large mutant mouse 
collection is available (Wilkinson et al., 2010).
There are however some disadvantages to using mouse, mainly in connection with accessing 
the embryo. A very condensed protocol for generating transgenic (Cho et al., 2009) 
offspring would be as follows:
1. Immature donor females are super-ovulated by injection with PMSG (pregnant 
mare's serum gonadotropin) and HCG (human chorionic gonadotropin) and mated 
with stud males.
2. 12 hours post coitus the oviducts from the killed donor females are collected and the 
eggs harvested and placed in culture
3. Eggs microinjected with purified cloned DNA or plasmid.
4. Surviving eggs are implanted in pseudo-pregnant females (asexual mating with 
vasectomised males and then screen for plugging). These mice are anesthetised and 
following the surgical exposure of the infundibulum 15-20 eggs are injected into the 
ampulla of the oviduct. The oviduct and ovary are tucked back into the cavity and 
wound closed up. This is repeated on the other side of the mouse. The30-40 eggs 
implanted should give 5-10 pups depending on skill level.
5. Following birth at ~20 days, or earlier embryo extraction, the embryos can be 
processed depending on requirements e.g. further mating or staining for reporter 
vector.
6. If a germline is being developed the pups should be genotyped to identify transgenic 
mice. These mice are the F0 or founder mice.
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7. Once the founders reach sexual maturity, they can be crossed with wild-type mice, 
preferably from the same strain as the FO mice, to establish separate transgenic lines.
8. After verifying transmission from founder mice (FO) to offspring (FI), transgene 
expression within each line of the FI or F2 generation has to be examined in most of 
the organs to prove that the line has proper temporal and spatial gene expression 
patterns and no leaky expression.
Another problem is that some early acting phenotypes are difficult to study because they are 
embryonic lethal (Xie et al., 2005), further embryonic manipulation, following 
reimplantation, is difficult as the embryo is inside the mother. Development and life-cycle of 
the animals is relatively slow (Bier and McGinnis, 2004).
1.5.2 Chickens offer Advantages and Disadvantages as a Model 
Organism in comparison with Mice.
The protocol for generating transgenic mice quite complicated, time-consuming and 
expensive. In contrast using chick is as the model organism is faster and easier because the 
embryo is accessible in ovo, the chick embryos do not have to be implanted and chicks 
mature quicker, for example 2 days development in chick is equivalent to about 9.5 days in 
mouse (Butler and Juurlink, 1987), allowing for a faster turnaround. From a cost basis, 
chickens are ideally suited as a model because fertilised eggs are cheap, costing 
approximately 33 pence each and are easily obtained from commercial hatcheries that 
produce large amounts of fertilized eggs for the pharmaceutical industry or agriculture. 
Maintenance costs are extremely low, there being no animals to feed or house by the 
experimenter and the equipment used for storing and incubating the eggs are widely used in 
poultry farming.
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There are nonetheless disadvantages to using chick as against mice, for example the chick 
genome (International Chicken Genome Sequencing, 2004) hasn't been as well characterised 
as the genome of the mice typically used in laboratories. Initially generating transgenic 
chickens proved difficult (Dodgson, 2003, Siegel et al., 2006) however the protocol is now 
better established (van de Lavoir et al., 2006, Chapman et al., 2005, Mozdziak et al., 2003, 
Koo et al., 2006, McGrew et al., 2004)
However, because evolution in the genome doesn't follow a single linear pathway, each 
branch evolves separately at different mutation rates this leads to leading to some 
anomalies. For example although the chick genome is less similar to human than the rodent 
genome; the last common ancestor shared between the human line and the chicken line is 
230 MYA whereas the last common ancestor with rodent is 75 MYA, it must be noted that 
the rodent genome has mutated more rapidly than the human genome (Li and Wu, 1987) 
and also that there are variations in the mutation rate across genomes both of which pose 
their own challenges (Hodgkinson and Eyre-Walker, 2011).
1.6 Analysis of gene expression by reporter vector.
Many diseases are the result of abnormalities in genes or chromosomes which can be 
caused by a mutation in a single gene and be Mendelian, or be more complex and be caused 
by mutations in several genes i.e. be polygenic. Lifestyle and environmental factors may also 
contribute to the development of the disease. Because of the complexity of the polygenic 
and multifactorial the identification of causes of Mendelian diseases is much more 
advanced. One of the many diseases caused by genetic mutation is Sickle cell disease (SCD), 
also known as sickle cell anaemia (SCA).
SCD is the result of a point mutation in the haemoglobin beta gene (HBB) that causes the
amino acid valine to replace glutamic acid in the HbA (3 chains and is most prevalent in sub-
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Saharan Africa, India, Saudi Arabia and Mediterranean countries (World Health 
Organisation., 2006). Mouse models have been generated to study SCD. One such is the 
homologous knock-in, which replaces the mouse globin genes with human genes (Wu et al., 
2006).
Cystic fibrosis (CF) is an autosomal recessive genetic disease that is frequently fatal, and is 
more prevalent in Caucasians than other ethnic groups. It causes the body to produce thick 
mucus that clogs the lungs, leading to infection, and blocks the pancreas, preventing 
digestive enzymes from getting to the intestines. Since the identification of the gene 
responsible, the cystic fibrosis transmembrane conductance regulator gene (CTFR) 
(Rommens et al., 1989, Riordan et al., 1989, Kerem et al., 1989) many CF-causing mutations 
associated with CFTR. However, the leading cause of cystic fibrosis is produced by having the 
CFTF?AF508 mutation (Bobadilla et al., 2002) which is a deletion of the three nucleotides 
that code for phenylalanine (F) at position 508 (Kerem et al., 1989).
Huntington's chorea or disease is an autosomal dominant genetic neurodegenerative 
movement disorder is caused by multiple repeats of a CAG triplet at the 5' end the 
Huntingtin gene (Macdonald et al., 1993) resulting in a toxic gain-of-function. The CAG 
triplet codes for the amino acid glutamine. Typically there are up to 35 repeats of the triplet, 
but above that number of copies the phenotype becomes evident with higher number of 
repeats associated with an earlier onset age (Ravina et al., 2008, Andrew et al., 1993).
Analysing the effect of gene mutation and its associated expression has a long history and 
many methods have been used. One method is to start at the disease level and search for 
genetic differences between the affected population and the healthy population. This has 
become more automated now with the deciphering of the genetic codes for various 
organisms and several humans and the advent of gene-wide association studies (GWAS).
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Another method is to observe the result to the phenotype when a gene is knocked out or 
indeed, knocked-in. Due to redundancy gene knock-out sometimes will have little or no 
effect (Perez-Perez et al., 2009). Conversely, due to the same gene being used many times in 
development the knock-out of certain genes may result in multiple phenotypic changes and 
so be lethal. This however can be overcome by using tissue-specific enhancers that drive 
site-specific recombinases in specific tissues to knock out the target gene in a very explicit 
manner (Hirano et al., 2011, Kos, 2004). A similar method uses tissue-specific enhancers to 
drive a toxin that destroys certain cells {Lee et al., 2000). There are also many other methods 
such as the Cre-Lox recombination system {Sauer and Henderson, 1988, Sauer, 1987). This 
system consists of the Cre recombinase enzyme that recombines a pair of short target 
sequences called the Lox sequences. The Cre protein cuts the DNA at both Lox sequences 
sites by the Cre protein and the strands are re-joined by DNA ligase. Inverted Lox sites will 
cause an inversion of the intervening DNA, while a direct repeat of Lox sequences will cause 
deletion of the intervening DNA. Translocation of the DNA to another chromosome can also 
be arranged as can triggering by chemical or heat-shock. A system with similar function is 
the FLP-FRT (Zhu and Sadowski, 1995, Turan and Bode, 2011, Schlake and Bode, 1994) but 
this uses the recombinase (FLP) on the flippase recognition target (FRT).
There are also the "Tetracycline-Controlled Transcriptional Activation Systems", methods of 
inducible gene expression where transcription is reversibly turned on in the presence {Tet­
on) (Gossen et al., 1995) or absence (Tet-off) (Gossen and Bujard, 1992) of the antibiotic 
tetracycline, doxycycline or similar (Gossen and Bujard, 2002).
None of the above methods were used in the development of this thesis; instead a closed 
reporter vector method was used. In this method a putative enhancer sequence is inserted 
upstream of a minimal promoter and a chromogenic or fluorescent reporter gene. If the 
enhancer is activated by intercellular signals the promoter causes the expression of the
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reporter gene and from this the temporal and spatial expression pattern of when and where 
an enhancer is active can be ascertained. This reporter system is usually introduced into the 
host organism in the form of a plasmid. Plasmids are circular DNA molecules that are 
separate from the DNA of the host cell, and typically remain so and therefore become more 
dilute at each cell-division, although some may undergo restriction enzyme digestion and 
become incorporated into the host's genome. Plasmids are very useful in the laboratory 
because they can be extracted from their host cell, manipulated by, for example, restriction 
enzymes that will open the plasmids and so allow the insertion of foreign DNA into the 
plasmid. Following ligation, where the circular plasmid is reformed containing the foreign 
DNA, they can then be inserted into a different cell and express the mRNA coded-for by the 
inserted DNA. At this stage they are known as vectors. They are known as expression vectors 
where they are constitutively active or reporter vectors where they only become active in 
response to a specific event or signal.
in the case of a eukaryotic vector a number of regulatory sequences are required in the 
plasmid for it to function as a vector. The most important is the transcription promoter 
sequence to allow assembly of the RNA polymerase and its associated transcription 
machinery. A polyadenylation sequence to insert the polyA tail on the mRNA is also needed. 
An enhancer sequence is similarly required to increase transcription starts above a low, 
basal level. For an expression vector, which will be constitutively on, the promoter/enhancer 
combination should be strong and the enhancer should respond to signals that are 
constantly expressed by the host cell. One such promoter is the p-actin promoter that in its 
native state is responsible for the expression of the gene ACTB. ACTB codes for a 
cytoskeletal actin that, being vital for the structure and integrity of eukaryotic cells is 
ubiquitously expressed. Another promoter that is constitutively active and strong in many 
infected eukaryotic cells is the cytomegalovirus (CMV) immediate early promoter (Boshart et
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al., 1985). This makes CMV useful as a promoter in plasmids but this can vary in expression 
and can give poor results in chick where expression is largely confined to the pancreas, 
although it does function at some level in most tissues (McGrew et al., 2004).
Where a reporter vector is required, the needs for the promoter-enhancer combination 
differ somewhat, depending on the circumstances. When testing whether an enhancer is 
being activated or not it is vital that promoter only becomes active in conjunction with this 
activated enhancer. The promoter must on no account be 'leaky', i.e. allow transcription of 
the reporter gene to start without the signal from the activated enhancer. Some reporter 
vectors use a minimal promoter to provide this functionality.
A minimal promoter consists of the few nucleotides in those sequences that are absolutely 
required for binding of the transcription factors to cause transcription of the gene. The 
human (3-globin minimal promoter region contains CAC, CAAT and TATA box regions it also 
binds the NF-E1 (also known as GATA-1) nuclear factor and ubiquitous factors (deBoer et al., 
1988).
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4-------------------------promoter----------------------- . —> 4-------- gene---------- t 4-------------------------------------3’ flanking enhancer.
OCTA
internal
enhancer
minimal promoter
CAC CAAT
-200 -100 +1 poly(A) +2200 +2300 +;
Figure 3 Schematic representation of the factors binding to the human ,p-globin promoter 
(deBoer et al., 1988) and 3' enhancer (Wall et al., 1988). The promoter and enhancer are 
on the same scale, the gene and immediate 3' flanking region have been compressed to a 
smaller scale. The symbols indicate the various protein factors. CDP, NFI, NF-E1, CPI, a2 
and an octamer binding protein, b3/c2 Wall 1988 (Wall et al., 1988). Note that the factors 
binding to the minimal promoter (TATA, CAAT and CAC boxes) have not been indicated. 
Solid double arrows indicate binding of different factors to the same or overlapping sites. 
(deBoer et al., 1988).
-240 NFI
KF-E1 FF-E1
TTTTTAGTAGCAATTTGTACTCATGGTAT^GGGCCA,
AAAAATCATCGTTAAACATGACTiACCATALirlCCGGT
ACAGATATATCTTkk
TCTCTATATAGAAfT
GAGGGAGGGC
CTCCCTCCCG
TGAGGGTTTGAAGTCCAACTCCTAAGLLAG[GtCAGAAGAGCCAAGGACAGGTACGGCTG 
ACTCCCAAACTTCAGGTTGAGGAfTTCGGTCACjGGTCTTCTCGGTTCrTGTCCATGCCGAC
-120
NF-E1 CAC CAC CAAT
CTCCCAGG 
GAGGGTCC
t:atcacttaga:ctcaccctgtggag:cacaccctagggttggccaatcta 
a;tagtgaatct:gagtggga:acctcsgtgtgggatcccaaccggttagat
*60 TATA 41
AGCAGGGAGGGCAGGAGCCAGGGCTGGGClATAAAAiGTCAGGGCAGAGCCATCTATTGCTT
t.cgtccctcccgtcctcggtcccgacccg[[atttt)cagtcccgtctcggtagataacgaa
Figure 4 The human ^Globin gene layout. The minimal promoter k black bar and runs in 
the region -100 to +1. The boxes indicate consensus sequences TATA, CAAT, CAC, NF-EI and 
NFI. Adapted from Fig 2 (deBoer et al., 1988).
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1.7 Transfection of selected Tissue with Reporter Vector.
In order to function the reporter vector has to be transfected into the cells of the organism 
under investigation. There are many different ways of transfecting cells ranging from 
chemical (e.g. Lipofection), through Biolistic (particle-based) to viral-based.
Of three non-viral methods investigated to transiently transfect chick eggs in-ovo 
(Lipofection, Biolistics and Electroporation), electroporation was found to give the highest 
survival rate of 53.6% (30/56) and highest transfection rate 50.0% (15/30) (Muramatsu et al., 
1997). Electroporation or electro-transfection, is popular because it works on most types 
of cells, is cheap, cloning can be directed to a particular location such as the neural tube, it 
can be efficient with many cells taking up the DNA (Miller and Nickoloff, 1995), had been 
successful in neural tube (Timmer et al., 2001) and of particular interest, can be used in-ovo 
into chick (Muramatsu et al., 1997, Momose et al., 1999). All of these methods are being 
constantly improved, but at the time electro-transfection was deemed to be the most 
suitable and was used as the transfection method during the preparation of this thesis.
Electro-transfection consists of two main stages, the electroporation or 
electropermeabilization stage where the cell's membrane is made porous and the 
electrophoresis stage where the DNA is moved towards the membrane (Figure 5).
Electroporation is achieved by placing an electric field sufficient to cause a potential 
difference of a critical value across the cell. When this critical value Is reached, molecules, 
which under normal conditions would not be able to penetrate the cell's membrane, are 
able to do so. It is not fully understood what events occur within the membrane to facilitate 
this. One theory is that the electrical field increases surface tension thus altering the balance 
of the two opposing forces of surface tension and line tension. As surface tension favours 
pore formation the opposing force of line tension is overcome thus pore formation is
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favoured (Weaver, 1995). An alternative theory suggests that the electric field compresses 
the membrane bilayer, while a further theory is that polar head group of the phospholipids 
is reorganization resulting in a weakening of the hydration layer (Stulen, 1981, Lopez et al., 
1988). Whichever of these theories eventually proves correct the electroporation is 
asymmetrical with greatest effect being on the sides facing the electrodes and being most 
pronounced on the side facing the anode (the positive electrode) (Hibino et al., 1993).
The critical value to allow poration, at a particular point on the cell, is typically between 
200mV-600mV (Teissie and Rols, 1993, Gabriel and Teissie, 1997) and is independent of the 
cell type. The electric field required to achieve this critical value is inversely dependant on 
cells size, bacteria require up to 200 kV/cm whilst large cells only require 200V/cm (Teissie 
and Rols, 1993). Electrically coupled cells such as those in developing chick neural tube 
(Sheridan, 1968) behave electrically as if they were a single large cell thus reducing the 
voltage required for poration.
A further complication is that once the critical field strength has been reached, it is the 
duration and number of electric pulses that determines the extent of poration, increasing 
the field strength only increases the area where the poration occurs (Gabriel and Teissie, 
1997). Too high a field strength will results in irreversible poration or Joule heating, both 
resulting in cell death. A square wave pulse is now more favoured than that with an 
exponential decay as it reduces the amount of time the electric field is applied and thus 
reduces the Joule heating and risk of damage i.e. burning.
Electrotransfection's disadvantages stem mainly from this risk of cell damage and the non­
specific transport, of for example, calcium and sodium into the cell and, for example, 
potassium, out of the cell when the membrane has been permeabilized.
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Figure 5 Electro-transfection process.
(1) Cross section through embryonic torso showing cells of the neural tube and its lumen. At this 
stage plasmid has been injected into neural tube and current pulses applied across the embryo 
from the two electrodes. Plasmid (green dots) are shown attracted by the anode (+) by 
electrophoresis and some of the cells are shown as transfected with plasmid. This coincides with 
image 2C. The direction of the current flow from anode to cathode is indicated with a red arrow 
whilst the electron flow from cathode to anode is shown with a green arrow. (2)Timeline of 
electroporation: (A) Prior to application of electric field the cell is shown as circular with plasma 
membrane, cytoplasm and nucleus marked. Plasmids in the extra-cellular space are shown as green 
circles. The plasma membrane is intact and the cell controls most transport in and out of the cell. 
(B)The neural tube is outlined in grey with two representative cells B' and B" shown. During 
application of electrical field the cells (B' and B") are shown as deformed and pores have opened 
within the cell's plasma membrane on the side nearest the anode (shown as red bar) which is now 
hyperpolarised, and to a lesser extent on the side facing the cathode (shown as black bar), which is 
depolarised. The plasmids have undergone electrophoretic migration towards the anode and so 
away from cell B', and some are in intimate contact with both the intact and permeated parts of the 
membrane of the cell near the anode (B"). (C) Electric field is removed and plasmids at the 
permeated part of the membrane are translocated into the cytoplasm. The plasma membrane has 
started to regain its integrity but the cell is still at risk of non-specific migration of molecules into 
and out of the cell. (D) Several hours later the membrane has further regained its integrity and the 
plasmids have migrated intracellularly and are now present in the nucleus, probably as a result of 
mitotic activity and constitutively active plasmid should express their protein and be detectable 
within a day.(2) adapted frovn(Escoffre et a!., 2009)
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1.8 Long-term Anxiety is debilitating and costly.
Anxiety and fear are familiar traits in humans and animals and in the correct context 
increase survival (Olsson and Phelps, 2007, Marks and Nesse, 1994). However, many people 
in the modern, relatively safe environment, exhibit levels of these emotions that are 
maladaptive and interfere with normal functioning.
These anxiety disorders result in behavioural effects that may by diagnosed as one of the 
well characterised conditions such as panic attack, post traumatic panic disorder, 
generalised anxiety disorder or social phobia (Kessler et al., 2005).
Indeed, anxiety disorders are now considered a collection of a number of associated 
disorders incorporating fearfulness, emotional instability and stress reactivity that include 
general anxiety disorder (GAD), panic disorder, agoraphobia, social phobia, specific phobia, 
obsessive-compulsive disorder (OCD), acute stress disorder and post-traumatic stress 
disorder (PTSD) (American Psychiatric Association, 2000).
The personal cost of these anxiety-related disorders is enormous and so too is the cost to 
the economy due to loss of productivity. In England, the total number of people with anxiety 
disorders was estimated to be 2.28 million in 2007 however only 49% of these are in contact 
with services and only 46% of these receive treatment. The cost of treatment was £1.2 
billion and when loss of earnings, for those under 65, of £7.7 billion is added to this the total 
cost was £8.9 billion (King's Fund et al., 2008). If 95% of the current sufferers were treated 
the treatment cost would rise to £2.1 billion but the loss of earnings should reduce (King's 
Fund et al., 2008). Interestingly, presenteeism from mental illness costs the UK economy 
almost double the cost of absence due to mental illness (Sainsbury Centre for Mental 
Health, 2011). The number of those suffering from anxiety disorder is predicted to increase
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due to demographic changes in age and ethnicity. This will cause the cost of treatment to 
rise to an estimated £2.04 billion and loss of earnings to £12.15 billion in 2026.
Large though these figures are they may be underestimated as they are based on anxiety 
disorders in the community being 5.4% but other surveys showed higher rates, the United 
States National Comorbidity Survey Replication returned an 18.1% rate (Reviewed in 
(Baumeister and Harter, 2007)). Another factor is the age-related rate which increases with 
age, reaching a maximum in the 45-54 age group and then reducing after that. This 
reduction may only be an artifact because other conditions may hide anxiety disorders 
(Alwahhabi, 2003) and a Dutch study found the rate for older people (55-85 years old) to be 
10.2% (Beekman et a!., 1998).
A number of treatment regimens are available, either alone or in combination, including 
Cognitive Behavioural Therapy, Psychotherapy/Counseling and drug therapy. Drug therapy 
can include {3-blockers, benzodiazepines, anxiolytics and antidepressants. All of these have 
greater or lesser side effects ranging from the high potential of addiction to benzodiazepine, 
the less likely heart failure associated with (3-blockers to the annoying dry-mouth that is a 
side effect of most of these medications (Papadakis etal., 2013, Cecil etal., 2004, Longoand 
Harrison, 2012).
Some of these medications are only marginally better or no better than placebos. Two 
Japanese double-blind trials found placebos as effective as Buspirone (Okada et al., 1993) 
although Buspirone is still prescribed for anxiety in the UK (MIMS, 2012).
In England, of the 54% of patients treated, varying rates of success from the different 
treatment regimens have been reported (Table 1) with combined drug and counselling 
treatment being the most effective, however the report did not specify if there was any 
recurrence of the condition.
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Treatment Patients/% Health Improves/%
Medication only 35 54
Psychological 09 46
Therapy only
Combined Treatment 11 72
No treatment 46 26
Table 1 Treatment and success obtained among people with anxiety disorders in contact 
with mental Health services in England. Data from (King's Fund et al., 2008).
Diagnosing anxiety and many other mental illnesses is highly subjective, relying on the 
patient responding to a questionnaire often based on the latest Diagnostic and Statistical 
Manual of Mental Disorders (American Psychiatric Association, 2000) and the interpretation 
and diagnostic skills of the clinician. Given that the patient may be nervous due to the 
clinical setting and may be presenting with comorbidity, either physical (Orhan and Ulu§ahin, 
2001) or mental (Freeman et al., 2002), isolating anxiety as a diagnosis may not be 
straightforward . A genetic or biomarker test would help remove the subjectiveness inherent 
in the current system and so inform the diagnosis and subsequent treatment, thus reducing 
the risk of an inappropriate treatment regimen with its associated iatrogenic risks.
One potential genetic test would be of the expression rate of certain genes that are 
implicated in mood and anxiety.
1.9 We are all different due to Genetic and Genomic variations
The genome of each advanced organism differs due to germ-line and somatic mutations 
and/or polymorphisms. There is no biochemical difference between a mutation and a 
polymorphism; they differ only in frequency of occurrence. A mutation is defined as a
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polymorphism when it affects at least 1% of the population at which stage no single allele is
deemed to be the standard sequence, but instead there are a number of equally acceptable 
variants (Harris, 1969).
Depending on what the variation in DNA is, and where it occurs, defines if there will be any 
phenotypic effect. If the variation occurs in an exonic region it is possible that there will be a 
variation in the protein that is being coded for. When the mutation occurs in a non-coding 
DNA sequence, there will probably not be any effect on any protein sequence; however 
there may be more subtle effects such as rate of protein expression. It is possible that the 
sequence change may produce a synonymous codon and produce no effect whatsoever.
These mutations have been classified into a number of categories that includes; single 
nucleotide polymorphism (SNPs); insertion-deletions( INDEL); variable number of tandem 
repeats (VNTR, minisatellite (Jeffreys et al., 1985, Fondon and Garner, 2004)); Single 
Tandem Repeats (STR,microsatellite (Turnpenny and Ellard, 2005, Turnpenny et al., 2012)); 
copy number variants (CNV (Sebat et al., 2004, Korbel et al., 2007)) and repetitive elements 
e.g. Alu, LINES, SINES (Darling et al., 1982, Schmid and Deininger, 1975, Singer, 1982)
VNTRs are a short sequence of DNA (20-50 nucleotides) that is repeated a variable number 
of times (Jeffreys etal., 1985). These are not uniformly distributed through the genome but 
tend to be concentrated at telomeres and in hypervariable regions. STRs are similar to 
VNTRs but are very short sequence of DNA (2-6 nucleotides) that are also repeated a 
variable number of times (Nakamura, 2009).
CNVs describe the gains and losses of large blocks of DNA sequence (10K - 5000K) and are 
implicated in vulnerability and resistance to disease whereas a SNP defines when a single 
nucleotide is exchanged for another (A,T,C or G) resulting in a DNA sequence that differs 
between members of a biological species or paired chromosomes in an individual.
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Various human-based association studies have shown that there is a link between 
polymorphisms in genes and their control regions that affect, for example, the serotonergic 
system (Inada et al., 2003), the dopaminergic system (Maron et al., 2005), G-protein 
signalling regulation (Koenen et al., 2009) and modulation of monoamine metabolism 
(Domschke et al., 2007).
If a system were available to rapidly screen these control regions a clinical tool could be 
developed. This thesis describes the initial development of this methodology and covers the 
selection of a gene to investigate, identification of putative control regions of that gene and 
the use of chick as a model organism.
1.10 Limbic System Associated Membrane Protein gene {LSAMP) has 
been implicated in Anxiety and Mood Disorders.
Association studies of genetic variations in LSAMP have shown SNPs to be implicated in 
panic disorder (Koido et al., 2006, Maron et al., 2006). A report compared DNA from 288 
male suicide victims and 327 healthy male volunteers conveyed a link to suicide (Must et al., 
2008) appears to be tenuous at best. SIMP (rs7632246 A/C) of the LSAMP gene is related to 
panic disorder (Koido et al., 2006, Maron et al., 2006). LSAMP has also been identified in 
two rodent-based studies as an important regulator of behaviour. In the first of the rodent- 
based studies, wt Wistar rats were classified as anxious, intermediate or non-anxious, 
depending on their exploratory activity in an elevated plus maze (Nelovkov et al., 2003). 
Although Wistar rats are an outbred strain, which should result in genetic variation the 
regimen under which they are allowed to breed can result in differing genetic variation 
between colonies. Following comparison of the gene expression between the anxious and 
non-anxious rats 96 differences were found, but Nelovkov highlighted increased LSAMP 
expression as being the most intriguing. Further work (Catania et al., 2008) demonstrated
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that the genetic deletion of LSAMP in mice causes hyperactivity in novel environments. In 
generating the knock-out mice, one heterozygous LSAMP founder was obtained and back- 
crossed into the C57BL/6J strain for more than 10 generations for all their experiments.
The knockout mice showed a higher exploratory drive than their wt counterparts, which is 
taken to be compatible with lower anxiety levels. These findings indicate that different 
expression levels of LSAMP may be involved in certain mental dysfunctions. Changes in 
LSAMP expression are therefore relevant to anxiety. LSAMP has also been implicated in 
mental health issues such as schizophrenia (Behan et al., 2009), male completed suicide 
(Must et al., 2008), panic disorder (Maron et a!., 2006), and mood and anxiety disorders 
(Koido et al., 2006). Problems resulting from LSAMP's expression are not confined solely to 
affective disorders. Mutations in LSAMP that reduce its expression are implicated in left 
main artery disease. It is purported that the lower levels of LAMP in the arterial wall increase 
the production of smooth muscle cells possibly resulting in worsened atherogenesis (Wang 
et al., 2008).
Given the evidence that LSAMP expression is implicated in anxiety and mood and the 
potential economic savings that would accrue if an effective diagnostic tool could be 
developed, LSAMP was selected as the first gene to be investigated.
1.11 Limbic System Associated Membrane Protein (LAMP) is a 
member of the Immunoglobulin Superfamily (IgSF).
LAMP is a member of the IgLON family of the Immunoglobulin Superfamily (IgSF) (Pimenta et 
al., 1995). Immunoglobulins are probably best known for their role in antibodies of the 
immune system where they can discriminate between auto-generated proteins, foreign,
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unwanted proteins and other antigens. Immunoglobulins are also involved in cellular 
recognition and adhesion processes. This ability to recognise and bind specific 
complementary elements is provided by a domain known as an immunoglobulin domain or 
fold (Bork et alv 1994, Brummendorf and Rathjen, 1995). The immunoglobulin fold consist of 
two anti-parallel arrays of (3-strands that form two (3-pleated sheets. The two sheets are 
joined together by disulphide bonds (Figure 6).
By definition, each member of the hundred-strong immunoglobulin superfamily (IgSF) 
contains at least one Ig-like domain. Members of this superfamily are commonly associated 
with roles in the immune system such as cell surface antigen receptors, antigen presentation 
to lymphocytes and cell adhesion molecules (Table 1). IgCAMs form the largest family of 
calcium-independent cell adhesion molecules in vertebrates and some act as signal 
receptors that transmit information from external sources to the signalling systems within 
the cell (Brummendorf and Rathjen, 1995).
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Antigen receptors
Antibodies
PiGR
TITIN
MHCs
NCAM
ICAMs
VC AM-1
CTX family
Co-receptors
SIGLEC family
T-cell receptors
CD4/CD8/CD19
ig binding Receptors
Antigen Presentation
Receptor Tyrosine 
Kinase/Phosphatase
Cytokine and Growth Factor 
Receptors
Table 2 IgSF functions. Example of the function of the IgSF and some of the members 
associated with those function. Data from (Walmod et al., 2007) (Barclay, 1999) (Rougon 
and Hobert, 2003) (Buck, 1992)
1.12 An IgCAM must contain at least one Ig-like domain.
The Ig-like domains of the IgCAMs range from 70 to 110 a.a. and are typically formed by two 
anti-parallel 3 sheets packed face-to-face. The sheets themselves consist of between 3 and 
5 anti-parallel 3-strands designated A through G. Each strand is 5 to 10 amino acids long 
joined by loops (Williams and Barclay, 1988) of variable lengths (Brummendorf and Rathjen, 
1995). The cysteine residues contained by most Ig-like domains that form the disulphide 
bridge occur on strands B and F, about 55 to 75 amino acids apart (Williams and Barclay, 
1988). The Ig-like sequences had been categorised initially into Cl, C2 and V sets (Williams
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and Barclay, 1988) and later an I set, that differs in the count and length of the (3-sheets and 
length and structure of the loops was described. The V and Cl are Variable and Constant as 
with immunoglobulins, C2 combines characteristics of both, having the smaller loop of the 
Cl-type but some amino acid sequence towards the C-terminal similar to V. The IgSF 
domains of lower organisms are found in the I set (Bateman et al., 1996, Harpaz and 
Chothia, 1994).
Figure 6 Diagram of strand topologies in IgF glycoprotein. One ,P-sheet of Ig type C2-like 
domains contains strands A. B. E. and D, while the opposing sheet contains strands G. F, 
and C. (Adapted from (Williams and Barclay, 1988)).
As previously mentioned IgCAMs must have at least one Ig-like domain; P0 the smallest, 
possess only a single Ig-like domain (Figure 7), but as well as the Ig-like domains IgCAMs can 
also include other protein domains (Figure 7) such as Fibronectin III (Brummendorf and 
Rathjen, 1995). IgCAMs can exhibit heterophilic binding, i.e. bind to non-identical adhesion 
molecules as well as homophilic binding, i.e. bind to identical molecules as themselves 
(Maness and Schachner, 2007). They may have a cytoplasmic transmembrane region, be
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GPl-anchored and so possess no transmembrane region (Maness and Schachner, 2007) or 
lack a GPl-anchor and thus be soluble (Lodge et al.; 2001b). As well as having a binding 
function some IgCAMs can communicate intracellularly. For example some forms of N-CAM 
associate with Src family cytoplasmic tyrosine kinases which relay signals by phosphorylating 
intracellular proteins on tyrosines (Beggs et al., 1997, Paratcha et al., 2003, Maness et al., 
1996). Other Ig family members are transmembrane tyrosine phosphatases that help guide 
growing axons to their targets by dephosphorylating intracellular proteins (Angers-Loustau 
et al., 1999, Sallee et al., 2006, Burridge et al., 2006, Bouyain and Watkins, 2010, Revest et 
al., 1999). IgCAMs LI and NCAM have been shown to act as signalling co-receptors in 
neuronal migration and signalling outgrowth (Schmid and Maness, 2008).
The extracellular portion of some IgCAMs can be cleaved off by 'a member of the disintegrin 
and metalloprotease' family (ADAM) and 'matrix metalloprotease' (MMP) and shed resulting 
in soluble ligands which can interact with receptors. An example of this is given by the 
Junctional Adhesion Molecule C (JAMC) which appears to promote angenesis (Rabquer et al., 
2010). Upon cleavage the intracellular portion can be released into the cytosol and can 
influence cellular functions. When the extracellular portion of LI is cleaved the intracellular 
fragment is released from the membrane by y-secretase and then enters the nucleus and 
influences the transcription of certain genes, for example |33-integrin and cathepsin-B 
(Riedle etal., 2009).
Two members of the IgSF, Sdk-1 and Sdk-2, are expressed by separate sets of neurons that 
subdivide the dendrites into narrow sublaminae in the chicken retina. The cell.adhesion 
molecules are located on synapses and appear to use homophilic binding to direct formation 
of explicit contacts (Yamagata et al., 2002).
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When forming dimers or multimers in cis or in trans it is understood that many IgCAMs 
remain fully extended, however some adopt what is referred to as a 'horseshoe' 
conformation i.e. the Ig-like domains at the N terminus bend over. One example of this is 
neurofascin (Liu et al., 2011) where the outermost Ig-like domains bend over. Another IgSF 
member, consisting of two Ig-like domains and a transmembrane region, that adopts a 
horseshoe formation is the coxsackievirus-adenovirus receptor (CAR). This it appears to do 
when it homophilically interacts in c/s (Patzke et al., 2010), when binding in trans it appears 
to assume a more vertical stance.
The role of the IgCAM, 'Close Homologue of LI' (CHL1) has been found to have the 
additional and unexpected role of being involved in the regulation of the uncoating clathrin 
coated synaptic vesicles (CCSVs). This is achieved by CHL1 associating with the constitutively 
active heat-shock protein Hsc70 and forming a complex with it in the plasma membrane 
(Leshchyns'ka et ai., 2006). As CHL1 gene mutations have been linked to schizophrenia 
(Sakurai et al., 2002, Montag-Sallaz et al., 2003) this opens an interesting new path for 
investigation into IgCAMs and associated disorders.
1.13 LAMP is GPI-anchored to the cell membrane.
The most common membrane linkage of IgCAMs is a type I with a 25 amino acid a-helix 
hydrophobic region that spans the membrane (Beckerle, 2001), however 
glycosylphosphatidylinositol (GPI) anchoring is not uncommon and is found in NCAM-120 
(Leshchyns'ka et al., 2003) contactin,axonin-l and BIG-1 and BIG-2 (Katidou et al., 2008) as 
well as the IgLON sub-family (Funatsu et al., 1999). LAMP is therefore GPI anchored.
1.14 IgCAMs differ in form and function.
IgCAMs consist of individual members and families ranging in decreasing complexity ranging 
from Sidekick which contains many extracellular domains (thirteen F3-homology modules
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and six Ig-like molecules) to P0 which contains only 1 extracellular domain {Figure 7). Neel 
proteins are an alterant name for SynCAM proteins (Biederer, 2006)
The different IgSF isoforms may be generated by alternate splicing of RNA transcript from a 
single gene, resulting in a large number of proteins with differing capabilities. Other 
modifications can also affect the function of the protein, for example the post-translational 
addition of polysialic acid of NCAM increases the range of inter-membrane repulsion 
negating homophilic NCAM and NCAM-mediated cadherin binding (Johnson et al., 2005).
IgCAMs with their wide variety of structures, expression patterns and interactions are ideal 
molecules to provide much of the extensive range of cues, both cell-cell and cell-ECM, 
required for a complex assembly to be formed from the building blocks of individual cells. 
IgCAMs have a role throughout the whole life of a multi-celled organism. During 
development the exquisite control required for neuronal induction, migration, correct target 
location and plasticity is provided by IgCAMs (Walsh and Doherty, 1997).
Due to their widespread expression some IgCAMs probably have a generalised role 
(Brummendorf and Rathjen, 1995) whilst others exhibit a specific expression pattern which 
indicates a tissue-specific role (Schwarz et al., 2009). The specific tissue and development 
stage regulates the type of variants generated by post-translation modification and 
alternative splicing (Walsh and Doherty, 1997, Hassel et al., 1997, Volkmer et al., 2012, 
Shapiro et al., 2007).
IgCAMs interact with other IgCAMs and proteins from other families indicating that they 
take part in a widespread network of control and interaction. Cadherins and IgCAMs are 
often found on the same cells and although cadherins exhibit the stronger binding that is 
required to segregate cells into tissues and maintain the tissue integrity, N-Cam and other 
IgSF may be involved in fine-tuning the adhesion in development. For example cadherin-
31
mediated aggregation (Dahl et al., 1996) and NCAM-mediated segregation (Esni et al., 1999) 
allow for the formation of the islets of Langerhans. It has been shown in rodent that 
inhibition of cadherin function preventing aggregation results in the fatal result of no islet 
formation, whereas the inhibition of N-CAM allows for the formation of islets, albeit 
disorganised. It is hypothesised that non-junctional CAMs initiate cell-cell adhesions which 
are then orientated and stabilised by the organized intracellular junctions ( e.g. 
desmosomes) (Alberts, 2002, Vestweber, 2000).
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Figure 7 Ig-like CAMs in ascending order of complexity starting with those containing one 
Ig-like domain (P0) and continuing on to those containing multiple Ig-like and FibronectinB- 
like domains. The IgLON family is indicated by red arrow and box. Figure 2-1 (Walmod et 
al., 2007)
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Figure 8 Examples of Immunoglobulin-superfamily cell adhesion molecule and their 
domains. Known binding interactions are also shown. Adapted from (Walmod et al., 2007)
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1.15 IgLONs are a subfamily of the IgSF
Superfamily
1.15.1 Introduction to IgLONs
IgLONs, members of the IgSF, are expressed in the nervous system during development and 
maturity (Akeel et al., 2011). During development they are probably involved in 
synaptogenesis, axonal outgrowth and differentiation of neuronal precursor in the brain and 
retina.
The IgLON subfamily consists of four main members (Table 2), LSAMP (Nakajima et al., 1997, 
Hancox et al., 1997, Wilson et al., 1996, Zhukareva and Levitt, 1995, Brummendorf et al., 
1997), OBCAM (Schofield et al., 1989),Neurotrimin (Ntm/CEPU-1) (Struyk et al., 1995) and 
the last member of the family, Kilon (KILON/Ntr) (Funatsu et al., 1999, Marg et al., 1999, 
Schafer et al., 2005). The rLON' in the name comes from the initial letters of the three 
original family members (Pimenta et al., 1995).
Originally it was purported that IgLONs functioned as axonal guidance molecules (Hachisuka 
et al., 2000, Pimenta et al., 1995), however LAMP was also described as facilitating axon 
target recognition during the formation of thalamocortical projections; LAMP repulsed non- 
limbic thalamic and cortical axons whereas, in a stripe assay, the limbic system axons 
preferred the LAMP substrate (Mann et al., 1998). More recently it was suggested that their 
most important role may not be that of axon guidance but that of cell-cell adhesion and 
recognition (McNamee et al., 2002).
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1.15.2 IgLON structure
The IgLON structure typically consists of three Ig-like domains GPI-anchored to the cell's 
membrane (Figure 9) and located to lipid raft domains. However, CEPU-se, an isoform of 
CEPU1 (Lodge et aL, 2001a), lacks the GPI anchoring domain and is therefore soluble. In 
chick, there is also a short version of KILON/Ntr that lacks the third Ig-like domain (Marg et 
aL, 1999). LAMP and Ntm/CEPU-1 both have (3-isoforms containing an insertion between 
the third Ig-like domain and the GPI anchor (Pimenta and Levitt, 2004, Lodge et aL, 2001a).
IgLONs exhibit a high degree of inter-sequence similarity (Table 3) with, for example in 
human, OPCML having 76% similarity with NTM (Goujon et aL, 2010). There is also a high 
degree of inter-species similarity (Table 4) with, for example, an 85.% similarity between 
human and chicken LSAMP DNA, while the LAMP-protein's amino acid sequence shares 
91.1% similarity. When human and chick's NTM is compared the DNA sequence shares 
78.1% similarity and the resulting proteins, Neurotrimin and CEPU-1, are 80.4% similar 
(NCBI-Homologene, 2011). These data compare favourably with the earlier findings that the 
CEPU-1 protein had high similarity with the other IgLONs i.e. 76% with Ntm, 68% with 
OBCAM and 54% with LAMP (Spaltmann and Brummendorf, 1996).
The protein sizes of all the IgLONs in human are very similar with LAMP being 37393 Daltons 
(Da), OBCAM 38008 Da, Neurotrimin 37971 Da and Kilon 38719 Da (Magrane and 
Consortium, 2011) but as these proteins are highly glycosylated their apparent weight 
increases considerably. This difference was demonstrated in GLUT1 where its apparent 
molecular weight reduced to 38,000 Da from 55,000 Da with the loss of glycosylation (Asano 
et aL, 1991). A similar effect of glycosylation on the IgLONs would result in the apparent
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55,000 Da found from the immuno-blots described in earlier literature (Struyk et al., 1995, 
Spaltmann and Brummendorf, 1996, Brummendorf et al., 1997).
Protein Gene
Human Chick Rat/mouse Abbreviation 
used in text of 
thesis t
Mammalian Chicken
homologues
Abbreviation 
used in text of 
thesis t
Name Symbol Synonyms synonym symbol
LSAMP LSAMP LSAMP limbic 
system- 
associated 
membrane 
protein
LSAMP IgLON family 
member 3, 
IGLON3,
LSAMP
chLAMP Lsamp LSAMP
OBCAM OBCAM OBCAM opioid 
binding 
protein/ 
cell adhesion 
molecule-like
OPCML IgLON family 
member 1, 
IGLON1, 
OBCAM,
OPCM
OBCAM Opcml OPCML
Neurotrimin CEPU-1
(Spaltmann and
Brummendorf,
1996)
Ntm/CEPU-1 neurotrimin NTM HNT,
IgLON family 
member 2, 
IGLON2, 
neurotrimin, 
NTRI
CEPU,
CEPU-SE,
HNT
Ntm NTM
Kilon Neurotractin
(Marg et al.,
1999)
KILON/Ntr neuronal 
growth 
regulator 1
NEGRI a kindred of 
IgLON,
IgLON family 
member 4 
IGLON4,
KILON,
MGC46680,
neurotractin
Ntra
NTRA-L,
NTRA-S
Negri NEGRI
Table 3 Symbols and names of the IgLON family of CAMs showing their name in mammals, 
chicken, abbreviations used in thesis, their gene name, symbols and synonyms as 
approved for human by HUGO Gene Nomenclature Committee at the European 
Bioinformatics Institute (HGNC) seal 2011 (Seal et al., 2011); chick synonym. Chicken Gene
Nomenclature Consortium (CGNC) (Burt et al., 2009); rat symbols from Rat Genome 
Database (RGD, 2011, Shimoyama et al., 2011) and mouse data from Mouse Genome 
Database (Eppig et al., 2012)
+ Symbols specific to an organism may appear in tables and material imported.
37
OPCML LSAMP NTM NEGRI
OPCML — 54 76 46
LSAMP — — 55 55
NTM — — — 45
NEGRI — — — —
Table 4 ClustalW comparison of percentage similarities between members of the IgLON 
family in human. OPCML/NTM exhibit the greatest similarity at 76% whilst NTM/NEGR1 
share the least at 45%. (ClustalW using the following accession numbers - LSAMP, 
U41901;OPCML,NM_002545; NTM, NM_016522; NEGRI, NMJL73808 (Goujon et al., 
2010).
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Species symbol %id %id
protein DNA
H.sapiens LSAMP
P.troglodytes LSAMP 99.7 99.7
B.taurus LSAMP 98.3 94.3
M.musculus Lsamp 99.0 94.2
R.norvegicus Lsamp 98.8 94.2
G.gallus LSAMP 91.1 85.1
H.sapiens OPCML
P.troglodytes OPCML 100.0 99.8
B.taurus OPCML 97.7 90.6
M.musculus Opcml 95.5 89.5
R.norvegicus Opcml 98.3 92.7
G.gallus OPCML 85.2 79.5
H.sapiens NTM
P.troglodytes NTM 99.3 99.2
B.taurus NTM 98.5 91.1
M.musculus Ntm 98.1 90.0
R.norvegicus Ntm 97.7 91.0
G.gallus NTM 80.4 78.1
H.sapiens NEGRI
P.troglodytes NEGRI 98.6 98.7
B.taurus NEGRI 97.7 95.9
M.musculus Negri 95.7 88.8
R.norvegicus Negri 96.0 89.9
G.gallus NEGRI 82.6 80.0
Table 5 IgLON inter-species protein and DNA sequence homology. All have been compared 
using Human as the base sequence. Data (NCBI-Homologene, 2011).
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Figure 9 IgLON cell adhesion molecules. Most IgLONs have 3 Ig-like domains, are 
glycosylated, GPI anchored and localised to micro-membrane regions of the cell 
membrane. These micro-membrane regions are enriched with cholesterol and 
sphingolipids and are known as lipid rafts. (A) ctLAMP, OBCAM, aCEPU-1 and the long form 
of NTR(NTR-L) typifies this isoform. However (B) (5 isoforms of LSAMP and CEPU-1 have 
been characterised with an insertion between the GPI anchor and its nearest Ig-like 
domain. (C) A short form of NTR (NTR-S) has been isolated that lacks the third Ig-like 
domain and (D) in chicken, a form of CEPU (CEPU-l-se) lacking the GPI anchor and is 
therefore soluble Lodge 2001. Figure adapted from Mark Howard.
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1.15.3 IgLON expression pattern
OBCAM, in rat, was found mainly in the cerebral cortex and hippocampus but at low levels in 
the cerebellum, spinal cord and medulla oblongata whereas Kilon had a much more 
widespread expression pattern being located on the cerebral cortex, hippocampus, 
cerebellum, olfactory bud and diencephalon (Miyata et al., 2003a). OBCAM is synthesized 
within the somata, attached to vasopressin neurosecretory granules by the GPI anchor, and 
transported to the dendrites (Miyata et al., 2003b).
OBCAM was found as both mRNA and protein in the cat primary visual cortex at various 
postnatal ages. OBCAM expression level was high in young and diminished in older visual 
cortexes. OBCAM was also found in the soma and dendrites of pyramidal neurons in all 
cortical layers of the cats. Immuno-staining showed fewer OBCAM-positive neurons and 
neurites and at a lower staining intensity than younger cats however the OBCAM levels were 
higher in dark-reared cats than in those normally reared, at the same age, thus indicating 
that OBCAM may have a role in visual cortex development and plasticity (Li et al., 2006). 
Miyata's group furthermore showed that OBCAM was also located on cortical astrocytes and 
appears to be involved in control of cell proliferation and cell growth (Sugimoto et al., 2010).
LAMP protein is found on neural surfaces on the somata and proximal dendrites of neurons 
and axons of the brain during early development however this changes during postnatal 
development when in adulthood LAMP is only found on postsynaptic sites of the limbic 
neurons (Horton and Levitt, 1988, Zacco et al., 1990). LAMP, but not CEPU-1, was found in 
most of the migrating crest cells of the anterior region of the neural tube (Kimura et al., 
2001). LAMP is also found in the mid- and hindbrain regions of rat (Reinoso et al., 1996).
In chick total-brain assays short transcripts, shown as gll/gl9 in Figure 14, of LSAMP 
isoforms were found to be expressed equally at all stages from E8 whilst a longer transcript,
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shown as g9 in Figure 14, isoform did not reach full expression until after E10 and became 
the prominent isoform at later stages (Brummendorf et al., 1997).
LAMP is found on the cortical and sub-cortical regions of the limbic-system e.g. amygdala, 
hippocampus, perirhinal and cingulate cortexes and the striatum of both the developing and 
adult brain (Horton and Levitt, 1988, Levitt, 1984, Pimenta et al., 1996, Reinoso et al., 1996).
LAMP has also been located in bone (Kresse et al., 2009), in cardiac smooth muscle cells 
(Wang et al., 2008) and indeed if the data cited in the BioGPS database (Wu et al., 2009) are 
correct LAMP is found in 76 tissues and biological compartments.
1.16 IgLONs bind homo- and heterophilically in trans and also bind 
in c/s.
IgLONs bind both homo- and heterophilically in trans and there is also evidence of a cis 
binding interaction. Binding assays of homophilic FC recombinant IgLON proteins to IgLON 
expressing CHO cells (Figure 10 1A-1F) showed that in trans LSAMP had a higher affinity with 
Ntm/CEPU-1 and OBCAM and had a low homophilic interaction (Reed et al., 2004) although 
LSAMP had previously been shown to bind homophilically in trans (Zhukareva and Levitt, 
1995, Pimenta et al., 1995). Embryonic, limbic system neurons exhibited strong neurite 
outgrowth on LSAMP-expressing CHO cells (Pimenta et al., 1995). It was expected that when 
CEPU-1 and OBCAM were co-expressed on the surface of CHO cells the binding to LSAMP- 
FC recombinant protein would be increased (Figure 10 2A) but, unexpectedly the binding 
force was reduced ( Figure 10 2B) suggesting that Ntm/CEPU-1 and OBCAM were potentially 
binding in cis and in so doing the binding site for LSAMP was no longer exposed (Reed et al., 
2004). This was the first evidence of a dimeric IgLON (DlgLON), formed by cis interaction of 
IgLONs within the plane of the membrane. This finding was later confirmed and expanded
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on (McNamee et al., 2011) who showed that heterodynamic complexes form in the plane of 
the membrane.
The presence of two IgLONs either co-expressed on CHO cells or combined as a recombinant 
protein on an Fc tail, was found to have a functional effect. Outgrowth assays of E 7/8 chick 
forebrain neurons on doubly transfected CHO cells showed that neurite outgrowth initiation 
was inhibited by a substrate of DlgLON:CEPU-l-OBCAM (Figure 10 3A)and also 
DlgLON:CEPU-l-LSAMP (Figure 10 3B). Similarly, E8 neurite outgrowth was inhibited when 
DlgLON:CEPU-l-OBCAM-Fc (Figure 10 3C) recombinant protein was used as a substrate on 
poly-L-lysine base. E6 forebrain neurons, on the other hand, were unresponsive to the 
DiGLONs in the substrate, possibly owing to differences due to the stage of development, 
although analysis of the IgLON population expressed on the neurons appeared to show only 
marginal difference to those at E8 (McNamee et al., 2011).
LAMP has been shown to increase length of axons of LSA/WP-expressing neurons within the 
limbic system (McNamee et al., 2011).
Neurons phosphatidylinositol-specific phospholipase- C-stripped of their IgLONs, and 
collaterally all GPi-anchored proteins, were unresponsive to the DlgLON:CEPU-l-OBCAM-Fc 
recombinant protein suggesting that cell-surface IgLONs are required to respond to the 
signal (Akeel et al., 2011).
As IgLONs are GPl anchored to the cell membrane and therefore having no transmembrane 
component it is not known how they signal to the cell's interior. Because pertussis toxin was 
shown to negate the DlgLON:CEPU-l-OBCAM-Fc-generated inhibition, it is possible that part 
of the signal transduction pathway is facilitated by a G-protein coupled receptor (Akeel et 
al., 2011; Clarke and Moss, 1994,1997). IgLON binding interactions are probably affected by
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the mix of IgLONs expressed. Although homo-dimeric LSAMP-Fc recombinant protein had 
been shown to bind strongly to CEPU1 and to OBCAM expressed on the surface of CHO cells 
the lower than expected binding affinity between DlgLON:CEPU-l-OBCAM and LSAMP-FC 
(Reed et al., 2004) hinted at complexities in how IgLONs might bind as the mix in the 
population of IgLONs changed. For example, increased expression of CEPU-1 could result in a 
scenario where the number OBCAM homo-dimer DlgLONs, with their high trans affinity for 
LSAMP, changes to a population of CEPU-l-OBCAM DlgLONs, with their low irons binding 
affinity resulting in greatly reduced adhesion and increased cell motility. In certain 
circumstances this may be unwanted and contribute to metastasizing of malignant cells.
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Figure 10 IgLON and DlgLON interactions. 1 (A-F) Hierarchy of trans-binding affinities 
exhibited by recombinant homodimers attached to Fc tails. (A,B) LSAMP-Fc binds strongest 
to CEPU1 and OBCAM with binding affinity decreasing in (C) CEPU1-Fc<-»CEPU1 (D) CEPU1- 
Fc<-»OBCAM (E) OBCAM-Fc OBCAM and (F) LSAMP-Fc **LSAMP,
1 (G-J) Binding hierarchy of KILON/Ntr (Long) with (G) Ntm/CEPU-1 (H) LSAMP Binding 
hierarchy of KILON/Ntr (Short) with (I) Ntm/CEPU-1 [S form lower binding force than with 
L form] (J) LSAMP [no binding].
2 It was expected that (2A) LAMP-Fc would have a very high binding affinity with 
DlgLON:CEPU-l-OBCAM the contrary was found to be the case with (2B) LSAMP-Fc having 
very low to no binding affinity with DlgLON:CEPU-l-OBCAM
3 . In neurite outgrowth assays (3A) DlgLON:CEPU-l-OBCAM, (3B) DlgLON:CEPU-1-LSA/WP 
and recombinant protein (3C) CEPU-l-OBCAM-Fc all inhibited neurite outgrowth. (Reed et 
al., 2004) (Akeel et al., 2011)
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1.16.1 IgLON expression pattern and binding in chick
In chick, LAMP expression was found to be already active at HH stage 10 in the anterior-most 
region of the neural tube However at HH stage 14, the expression was limited to most of the 
neural crest cells, the anterior midbrain region and in the notochord. The notochord 
expression was absent at HH stage 25 at which stage expression had moved to the floor 
plate and the lumbar level of motoneuron columns (Figure 11). At the later stages of 
development, expression in motoneuron columns was seen at all levels of the spinal cord, 
but these data were not shown(Kimura et al., 2001)
Figure 11 Localisation of LAMP mRNA in chick embryos.
Whole-mount in situ hybridization (A) lateral view of HH stage 14. Small triangles indicate 
expression in the neural crest. Large triangles indicate expression in the notochord. Arrows 
indicate expression in the anterior midbrain. (B) Transverse section at the lumbar levels of 
chick embryos at HH stage 25. White arrows indicate expression in the floor plate and 
asterisks indicate the expression in motoneuron columns.
(Kimura et al., 2001)
Interestingly, the expression pattern and binding ability differ between some mammalian 
and chick IgLONs. For example, in chick the KILON/Ntr homophilic interaction identified on 
Ntm-expressing CHO cells (Gil et al., 1998) was absent (Marg et al., 1999).
Ntm/CEPUl forms noncovalent homodimers and multimers at the cell surface as evidenced 
by cross-linking studies of transfected CHO cells. Reaggregation of the transfected CHO cells
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and the specific binding of an Ntm/CEPUl-Fc construct to the transfected CHO show that
homophilic adhesion in trans is mediated by Ntm/CEPUl.
Differential adhesion force between the different IgLON isomers' was also described (Marg 
et al., 1999). In trans, the three-lg-domain form of neurotractin (neurotractin -L) bound 
strongly to CEPU-1 (Figure 10 1G) but weakly to LAMP (Figure 10 1H). No homophilic binding 
to neurotractin-L was observed (Figure 10 II). The two-lg-domain form of neurotractin 
(neurotractin-S) bound less strongly to CEPU-1 (Figure 10J) than the Lform while no LAMP 
binding could be detected (Figure 10K).
1.17 Transient adhesion and locomotion
Transient adhesions may be formed by non-junctional contact where the plasma 
membranes run parallel, typically with a 10-20nm gap between them. This non-junctional 
contact may be optimal for cell locomotion - close enough for traction and to allow 
transmembrane proteins to interact but not sufficiently close as to anchor the cell. Transient 
adhesion may also be involved in positioning and orienting the plasma membranes prior to 
the structural junctions being formed.
1.17.1 Can LSAMP bridge the intracellulargap?
A single Ig domain of ICAM-l has been measured at being between 3.3nm and 3.7nm 
(Staunton et al., 1990) whilst NCAM and VCAM-1 are between 3.5nm and 3.7nm (Becker et 
al., 1989, Osborn et al., 1994). Some IgCAMs protrude extracellularly by quite a distance ( 
Figure 7 Figure 8) and it easily imagined how they can physically interact. For example it is 
known that NCAMs bind NCAMs intracellularly. NCAM 140 consists of 4 Ig-like domains and 
2 Fibronectin III domains. The Ig-like domains alone would allow each NCAM 140 to protrude
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14nm from the plane of the membrane allowing two molecules on opposing cell surfaces to 
easily bridge the 10-20nm intercellular gap.
The LAMP protein is shorter than NCAM consisting of only three lg~like domains, however 
this would allow LAMP protrude from the plane of the membrane by about lOnm therefore 
intercellular transient binding of LAMP is theoretically feasible although it is proposed that 
on forebrain neurons at least, IgLONs interact with an, as yet unidentified, IgLON-containing 
receptor complex (Akeel et al., 2011) as it was shown that DlgLONs inhibit the initiation of 
neurite outgrowth from forebrain neurons. Because the CAMs involved in this transient 
adhesion do not necessarily require firm anchorage or transmembrane signalling regions 
they may be one of, or act like, the non-classic cadherins, such as the truncated, GPI- 
anchored T-cadherin (Ranschtand Dours-Zimmermann, 1991). GPI-anchored surface 
proteins having no cytoplasmic tail have no direct intracellular communication mechanism 
nor are they connected to the cytoskeleton although, in a poorly understood way, T- 
cadherin, for example, facilitates calcium dependent homophilic binding in vitro (Vestal and 
Ranscht, 1992). Another signalling mechanism for CAMs lacking a transmembrane moiety 
that has been suggested is that the stress and change in shape of the cell due to adhesion 
may act as a signal (Basson, 2008). GPI-anchoring results in a weak junction that probably 
relies on the Velcro principal of many weak adhesions providing a large overall result 
(Alberts et al., 2008). This weak anchoring could also be provided by certain members of the 
immunoglobulin-like-domain-containing cell adhesion molecules (IgCAMs) family.
1.17.2 Synaptic Formation is highly active during development and 
continues at a lower rate throughout life.
Synaptogenesis describes the formation of synapses. Synapses allow, typically, a chemical 
signal to be passed from a neuron, via its axon, to its target. Synaptogenesis is particularly
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active during neural system development and continues at a lower rate throughout life. The 
current model of synaptogenesis envisages three phases; attraction, contact and 
stabilization. Attraction of the axon to the general target area is facilitated by the repulsive 
and attractive substrate- and target-derived cues (Tessier-Lavigne and Goodman, 1996). 
Upon arrival in the target area more precise steering of the axon to its target may be 
required (Kalinovsky et al., 2011) eventually leading to initial contact between the axon and 
its specific target. This initial contact is typically made by filopodia that extend from both the 
axons and dendrites (Ziv and Smith, 1996, Jontes and Smith, 2000). Finally, via pre- and post- 
synaptic signalling, the desirable connections are identified and stabilized whilst the 
undesirable ones will fail to develop (Goodman and Shatz, 1993, Katz and Shatz, 1996).
Some IgSF proteins have been implicated in synaptic formation and interactions. NCAM 
functions as a homophilic CAM and, for example, is found on surface membranes of the 
mossy fiber terminals where they contact the apical dendrites of pyramidal neurons, and is 
also found, in rat, at both the pre- and post-synaptic membranes of some spine synapses in 
the dentate gyrus (Schuster et al., 2001). SynCAM overexpression has been implicated in 
either increasing the number of synaptic terminals or enhancing pre-synaptic 
neurotransmitter release (Biederer et al., 2002).
IgLONs are also involved in synaptogenesis; a single and double overexpression analyses 
indicated that IgLONs are involved in the regulation of synapse formation in hippocampal 
neurons. The single overexpression of LAMP or OBCAM increased dendritic numbers 
whereas that of CEPU/Kilon reduced dendritic numbers and Ntm was neutral in effect. 
Interestingly, neither the double overexpression of LAMP nor OBCAM had any effect on 
dendritic formation. When neurons overexpressed Kilon-Neurotrimin, LAMP-Neurotrimin, 
OBCAM-Neurotrimin and OBCAM-Kilon a significant reduction in dendritic growth was 
observed. The difference in the observed results from the homophilic and heterophilic
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overexpression indicates that it is possible that homophilic and heterophilic c/s-interactions 
on the post-synaptic site interact with pre-synaptic IgLONs to modify synapse formation 
{Hashimoto et al., 2009). In mouse hippocampal neurons OBCAM was found to be localised 
to post-synaptic dendritic spines, with a reduction and increase in synapses on dendrites 
matching the inhibition and overexpression of OBCAM (Yamada et al., 2007). This indicates 
that OBCAM is a synaptic CAM involved in synaptogenesis.
1.18 IgLONs may have a role as tumour supressing genes.
IgLONs may act as antioncogenes since loss or reduction of LSAMP expression correlates 
with renal clear cell carcinomas (Chen et al., 2003). A reduction of OPCML expression was 
found in epithelial ovarian cancer (Sellar et al., 2003) and also in gliomas and other brain 
tumours (Reed et al., 2007). In epithelial ovarian cancer, reduced expression of OPCML, 
LSAMP, and NEGRI, was found in the majority of tumours, but, conversely, h/VT expression 
was increased (Ntougkos et al., 2005). CEPUl/NTM appears to have a role in mediating 
oestrogen-induced sympathetic pruning in some peripheral targets (Krizsan-Agbas et al., 
2008).
1.19 LSAMP is a large and complex gene.
The LSAMP gene, in chick, has three isoforms and, depending on the isoform, consists of 
seven or eight exons (Table 5). It has two exons 1, named exons la and lb, containing the 
distal and proximal transcription start sites (TSSs) respectively from which the 3 transcripts 
are generated, a long form of 970 kbp and two shorter ones of ~286 kbp (Figure 14). These 
transcripts each code for a separate protein isoform, the long transcript codes for the g9 
isoform and the short transcript codes for the gll and gl9 isoforms (Figure 13, Figure 
14Figure 14). The LAMP protein isoforms (gll/gl9 in chick) coded for by the short
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transcripts differ in that gll has an amino acid insertions towards the 3' end consisting of 23 
amino acids (human, rat, mouse (Pimenta and Levitt, 2004)) and in chick, 12 amino acids 
(Figure 13). The function of this insertion is unknown but it hypothesised that extra 
flexibility and length conferred on the protein would be an advantage for molecular 
interactions (Brummendorf et al., 1997). Although Brummendorf calculated that the g9 and 
gll would start and end at the same location this is not supported by the Ensembl entries 
(Figure 14) which shows different start and end locations for all three isoforms.
The LSAMP gene in human extends for greater than 2.1 Mbp and consists of 10 exons (Figure 
12 and Figure 16). Like chick, the human form also has two exons 1 (Exon la and Exon lb), 
containing alternative TSSs, that are separated by > 1,5 Mbp which contributes greatly to the 
large size. Three transcripts are generated by the gene, one from Exon la and two beginning 
at Exon lb.
Surprisingly the long form of the human LSAMP gene is not documented in the nucleotide 
databases but was identified by cross species comparison using the Ensembl (Flicek et al., 
2011) chick transcript ENSGALT00000024337 (Figure 15). This long extent spans 2.1 Mbp in 
human (970 kbp in chick).
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Figure 12 Comparison of the intron-exon structures between LSAMP orthologs in mouse 
and human. Genomic diagram of the LSAMP gene in (A) mouse (B) human (C) Rat 
(Pimenta and Levitt, 2004) and (D) Chicken ( author's diagram, data taken from Ensembl 
(Flicek et al., 2011). The black oblongs indicate exons and the thin lines represent the 
introns with their genomic extent indicated below them, those in (D) may not be to same 
scale as A,B or C. The distances been exons are in kbp. The exons containing the upstream, 
distal TSS ( marked D-TSS) and proximal TSS (marked P-TSS) are shown. The TSSs are 
arrowed in (A) mouse and indicated with ATG. The site where the distal TSS is spliced into 
the proximal TSS is indicated by *.
g9 g11 g19
Figure 13 Domain models of chicken ISAMP-\sofarms. g9 is the isoform with the longest 
genomic extent whilst gll and gl9 share the same TSS. Key: Immunoglobulin-related 
domains are drawn as loops which are closed by disulphide bridges. Putative N-linked 
glycosylation sites are shown as lines ending with triangles and the GPI-anchor is marked 
by an arrow. The alternatively spliced signal peptides are represented by different boxes 
and the internal alternatively spliced 12 amino acid segment is indicated by a hatched 
ellipse. (Brummendorf et al., 1997)
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1.19.1 LSAMP's Genomic neighbourhood - an overview.
Although in human, LSAMP is on chromosome 1 and in chick it is on chromosome 3 there are 
similarities in the genomic vicinity. In both cases LSAMP is flanked by the same genes although they 
have different names depending on the species and the database ( Figure 15 and Figure 16). The 
nearest protein-coding characterised genes are Immunoglobulin Superfamily Member 11 (IGSF11) 
and Growth-associated protein 43 (GAP43). It is interesting to note that these three genes are 
related by family and/or function. LAMP, as has been discussed, is a member of the immunoglobulin 
-superfamily (IgSF) and is a cell adhesion molecule, IGSF11 is also a member of this family and 
functions as a cell adhesion molecule that through homophilic interaction stimulates cell growth 
(Harada et al., 2005). Neuromodulin, the protein encoded for by GAP43, is expressed at high levels in 
neuronal growth cones during development and axonal regeneration (Schleinitz et al., 2008). These 
similarities might indicate that that these genes may have originated from mutations to a common 
ancestral gene. There is however little similarity between the resulting peptide sequences coded for 
by the three genes (Table 6). It is also feasible that these genes may form part of an expression 
cluster whereby energy efficiency is achieved by the co-localisation of genes that are concurrently 
expressed. Although there may be an energy advantage a recent study has shown that if a cluster is 
perturbed transcription rates do not appear to be affected (Britton et al., 2011).
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Figure 15 ECR Browser (Ovcharenko et al., 2004) (using Ensembi nomenclature) compared using 
chick as base organism and human as target organism showing long form of LSAMP 
(ENSGALT00000024337), with its TSS identified by "Distal LSAMP", and the two shorter forms 
marked as LSAMP Short and indicated with Their TSS is marked "Proximal LSAMP TSS". The 
nearest characterised genes IGSF11 and GAP43 are also indicated.
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Figure 16 Genomic region surrounding LSAMP in human. ECR Browser output with human as base 
(reversed orientation to match chick) and chicken as target (Stringency 100bp/70% similarity) with 
the region downstream of LSAMP to its nearest neighbouring gene, IGSF11. One of the short 
human transcripts of LSAMP (RefSeq) is shown in blue; the second short transcript was not 
included in the human REFSEQ database but is similar in length and position to the annotated, 
short version. The long human transcript is shown in green and is manually inserted.
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IGSF11_
IsoB
(431aa)
IGSF11_
IsoA
(430aa)
Neuromoduli
njsol
(274aa)
Neuromod
ulin_lso2
(238aa)
LSAMP_3
38aa
(338aa)
LSAMP_3
45aa
(345aa)
LSAMPJL
05aa
(205aa)
IGSFllJsoB
96 6 6 15 14 16
IGSFllJsoA 6 6 15 13 16
Neuromodul
injsol 95 6 6 3
Neuromodul
in lso2 7 7 3
LSAMP_33Sa
a 94 71
LSAMP_345a
a 71
Table 7 Comparison of LSAMP, IGSF11 and Neuromodulin using ClustalW (Larkin et al., 2007). 
Little correlation was found between the different proteins although the different isoforms of the 
same proteins naturally did show high similarity.
Isoforms A and B of IGSF11 (NP_689751.2 ,NP_001015887.1),
Isoforms 1 and 2 of Neuromodulin/GAP43 (NP_001123536.1, NP_002036.1) NCBI protein 
sequences and LSAMP (NP_002329.2 (NCBI) or ENSP00000328455 (Ensembl) at 338 a.a. and also 
Ensembl sequences LSAMP ENSP00000419000 (345 a.a). ENSP00000418506 (205 a.a.).
KEY: SeqA/SeqB indicate the target and object respectively during the comparison process, length 
is the amino acid length of the protein sequence and the score indicates similarity, a higher score 
indicates greater similarity.
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1.19.2 LSAMP is inserted in human in the opposite direction to that in
chick
Over the course of evolution a chromosomal inversion of the region containing LSAMP appears to 
have occurred in various species. This has resulted in LSAMP being inserted in, for example, rat and 
human in reverse orientation (qter to pter) as is IGSF11, whereas GAP43 is inserted in the forward 
orientation (pter to qter). All these genes are in the forward orientation in mouse and chick.
1.19.3 Small and pseudo genes are also present in LSAMP's genomic 
neighbourhood.
There are other smaller genes and/or pseudo genes also in this genomic region. Two of these are in 
the intronic region within the iSAA/JP transcription unit and reside between the two TSSs. These 
genes are the non-protein-coding RNA gene, LOC285194 (forward orientation) and the pseudogene 
BZW1L1 (reverse orientation).
Human gene LSAMP-AS1 ( aka LSAMP-AS3, Ensembl gene ENSG00000243197, Entrez Gene: 285194) 
on the positive strand, produces six non-coding RNA transcripts, LSAMP-AS3-001 through LSAMP- 
AS3-006 (Figure 17). The short form of human-lSA/WP is located from 117,011,832-117,647,068, in 
reverse orientation on chromosome 3, the LSAMP-AS-OOx. pseudo genes are located downstream 
from LSAMP at 116,428,626-116,442,428, with GAP43 being inserted between the active and 
pseudo genes.
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1.19.4 The density of known genes varies between chromosomes
Some chromosomes such as the human chromosome 19 are gene rich (~25 genes/Mbp) 
whilst others such as human chromosomes 4 or 18 (~4 genes/Mbp) are more sparsely 
populated. Typically the genes on gene-dense chromosomes are smaller than those on the 
less dense chromosomes. The median size for genes on human chromosome 19 are ~12 kbp 
whilst on chromosome 4 they are ~38kpbs and chromosome 18 the median gene size is in 
the order of 50 kbp. For example, in human, the Hb9 gene is located on chromosome 7 and 
LSAMP is located on chromosome 3, both chromosomes have similar gene densities. 
Chromosome 7 is slightly more gene-dense at 6.96 genes/Mbp to chromosome 3's 6.08 
genes/Mbp (Treit et al., 2010). This, albeit only slightly lower gene-density, could allow for 
more control regions overall in the gene.
Although enhancers may be upstream, downstream, or intronic and are not confined to the 
immediate location of the gene, and don't even have to be on the same chromosome 
(Bateman et al., 2012, Spilianakis et al., 2005) many are found upstream of the gene they 
control (Mendelson and Quinn, 1993, Nakano et al., 2005, Iyer et al., 2010). However this is 
further complicated in LSAMP because of the large region between the two TSSs allowing for 
the possibility of ECRs associated with many other genes to be located there. The 
chromosomal inversion also has the potential to complicate matters further because if some 
enhancers moved with the inversion and others did not, enhancers that were adjacent at 
one point may now be several Mbp away.
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1.19.5 Known enhancers in the human LSAMPgenomic 
neighbourhood.
A DNA sequence, hs253, identified by the VISTA enhancer browser (Visel et ah, 2007)has 
been found to be an enhancer. This region is located in an intragenic locus of the human 
gene ZBZTB20 and is 907122 bp 5' (GRCh37.p2 NCBI reference assembly) to GAP43 
(neuromodulin isoform 2) and was found to drive expression in the somite region of 
embryonic day 11.5 mouse embryos. Two other sequences in the same genomic region 
were not found to drive expression at this stage of development.
1.20 Aim of the project
The aim of the project was to initiate the development a chick-based model to enable rapid 
identification of the enhancers of gene expression. The LSAMP gene was selected as the first 
gene to be investigated due to continuing interest within our laboratory of the family to 
which LSAMP belongs, and because of recent findings that indicate a possible link with 
anxiety and other affective disorders.
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CHAPTER 2.
62
2 Materials and Methods
The protocols used in the molecular biology described in this thesis, for general work were 
from the Cold Spring Harbor manual (Sambrook et al., 1989) and online (2006) or were as 
supplied by the manufacturers with their kits.
Reagents used are detailed in Table 20 and equipment used is in Table 21 and solution 
recipes are in Table 22 in the Appendix. Methods that differ from the generic description 
here are detailed in the relevant chapters.
2.1 Reporter plasmids:
2.1.1 pCRII
The pCRII vector, supplied by Invitrogen as part of its TA Cloning kit, is used for the direct 
cloning of Taq-amplified PCR fragments. Commonly used Sp6 and T7 promoter regions are 
included to facilitate sequencing. The multiple cloning sequences (MCS) contains restriction 
sites some of which bracket the TA cloning site and other restriction sites that are unique 
and permit directional insertion in downstream applications. Blue/white screening is also 
supported due to the inclusion of the LacZ gene. pCRII contains ampicillin and kanamycin 
resistant genes to allow for selection in suitable medium.
63
tecZaATG
Ml3 Reverse Primer
CAG GAA ACA GCT ATG Acjc ATG 
GTC CTT TGT CGA TAC TGG TAG
Sp6 Promoter
ATT ACG CCA AGC T ^T TTA GGT GAC ACT ATA GAA 
TAA TGC GGT TCG ATA AAT CCA CTG TGA TAT CTT
Nai\ Hind III Kpn I Sac I BsmH I Spe Iii 1 i i r
TAC TCA AGC TAT GCA TCA AGC TTG GTA CCG AGC TCG GAT CCA CTA GTA ACG GCC 
ATG AGT TCG ATA CGT AGT TCG AAC CAT GGC TCG AGC CTA GGT GAT CAT TGC CGG
BsfX I EcoR II I
GCC AGT GTG CTG GAA TTC GCC 
CGG TCA CAC GAC CTT AAG CGG
HAG GGC GAA TTC TGC AGA TAT 
TTC CCG CTT AAG ACG TCT ATA
BatK I Not I Xbo I
I I I
CCA TCA CAC TGG CGG CCG CTC 
GGT AGT GTG ACC GCC GGC GAG
Nsi\ Xba I Apa I
i i i
GAG CAT GCA TCT AGA GGG CCC AAT TCG 
CTC GTA CGT AGA TCT CCC GGG TTA AGC
CCC TAT 
GGG ATA
T7 Promoter Ml3 (-20) Forward Primer
CTG GCC GTC GTT TTA CAA CGT CGT GAC TGG GAA AAC 
GAC CGG CAG CAA AAT <3 TT GCA GCA CTG ACC CTT TTGTCA CTC AGC ATA ATG TTA AGT
n pCFHI-TOPO 
a 4.0 kb
Figure 18 Map of cloning vector pCRII (Courtesy of Invitrogen)
2.1.2 pl229
The pl229 reporter vector allows for testing of enhancer functionality (Yee and Rigby, 1993). 
pl229 was obtained as a gift from Dr. Alasdair Mackenzie (University of Aberdeen) and is a 
modified version of pBLUESCRIPT, with the entire LacZ ORF/cDNA under the control of a 
human pglobin minimal promoter inserted into the polylinker area.
This vector requires that an enhancer sequence is cloned upstream of the promoter, for 
which purpose an MCS is provided. When transcription factors bind the cloned enhancer 
sequence the human Pglobin minimal promoter is activated and the LacZ gene is 
transcribed. This results in the expression of (J-Gal by the cell. The P-Gal is later visualised by 
staining.
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Sadi - 664 - CC GCGG
Not\ - 670 - GCGGCC GC 
. Eag\ - 670 - CGGCXI!_G 
- A7>al - 677 - TTTAG A 
^ Spe\ - 683 - A'CTAG_T
Figure 19 Map of pl229. The location of the Ampicillin resistance gene (AmpR) and 
minimal human P-globin Promoter (hpglobin), LacZ gene and SV40 (PolyA generation) 
insertion into the pBluescript backbone. The T7 sequencing promoter is shown marked 
with a red line and the T3 sequencing promoter with a green line. DNA sequence supplied 
by Alasdair Mackenzie. The RE sites at the MCS that cut only once in the whole sequence 
are shown. For this thesis the Evolutionary Conserved Regions (ECRs) were inserted 
between Notl (+670 bp) and Spel (+683 bp). Arrows indicate ORFs. Map generated using 
pDRAW32 (pDRAW32 by AcaClone Software) from sequence supplied by Alasdair 
Mackenzie.
2.2 GFP Plasmid
In order to demonstrate that transfection had occurred and to locate this site a 
constitutively active GFP-expressing vector was co-injected with the pl229-based vector.
The plasmid used was an IRES-containing GFP-expressing reporter plasmid 
pCaPlinkmigiresEGFPmSCIal - a gift from Jon Gilthorpe (Department of Developmental 
Neurobiology, King's College London). A P-actin promoter upstream of the internal ribosome 
entry site (IRES) under influence of the cytomegalovirus enhancer resulting in 
constitutive expression by the plasmid resulting in high levels of expression of the, 
downstream, enhanced green fluorescent protein (eGFP) gene (Yaneza et al., 2002). The GFP
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signal was visualised by illumination via a band-pass filter centred at 488 nm using a 
fluorescent-capable microscope.
2.3 Molecular Biology Protocols
2.3.1 Construction ofpl229 Reporter Vector Construct
The transgenic reporter vector was constructed by PCR-amplification of a putative enhancer 
sequence and subsequently introducing it into the pl229 plasmid. This had been previously 
opened at the Notl/Spel sites in its MCS. Following cloning and population expansion the 
transgenic pl229-based plasmids were extracted (Figure 20). Chick embryos were co­
injected and transfected with the transgenic vector and also with the constitutively active 
IRES-GFP.The IRES-GFP was used as a marker of the injection site and a gauge of the efficacy 
of the transfection. Following incubation the embryos were stained to visualise the |3-Gai 
expression.
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Figure 20 Amplification and Insertion of ECR into pl229. (A) PCR Expansion of ECR 
sequence from whole-chick genomic DNA. It is assumed that a single, B'-adenine overhang 
will have been added to each end of the PCR product. (1) pCRII is supplied in the TA 
cloning kit, linearized and with a T overhang (2) The ECR fragment is cloned into the pCRII 
plasmid. (3) Competent bacteria (DHSct or TOP10F') are transformed with the pCRIkECR 
plasmid construct and the population of bacteria expanded. (4) Using a plasmid-prep kit, 
the bacteria are lysed and plasmids are harvested. (5) pCRIkECR plasmid construct is 
digested with Notl and Spel to release ECR, now with Notl and Spel sticky ends. (6) pl229 
plasmid is opened at Notl and Spel restriction sites and (7) pl229:ECR construct is formed 
by ligation. (8) Competent bacteria are transformed, population expanded and bacteria 
lysed to release the pl229:ECR construct.
2.4 Identifying putative enhancer sequences
2.4.1 ECRBrowser
An ECR is a region of non-coding DNA sequence that has been conserved across species over 
evolutionary time. The ECR Browser (Ovcharenko et al., 2004) gives a graphical 
representation of the regions conserved between the base species and target species. The 
region defined as being conserved is subject to the parameters of the length and percentage
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similarity of the sequences. The ECR Browser's default is that a sequence with a length of > 
lOObp and at least 70% identity between the sequences will be flagged as being an ECR. 
These criteria may be altered by the user.
Thirteen species are included in the database any of which may be selected as the 'base' 
against which one or all of the other organisms can be aligned and the conserved regions 
identified.
The ECR Browser key (Figure 21) is the example given on the website 
(http://ecrbrowser.decode.org/ ) to illustrate the features of the latest version of the ECR 
Browser's graphical representation by using the conservation between human and mouse of 
the SRPRB gene as an example.
Yellow:
UTR*coding exons
I ISRPRB
Salmon: I
intronic regions |j
Red: I
intergenic regions |
0 +
S'
+
Figure 21 Screenshot from the ECR Browser site showing the key to the graphical 
representation. ECRs are shown as a pink track encompassing both coding and non-coding 
genomic regions. The coding exons (blue), intronic regions (salmon) intergenic regions 
(red), transposons and simple repeats (green) and untranslated regions - UTRs (yellow) 
are shown as coloured peaks on a graph; the x-axis represents positions in the base 
genome and the y-axis represents percentage identity between the base and target 
genomes.
The ECR Browser was used as follows:
The base organism was selected (e.g. mouse) and the gene name or genomic location was
inserted in the location field. The request was submitted.
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The list of available species was returned by the ECR Browser and the required species 
was/were selected (e.g. chick). The stringency of the selection was redefined as required to 
produce a well-defined region identified as being an ECR and the request submitted. In this 
case the default value of length 100bp/70% identity was retained (Figure 22). The sequence 
length and location represented on the screen was adjusted as appropriate using the zoom 
and horizontal scroll functions. Placing the cursor on the ECR line (arrowed) linked to the 
ECR sequence of both the base (mouse) and target (chick) organisms. This function also gives 
the option to extend the sequence lOObp each side of the ECR, this is convenient when 
designing primers. The sequence (Figure 23) was copied and used to design the primers.
ECR ECR L»ft* Cecronat
PatmMxv Cucft Moon tmtfmtr twipt trtMffl
IQinwl imoor 100 TO <4 fMMh*
|ch*29«n99»-»81S2S2
! **gn rout t»ov«v» K> < p»oom«
R*OnC«n4n_____ 4 ^
*00%
TTOI- - - - - - - - - - '- - - - - - - - - - - - - - - - - - - - - - - - - - 4
Figure 22 ECR Browser output showing cross-species homology with Mouse as the base 
organism and target organisms in order of similarity, rat, human, frog, chicken and puffer- 
fish. ECR indicated by green arrow. Stringency at default (100bp/70%).
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Identities = 266/336 (79%), Gaps = 15/336 (4%) 
Strand=Plus/Plus
Query 12 TACACTGCGACATTCTGTAAATGAGATAATGATACATAAACCCGA-TGATCGATGTGACG
Mill lllllllllllll 11111111111111111111II1 MM 11II1111
TACACCGCGACATTCTGTACATGAGATAATGATACATAAACCCCCCTGATAGATGTGACA
70
Sbjct 12 71
Query 71 GGCCTGG-ATGTCTTCTCTAAATTAGCTGCTCACATCGACTGCTAATATTGT-GAGTTTA 
II II III II 1 1 1 1 1 1 III II 1 1 1 1 1 1 1 1 1 1 II III II 1 1 1 1 1 1
128
Sbj ct 72
M II III II 1 1 1 1 1 1 III II 1 1 1 1 1 1 1 1 1 1 1 1 III II 1 1 1 1 1 1
CCCCCGGGATGGCT-----CTAAATGAGCCGCCCGCATCGACTGCTGATAATGGCGCGTTTA 128
Query 129 TGAAAGCAATTTCGGTGCAATCGGCGAGAGGGTCTTCTTACfBHHIH^HHH 188
Sbj ct 129
MMMMMMMMM 1 1 Ml 1111111 II 1 1111111 MM II
TGAAAGCAATTTCGGTGCGAGCAGCGC - AGGGTCTGCTCGG^^^^^|HHI^Hl 187
Query 189 247
Sbj ct 188 241
Query 248 307
. ' ; . 1 ;, . ' II 1 II 1 1
Sbj ct 242 301
Query 308 TCAAAGCTGTATTTGTTCAATAG-AAGCAACAAGTC 342
II11111 1 Mill Ml 1 II 1111111II
TCAAAGCCGGATTTGCTCAGGGGAAATCAACAAGTC 337Sbj ct 302
Figure 23 Details from the ECR Browser grab function (base organism, mouse; target 
organism, chick) of the Hb9 ECR showing the mouse and chick ECR sequences. The mouse 
125bp sequence and the equivalent chick 120bp sequence highlighted. Aligned using 
BLASTN (Altschul et al., 1990)
2.5 Primer Design and synthesis
Suitable primer sequences were generated using Primer3 (Rozen and Skaletsky, 2000) 
(release 1.0b) using default settings with the putative-enhancer sequences marked as source 
sequence with square brackets, thereby forcing the primers to flank the core sequence.
The primers were synthesized (Sigma-Aldrich) and the region was amplified by either 
standard or gradient PCR using Taq polymerase with 2.5ng/pl whole chick genomic DNA as 
the template.
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2.6 PCR
Taq polymerase from different manufacturers was used; this depended on availability, being 
mainly supplied by Invitrogen and New England Laboratories. The mix for the PCR reaction 
was as per the manufacturer's instructions and consisted of the template DNA ( e.g. the 
whole chick genomic DNA (Merck-Novagen cat: 69233-3) or plasmid with insert), the 
forward and reverse primers, Taq polymerase, dNTPs PCR buffer, MgCI2, and nuclease-free 
water. An adjunct of DMSO 5% v/v or BSA at O.lug/lul was occasionally used in an attempt 
to improve the product yield.
Two PCR thermal cyclers were used, HYBAID, PCR SprintOOl and a gradient PCR system (MJ 
Research PTC-200 DNA Engine)
The programs used in the two systems are as detailed below (Table 8 Table 9) and typically 
25|il or 50pl volume was used in each PCR reaction.
Components ]pl Final concentration
10X PCR buffer minus Mg 5 IX
10 mM dNTP mixture 1 0.2 mM
50 mM MgCI2 1.5 1.5mM
Primer mix (10 pM each) 2.5 0.5 pM (each)
Template DNA 1-101
Taq DNA Polymerase or 0.25 1.25 units2
Platinum® Taq (5 U/pl)
Autoclaved distilled water to 50ul
Table 8 Standard PCR mix (Adapted from Invitrogen Part no. 18067017.pps Rev. date: 2 Jan 
2007)
Notes: 1 Whole chick gDNA used at 2ng/|il
2 When amplifying from whole-chick genomic DNA 2U taq/SOpI reaction used.
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Step Repeat Action Mins °C
1 Activate Taq 2 94
2 30 Denature DNA 1 94
Anneal primer
(Ta. typically 2°C below TM)
1 50-70
Extend DNA 1 72
3 Final incubation 10 72
4 Hold Infinity 4
Table 9 Standard PCR - Program 1/Step
Step Repeat Action Time °C
1 Activate Taq 10m 95
2 35 Denature DNA 20s 94
Anneal primer 30s 50 - 70
Extend DNA 40s 72
3 Final incubation 10m 72
4 Hold Indefinite 4
Table 10 Gradient PCR - Program AAA
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2.7 PCR Amplification of DNA.
2.7.1 Ligation of DNA strands into plasmid
Toq DNA polymerase has a terminal transferase activity that adds an adenylate nucleotide to 
the 3' end of the PCR product. The TOPO cloning vectors (Invitrogen) possess a 3' 
deoxythymidine overhanging nucleotide and topoisomerase which allows PCR products to 
be ligated efficiently into the vector.
In brief, using Invitrogen's TOPO® TA cloning kit (cat #46-0800) and following the 
manufacturer's instructions (25-0185-G-08-2701) 2 pi PCR reaction product, 1 pi salt 
solution, 2 pi ultra-pure water and Ipl TOPO cloning vector (pCRII) were mixed and 
incubated at room temperature for 20 minutes. This produced the pCRIkECR transgenic 
construct which were then used to transform E coli bacteria and the population was 
expanded.
2.7.2 Transformation and selection of colonies
Briefly, a vial of competent cells at -80°C was placed on ice for 5 minutes at which stage the 
cells were gently mixed. 2ul of the mixture from the previous ligation step, containing the 
ligated plasmid, was added to the vial of competent bacteria and the manufacturer's 
protocol was followed. Specifically, incubation on ice was allowed to progress for 30 minutes 
prior to heat-shock for 30 seconds at 42°C. Following the addition of 250ul of $OC medium 
at room temperature, incubation was allowed to proceed for 1 hour in a shaking incubator 
@ 37°C/ 250 bpm. Controls without plasmid were performed to test the efficacy of the 
antibiotic and to test for the presence of an antibiotic-resistant DNA strain.
Using a flamed, glass spreader lOpI and lOOpI of cells were spread onto LB agar plates 
doped with ampicillin at 50 pg/ml (Table 22 Appendix). The inverted plates were incubated
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overnight, in normal atmosphere, at 37°C to establish suitable colonies of bacteria- 
containing plasmichECR constructs.
2.73 Selecting and expanding colonies 
Colonies were selected by STET prep but more typically by PCR-screening of a smear from an 
individual colony and using the original primers that had been used to amplify the DNA from 
the genomic DNA. The PCR protocol previously described was followed, except that the 
smear replaced the l-10pl of DNA template. The resulting PCR output was checked for 
molecular weight by agarose gel electrophoresis.
2.8 STET prep (Sucrose, TRIS, EDTA, Triton) or Boiling Lysis Plasmid 
Extraction.
STET preps were also performed on occasion to establish the presence of plasmid. All steps 
performed at room temperature, unless stated otherwise.
1 ml of the overnight culture was pelleted by centrifugation for 1 minute at top speed and 
the ensuing supernatant was discarded.
The bacterial cell pellet was re-suspended in 350 pi STET buffer (8% w/v sucrose, 5% v/v 
Triton X-100, 50mM EDTA, pH 8.0, 50mM Tris-HCI, pH 8.0). 25ul 1 mg/ml lysozyme was 
added and mixed by vortexing. Following five minutes of incubation at room temperature, 
the bacteria were lysed at 95°C for 3 minutes and pelleted by centrifuging at top speed for 
10 minutes leaving the plasmid in the supernatant. The debris pellet was dragged out of the 
tube with a sterile yellow pipette-tip and discarded. 350 pi isopropanol (2-propanol) was 
added to the supernatant and mixed by inversion to precipitate the plasmid DNA, which was 
then pelleted by centrifuging for 7 minutes at top speed. The supernatant was then 
decanted and the remaining isopropanol was allowed to drain and/or evaporate at room 
temperature for 10 minutes by inverting tubes on tissue in a rack. The plasmid was re-
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suspended in 50 pi sterile DIW and heated at 55-60 °C for 10 minutes. Agarose gel 
electrophoresis was run to identify the presence of the plasmid.
2.9 Agarose gel electrophoresis
Throughout the work performed in this thesis, agarose gel electrophoresis was used to help 
determine the purity and estimate the concentration of the DNA, but mainly to extract the 
required DNA fragments for further processing.
2.9.1 Making and running the agarose gel.
Agarose gels were made by heating to boiling, agarose powder {Sigma ) in 1X TAE (Table 22 
Appendix) and casting the gel with 5 mm wells, as per standard protocols (Sambrook et al., 
1989, Cold Spring Harbor Protocols, 2006).When cooled the gel was submerged in fresh 1X 
TAE in the electrophoresis gel tank. Gels of different agarose concentrations were made 
depending on the DNA fragment sizes expected. A concentration of 0.8% agarose was used 
to measure high molecular weights such as plasmids (thousands of bp) and up to 1.8% 
agarose was used to measure fragments of low molecular weight (tens to hundreds of bp).
Sufficient sample to provide between lOng and 2 pg of dsDNA was mixed with appropriate 
amounts of loading buffer and made up with water. The loading buffers used were either 
BlueJuice 10X Cat. No.10816-015 for general use; Tracklt™ Cyan/Orange Loading Buffer 6X 
Cat. No.10482028, for DNA lengths lObp - Ikbs an^Tracklt™ Cyan/Yellow Loading Buffer 6X 
Cat No. 10482035 for DNA lengths of lOObp - lOkbp, all from Invitrogen) and SYBR® Green I 
nucleic acid gel stain (SigmaAldrich Catalogue number S9430) at a final concentration of 2X. 
20ul was loaded into the pre-formed wells in the agarose gel.
A DNA molecular weight marker (DNA ladder Ikb plus, Cat. No. 10787-018,100 bp 
molecular weight marker Cat. No. 15628-019. Tracklt™ 50 bp DNA Ladder Cat. No. 10488- 
043, Tracklt™ 100 bp DNA Ladder Cat. No. 10488-058, all from Invitrogen) mixed with SYBR®
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Green I nucleic acid gel stain was also loaded in separate lanes on the gel, if they were 
required.
A voltage of 5V/cm was applied across the gel and when the marker dye had migrated 
sufficiently the gel was viewed under a Dark Reader blue light transilluminator (excitation 
wavelength centred at ~400 to ~500 nm).
2.10 Recovery of DNA from Agarose Gels
2.10.1 Excision of DNA-containing gel
Whilst illuminated by the Dark Reader the fluorescing piece of gel containing the required 
DNA was excised from the agarose gel slab using a clean blade. The DNA was extracted from 
the agarose gel using either SV Gel clean-up kit where the manufacturers' protocol was 
followed by glass-fibre shattering. For glass-fibre shattering the DNA fragment was 
recovered by shattering the gel with centrifugation for 2 hours at 13,000 RPM through a 
punctured, fibreglass-filled 0.5 ml centrifuge tube mounted in a 1.5 ml centrifuge tube. The 
DNA fragment passes through to the 1.5 ml collecting tube whilst the agarose is retained by 
the fibreglass. This was followed by ethanol precipitation of the DNA fragment.
2.10.2 Ethanol Precipitation
Ethanol precipitation was performed by mixing one volume of DNA mixture, 2 volumes of 
ice-cold molecular-grade ethanol and 0.1 volumes of 3M Sodium Acetate (final 
concentration 0.3 M, pH 5.2) and agitating to ensure thorough mixing. This was stored for 
several hours at -80°C or overnight at -20°C or -80°C. Following the cold storage the mixture 
was centrifuged for 20 minutes at > 25,000 x g, the supernatant then removed by pipetting 
and the pellet washed once in 70% molecular-grade ethanol diluted in ultra-pure H20 and 
centrifuged at > 25,000 x g for 5 minutes. The supernatant was removed as before and the
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ethanol allowed to evaporate at room temperature. The pellet was the then re-suspended 
in a suitable volume of ultra-pure H20 to result in the desired DNA concentration.
2.10.3 SV Gel clean-up kit protocol
Promega Wizard SV Gel & PCR clean-up system Cat. #A9281 was used to extract the DNA 
from the agarose gel. This kit contains a Membrane Binding Solution (MBS) which dissolves 
the gel and assists the DNA to adhere to the membrane in the Minicolumn Assembly. A 
Membrane Wash Solution is provided to remove impurities and nuclease-free water to elute 
the DNA from the membrane. Briefly, the excised gel slice was dissolved at a ratio of l|»il 
MBS to Img of gei at 50-65°C or for a PCR amplification an equal volume of PCR reaction 
and MBS. The mixture was centrifuged through a Minicolumn Assembly at 16,000 x g for 1 
minute to transfer DNA to the membrane. The membrane was washed twice by centrifuging 
Membrane Wash Solution at 16,000 x g. Following evaporation of residual ethanol the DNA 
was eluted from the membrane in SOpJ of nuclease-free water.
2.10.4 Phase-lock gel Phenol/Chloroform Extraction
This process removes proteins from the nucleic acid. The nucleic acids remain in the 
aqueous phase and proteins separate into the organic phase or lie at the phase interface. 
Phase Lock Gel acts as a barrier between the organic and aqueous phases, allowing the 
nucleic-acid-containing phase to be more easily decanted or pipetted off.
PCR product was mixed with an equal volume of 25:24:1 (v/v) phenol, chloroform, isoamyl- 
alcohol, added to PLG tube and centrifuged for 5 minutes at 13,000 rpm. The nucleic-acid- 
containing aqueous upper phase was then decanted and ethanol precipitated.
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2.11 DNA Measurements
DNA concentration measurements were performed either using the standard protocol of 
absorbance at 260nm using a spectrophotometer or by using Invitrogen's Qubit Quantitation 
Platform {Cat. No. Q32857).
2.11.1 Qubit Quantitation Platform
Invitrogen's Qubit Quantitation Platform together with its associated assay kits was used to 
quantify amount of DNA. Two Quant-iT™ kits are available. The Quant-iT™ dsDNA BR Assay 
Kit (Cat. No. Q32850) is used for for normal DNA concentrations ranging from 2ng to 1000 ng 
whilst the Quant-iT™ dsDNA HS Assay Kit {Cat. No. Q32851) is used for low concentrations 
ranging from 0.2ng to lOOng. The manufacturer's protocols were followed for the Qubit 
Platform measurements. Briefly, sufficient working solution was made up by diluting the 
fluorescent reagent to XI in buffer and the system was calibrated using supplied standards 
diluted in the working solution. The sample, diluted if required to the kit's operational range, 
was added to the working solution. The reading produced for the sample was then 
calculated using the following equation:
Concentration of sample = QF X ^ DF)
Where:
QF = reading from Qubit fluorometer in ng/ml for HS and ng/ml for BR.
DF = Dilution factor
x = microlitres of sample used in assay.
78
2.12 Assay concentration of DNA and protein contamination by 
spectrophotometry
2.12.1 Concentration
DNA samples diluted in distilled water to give a concentration of between 10 ng/pl and 50 
ng/pl and dilution factor noted.
Spectrophotometer was calibrated at 260 nm using distilled water The optical density of the 
sample at 260 nm (OD26o ) was obtained and following formula used to calculate the DNA 
concentration in ng/pl.
OD 260 X 50 X dilution factor = concentration of DNA(ng/pl) 
where:
OD260 = optical density of sample at 260 nm.
2.12.2 Calculate DNA purity
The optical density of the DNA was measured as above at 260 nm (OD260) and also at 
280nm (OD280) and the following formula was applied:
DNA purity ratio = OD260
0^280
where:
OD260 = optical density of sample at 260 nm.
OD280 = optical density of sample at 280 nm.
A ratio of > 1.6 is required for successful transfection.
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2.13 Estimate DNA Concentration
Estimates of DNA concentration were also performed by comparing the intensity of the 
fluorescence from the DNA sample against the intensity of the fluorescence from a known 
quantity of molecular weight marker of approximately the same molecular weight.
2.14 Single and Serial Double Digest General Protocol
Restriction enzymes cut nucleic acid sequences at specific, usually palindromic motifs known 
as restriction sites. In double-stranded DNA the cuts may be blunt or have overhanging 
"sticky" ends. All digests used in this process resulted in overhanging ends.
2.14.1 Single Digest
Up to 17 pi of plasmid DNA, 10U of Restriction Enzyme (e.g. Notl - Invitrogen), 2ul 
compatible buffer (e.g. REact 3) were mixed in a thin-walled PCR tube and incubated for 3 
hours at 37°C.
The mixture was then run on a gel of suitable density (e.g. 0.8%) with either a MW marker 
and/or undigested plasmid in separate lanes. Because a linearized plasmid moves through 
an agarose at a different rate to a circular plasmid an apparent molecular weight size shift 
against the undigested plasmid indicates a successful cleavage by an enzyme.
2.15 Double Digest - Serial
2.15.1 First Digest
Same protocol as 'Single Digest' above was used.
2.15.2 Ethanol precipitation
The DNA was then ethanol precipitated to remove the first enzyme and its associated buffer. 
The DNA was then re-suspended in 17 pi H20 and lul of second restriction enzyme (e.g.
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Spel) and 2ul of its compatible buffer (e.g. REact 4) were added, mixed and incubated for 3 
hours at 37°C.
2.15.3 Second Digest
The DNA was separated through electrophoresis on an agarose gel. The band of the correct 
size was excised and the DNA fragment was recovered and purified as previously described.
Note: When the composition of the two buffers allowed it, the ethanol precipitation step 
was eliminated by modifying the buffer used by the first restriction enzyme to meet the 
second restriction enzyme's requirements.
2.15.4 Double Digest - Simultaneous, using Fermentas Fast Digest 
Protocol
The Fermentas FastDigest® product allows for the simultaneous digestion of DNA by 
multiple restriction enzymes in a single buffer.
Briefly, 2|il purified plasmid (~ 0.2 pg plasmid), 1 pi of each FastDigest® restriction enzyme 
(e.g. Notl and Spel), 14 pi ultra-pure water, 2pl 10X FastDigest® buffer were mixed and 
incubated at 37°C for 1 hour, followed by agarose-gel electrophoresis and extraction from 
gel.
2.15.5 Concentration of PCR product
The concentration of the PCR- amplified DNA fragments was increased by ethanol 
precipitation.
2.16 Cloning Strategy
Two cloning strategies were used, one allowed for directional cloning and the other was 
non-directional cloning.
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For directional cloning the restriction sites plus extra base pairs were incorporated into the 
outer extremities of the primers being synthesised. The extra base pairs were required as 
restriction enzymes will not reliably cut if the recognition site is at the end of the DNA. The 
number of extra base pairs required is restriction-enzymes dependent.
DNA was excised by digesting at the restriction sites Notl and Spel using appropriate 
restriction enzymes.
For non-directional cloning the putative enhancer was simply TA-cloned into pCRII-TOPO and 
following the overnight population expansion was excised from pCRII-TOPO using the Notl 
and Spel restriction enzyme sites flanking the insertion site.
2.16.1 Cloning putative BCR into reporter vector
The required ECR sequence was amplified by either PCR or PCR and TA cloning as previously 
described in " PCR Amplification of DNA". The putative enhancer was then ligated into the 
pl229 reporter.
2.16.2 Ligation of putative enhancer into pl229 vector.
The putative enhancer was ligated into the pl229 reporter vector using lnvitrogen'sT4 
Ligase (Cat. No. 15224-041) and the manufacturer's protocol for general cloning was 
followed (Invitrogen DOC. REV. 051502 p3). The lnsert:Vector molar ratio was calculated 
with a target of 3:1 to be used in the protocol. For cohesive ends 3-30 fmols of Vector ends 
and 9-90 fmol Insert ends are required. In brief, for a 20p.l reaction, reaction buffer (final 
concentration IX) vector and insert DNA to a total of 0.01-0.1 pg (cohesive ends) were 
mixed with 1 unit of T4 DNA ligase and incubated for 5 minutes. This was then used to 
transform competent bacteria as described previously in "Transformation and selection of 
colonies".
2.17 Shrimp Alkaline Phosphatase (SAP) protocol
82
Shrimp Alkaline Phosphatase (SAP) (Fermentas Catalogue Number EF0511) catalyses the 
release of S'-phosphate groups from DNA and reduces the risk of the vector re-annealing. 
Although typically only required for matching or blunt ends, due to problems encountered, 
this protocol was used on a number of occasions.
2.17.1 SAP treatment Protocol for dephosphorylation of DNA 5 - 
termini
17 \x\ of the solution containing the DNA sample, 10X reaction buffer 2 |il, and SAP (1 pi at 1 
unit/1 pi) were incubated at 37°C for 30 minutes and reaction was stopped by heating at 
65°C for 15 min
2.X8 Plasmid Purification
2.18.1 Plasmid prep
To produce plasmids suitable for electroporation, with a 260nm:280nm A ratio >1.6, 
overnight cultures of bacteria containing the plasmids were purified using plasmid prep kits 
from different manufacturers depending on availability. These were PureYield™ Plasmid 
prep (Promega), GenElute™ Plasmid (Sigma-Aldrich) and Qiagen's (Cat: 12143) products. The 
mini, midi and maxi versions of their products were used depending on the amount of 
culture being purified. The manufacturer's protocols were followed. The general 
methodology comprises lysing the bacteria to release the plasmid, recovery of the plasmid 
on a membrane, followed by elution to release the plasmids. Ethanol precipitation was the 
used to achieve ~5ug/p.l suspended in PBS + ImM Mg2+ required for transfection.
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2.18.2 Sequencing
Promoter sequences, such as SP6, T3 orT7, are incorporated into many plasmids, bracketing 
the insertion site to allow sequencing from either end of the insert. Sequencing of the 
plasmids was performed by Lark Technologies (now Beckman Coulter) using their most 
simple offering i.e. Silver service on Perkins Elmer Biosystems DNA analysers from the 
appropriate promoter(s). Sp6 and T7 promoters were used in pCRII-TOPO and although 
pl229 contains the T3 and the T7 promoters, only T7 is sufficiently close to the insertion site 
to permit sequencing.
2.19 AB290 Rb anti-GFP
Same procedure as for MNR2 was followed except that the primary antibody, Ab290, was 
used at 1:2000 and that Alexa 555 rat anti-rabbit at 1:250 was used as the secondary 
antibody.
2.20 Injection and transfection by electroporation.
2.20.1 Age of embryo
The most suitable Hamburger-Hamilton (HH) stage to inject the neural tube was found to be 
at about HH14. Earlier than this and the NT had not formed a closed central canal of 
sufficient length, later than this and the central canal of the neural tube becomes too small.
2.20.2 Plasmid Mixes for Injection
The plasmid mix was made of a mixture of two plasmids at a maximum plasmid load of 
6pg/|ih
The IRES-GFP constitutively active plasmid (final concentration of 2ug/|il) and the pl229 
chromagenic reporter plasmid containing the sequence under test (final concentration of
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3ug/nl) were suspended in PBS +lmM Mg2+. A small amount of Fast Green (FG) was added 
to assist visualization during the injection process.
The co-injection of the GFP-expressing vector allowed confirmation that the transfection 
process had been successful and to indicated where the blue chromogenic stain would be 
located. Because the GFP is visualized using a fluorescent-type microscope it avoided the 
chromogenic processing that necessitated the sacrifice of the embryo by extraction from the 
egg and processing for staining.
2.21 Accessing the Embryos
Two methods have been used in the experiments used in the development of this thesis; 
Mammocking and Windowing.
In both cases the eggs had been marked (usually with the start-of-incubation date), and had 
been placed in the incubator with this label uppermost. Because the embryos float to the 
highest part of the egg this indicated where it as anticipated that the embryo would be 
located.
The egg was removed from the incubator and rocked gently to dislodge the embryo as some 
embryos have a tendency to adhere to membrane.
The eggshell was sterilized by spraying it with 70% ethanol.
2.21.1 Mammocking Eggs:
Hammocks had been prepared by placing a piece of non-PVC cling-film over 2.5" length of 
plastic pipe of 3" diameter and secured with an elastic band to form a cup or hammock 
about 1.5" deep.
The egg, kept in the same orientation in which it had been incubated, was then cracked on 
the bottom and its contents emptied into the hammock. The embryo was then ready for
85
injection. A Petrie dish was then placed on top to maintain humidity and prevent ingress of 
dirt.
Due to yolk breakage, infection and a concomitant high mortality rate the hammocking 
method was abandoned in favour of 'windowing'.
2.21.2 Windowing eggs:
This windowing method removed the need to empty the egg out of the shell with its 
attendant risk of damage to the yolk, which becomes very delicate following fertilization.
As this process consists of cutting a hole in the eggshell a sufficient amount of the albumin 
had to be removed to prevent it overflowing from the hole.
The pointed end of the egg was punctured with the egg punch and a 19G hypodermic needle 
mounted on a syringe was introduced through the hole and directed below the equator 
mark to avoid the yolk, and between 2.5 and 4 ml of albumen was aspirated. This amount 
depended on the size and freshness of the egg, typically the larger and fresher the eggs the 
greater the amount that had to be aspirated.
An oblong of 2.5 cm by 1.8 cm was marked on the top of the egg, centred on where it was 
anticipated the embryo should be, i.e. on the part of the egg that was highest during 
incubation.
Using a 38 cm diamond cutting wheel mounted on a flexible shaft attached to a Dremel-type 
rotary multi-tool the marked oblong was cut through the shell (Figure 24) avoiding 
puncturing of the membrane if possible.
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Figure 24 Egg being windowed showing shell cut through exposing the membrane. To top of picture is the 
cutting disc mounted in the chuck of the Multitool.
The dust from the cutting was removed from the egg and the membrane was cut through on 
the long (2.5cm) sides of the oblong with a scalpel. A suitable length of Sellotape® Magic 
tape (2.5 cm wide) was placed over partially cut oblong or "window". This was pressed on to 
the cut out portion of the shell and onto the shell at one of the narrow cuts to provide a 
hinge. The tape was not stuck down on the long sides nor at the other short end. The 
membrane at the free, short side was cut and the piece of shell, thus hinged on the other 
short side, was raised.
A check was made that sufficient albumen had been removed so that leakage would not 
occur, bubbles that may have formed in the albumin were burst with the hypodermic 
needle, and any membrane that could dip into the albumin was removed. The window was 
then closed and the Sellotape® was lightly pressed down all around to form a seal. Originally 
ordinary clear Sellotape® was used but subsequently Magic Scotch tape was used and this 
reduced the reduced the risk of eggshell breakage when manipulating the tape, presumably 
due to the lower adhesion of the adhesive on the Magic tape.
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The puncture hole was sealed with a piece of laboratory tape (Shamrock brand) and the egg 
was then ready for injection.
2.21.3 Plasmid injection
7% India Ink (Pelikan Fount India ink) in PBS was sometimes injected under the embryo to 
help visualise it, but this appeared reduce survival of the embryo and was avoided if 
possible.
The membrane covering the embryo was the removed using a forceps.
A micropipette of borosilicate capillary glass tubing, with filament, (Warner Instruments, 
G150TF-3) had previously been pulled (Sutter Instruments Model P-87 Flaming/Brown 
pipette puller) and attached to a flexible mouth tube. These were then loaded with the 
plasmid mix. The neural tube or brain, as appropriate, of the chick embryo was pierced with 
the micropipette tip ( Figure 25) and the plasmids injected into the central canal of the 
neural tube or the lumen of the brain using a small amount of buccal pressure.
Gold plated electroporator electrodes of 3mm or 5mm length (Harvard Apparatus, Inc. 
BTX Model 514(3mm) 512(5 mm)) were placed each side of the embryo with a gap of 5 
mm and connected to the electroporator. A drop or two of L15 was sometimes placed on 
the electrodes to improve electrical contact.
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Figure 25 Neural tube of a chick being injected using a micropipette. Note this picture is of a windowed egg 
with the shell visible, and not an egg in a hammock.
2.21A Electroporation
Upon withdrawal of the micropipette the embryo was electroporated with a number of 
pulses (typically 5) at a determined voltage (ranging from 40V to 15V) with a pulse length 
ranging from (SOmsecs - 20msecs) duration, with a gap length ranging from random gap to 
100 msecs.
The electric charge across the tissue causes pores in the cells to form and at the same time 
the plasmid DNA, which is negatively charged, is drawn towards the positively charged 
electrode and is drawn into the cells through the pores Figure 26.
Figure 26 Diagram showing electroporation of neural tube. The plasmid having been 
injected into the lumen upon passing of current through the electrodes, is drawn towards 
the positive pole and transfects some of the cells (shown in green).
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Because the DNA is drawn towards the anode the placement of the electrodes in relation to 
the tissue will alter the location of the tissue that will be transfected. When transfecting 
tissue of the neural tube with DNA injected into the central canal, when both electrodes are 
placed one on each side of the torso at the midline of the dorso-ventral axis the centre-point 
of electroporation will occur at the midline on the anode side. If the cathode is placed 
ventrally of the midline and the anode is placed dorsally the electroporation will occur in the 
dorsal half of the anode side and vice-versa if the anode is placed ventrally and the cathode 
dorsally (Figure 27). This manipulation can be used to advantage to target a particular 
location however it can unintentionally and lead to the undesirable result of only part of the 
lateral half of the neural tube being transfected.
bc
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Figure 27 Targeting of region to be electroporated by positioning of electrodes, shown in a 
cross section of embryonic chick torso. (A) Both electrodes placed at midline results in the 
centre-point of electroporation occurring at the midline of the anode side. (B) Cathode 
placed ventrally and anode placed dorsally results in the centre of electroporated tissue 
being more dorsal. (C) Cathode placed dorsally and anode ventrally results in the centre of 
electroporated tissue being more ventral.
Two electroporators were used during the development of this thesis. The first 
electroporator was battery powered with limited controls (Digitimer Isolated Stimulator 
Model DS2). When using this model the voltage was typically set at 40V with a pulse length
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of SOmsecs. The trigger being a manual push-switch produced, by its nature, a random gap 
length between pulses. The only control of gap length was the very subjective, pressing the 
trigger button at a fast or slow rate.
The second electroporator was a more advanced, mains-powered, Ovodyne TSS20 with 
user-selected but machine-implemented gap timing. There is also a maximum current limit 
to help reduce tissue damage. Following the commissioning of this instrument the 
electroporation success increased.
The embryo was then covered, by a petri dish when the Hammocking method was used. 
When using the windowing system the shell fragment was taped down or if the shell 
fragment was lost, taping over the window. The embryo was then placed in a humidified 
incubator.
Two types of humidifier were used; the earlier experiments used a humidifier set at 37°C 
and passive humidification. The later experiments had the advantage of a specialised egg 
incubator system (Brinsea Ova Easy 380 with H22 Digital Humidity Management Module) set 
at 37.8°C and with an active humidity system set at 35%.
Following the incubation period, the embryos that expressed GFP fluorescence in the 
appropriate location, were harvested, fixed, permeabilized and stained for fc-galactosidase 
[iacZ) activity using X-gal as the chromogenic substrate as described below.
2.21.5 Harvesting Embryos
The embryos were extracted from the shell by severing the vitelline membrane and blood 
vessels from around the embryo by using sharp forceps. The embryo was then scooped up 
using curved-shank tweezers, a spatula or a small laboratory spoon. The embryos were then 
irrigated with Hank's or other buffered solution. The embryos were then cleaned up, using 
sharp forceps, by removing any remaining vitelline membrane and unwanted tissue. The
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membrane surrounding the embryo and viscera were typically removed at this stage from 
the more advanced embryos. This clean-up was performed on the more delicate embryos 
that were at an earlier stage of development after they had spent some time in the fixative.
2.21.6 Fixing Embryos
The embryos were immersed in 4% paraformaldehyde fixative (Table 22 Appendix) for a 
period sufficiently long to maintain tissue integrity but not sufficient to destroy the 
15-galactosidase enzyme activity. This period was typically from 1 to 4 hours, 
depending on the age of and size of the embryo. Following this treatment the 
embryos were ready for further processing such as staining and sectioning.
2.22 Whole-chick embryo staining protocol
Adapted from (Nagy etal., 2007)
2.22.1 Washing:
The paraformaldehyde was aspirated from the suitably fixed embryos. These were then 
washed in embryonic detergent rinse (Table 22 Appendix) three times for 15mins per wash 
on a rocking table (30 bpm) prior to staining.
2.22.2 Staining:
The embryos were submerged in staining solution (Table 22 Appendix), typically ~500 pi to 2 
ml per embryo, depending on the embryos size.
2.22.3 Developing the stain:
Depending on the circumstances a number of protocols were used for developing the indigo 
stain. The embryos were either placed at 37°C with the stain expected to be visible within 5 
hours; or overnight at RT on a rocking table (30 bpm), if no staining was visible further 
incubation at 37°C was undertaken. Some embryos were also stored for several days at 4°C, 
prior to incubation at 37°C.
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When stain was visible the reaction was typically stopped in 70% Ethanol.
2.22.4 Mounting chick embryos on cork discs.
To cryo-protect the tissue/embryo it was immersed, until sinking, in the succession of 6%, 
12% and 18% sucrose in working-strength Millonig's Phosphate Buffer (0.125M, pH7.4) with 
0.1% NaN3.
The required section of a cryo-protected embryo was placed in the desired orientation, in a 
dome of optimal cutting temperature (OCT)-type embedding compound (Bright Cryo-M-Bed 
medium) on a cork disc.
Iso-pentane was placed in a plastic beaker and suspended over liquid nitrogen in a Dewar's 
flask. The cork disc was then placed in the ultra-cold iso-pentane for about 1 minute to allow 
the OCT and tissue to freeze at which point it was immersed in the liquid nitrogen.
The tissue typically then stored at -80°C
2.23 MNR2 (Hb9) Antibody-staining of chick embryos.
Sections (10 micron) of chick neural tube (E5,E6,E7) were mounted on gelatine subbed 
slides,paraformaldehyde was quenched (15 minutes in 0.2M Glycine pH 7.4), non-specific 
antibody sites blocked in diluent (15-30 minutes) (Table 22 Appendix), stained with primary 
antibody at 1:5 in diluent (BOmins - 1 hour at RT), dip washed (3 times) in HBSS, stained with 
Alexa 488 rabbit anti-mouse secondary antibody at 1:200 in diluent (1 hour at RT), dip 
washed (3 times) in HBSS and once in de-ionized water and cover-slipped using DAKO 
medium as adhesive.
2.24 DARI staining
Nuclear staining was achieved by co-application of DAPI (1:100 in diluent) with the 
secondary antibody.
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Chapter 3
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3 Development of a Positive Control to demonstrate pl229-based 
system would function in chick.
The expression of genes by cells is under very stringent control. Of particular interest in this 
work are the c/s-acting enhancers and/or repressors of gene expression. These regions bind 
the transcription factors that are produced by the cell and either increase or decrease the 
rate of transcription initiation.
One way to identify these regulatory regions is by is to identify regions of DNA that have 
been restrained over evolutionary time. These evolutionary conserved regions (ECRs) can 
then be tested as putative enhancers by insertion into a reporter vector.
3.1 Selection of positive control genes and enhancer.
Prior to using the chick-based model, as described in Chapter 1, to assay the ECRs for 
LSA/WP-enhancer activity, a positive control, with known enhancer function, was required to 
show that we could make the proposed system and that it would be shown to function.
A number of criteria were specified for the positive control enhancer; it should be for a 
known promoter of a gene that is expressed early in development in the neural tube of chick 
and that it should reliably produce a strong, easily detectable signal.
The reason for selecting a gene expressed early in development was that LSAMP expression 
was to be investigated at this stage of development and the gene being used for the positive 
control should match this temporal expression pattern. The neural-tube location was 
desirable because it was in this location that the investigation into LSAMP was to 
commence.
A number of candidate genes and their known enhancers were investigated and of these 
genes Pax3 and Hb9 appeared to be the most promising. Pax3 is a member of the paired box
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(PAX) family of transcription factors and minimal enhancer elements sufficient for Pax3 
expression in neural crest cells had been identified (Milewski et al.# 2004). Hb9 is a 
transcription factor with a 5', 125 bp region (Figure 28) demonstrated in E10.5- Ell.5 mouse 
(Figure 29), to be both sufficient and necessary to drive reporter gene expression in the 
appropriate location, i.e. the spinal motor neurons. Reporter vector, pl229 was also 
selected fortesting.
3.2 The PAX3 gene was not required for proof-of-concept testing.
Because results were obtained using the Hb9 enhancer in pl229 no further reference to 
PaxB or PGL3 will be made except to say that the equivalent chicken PAX3 enhancer 
sequence was identified using cross-species homology as described in detail for Hb9, but the 
PAX3 enhancer region proved difficult to amplify from whole chick genomic DNA. Although 
this was eventually achieved using nested PCR and the reporter plasmid subsequently 
cloned, the positive results obtained from the Hb9 ECR obviated the need to pursue the 
Pax3 enhancer and work on it and other genes was abandoned (data not shown).
3.3 The Hb9 gene was used for proof-of-concept testing.
The Hb9 gene encodes a nuclear protein, which contains a homeobox domain and is a 
transcription factor. Mutations in this gene can lead to sacral agenesis (Li et al., 1999, Ross 
et al., 1998). Hb9 is expressed by spinal motor-neurons in the developing central nervous 
system and is a marker for motor neurons (Tanabe et al., 1998, Arber et al., 1999). Previous 
studies had shown that in mouse a 9kb 5' promoter region was sufficient to drive gene 
expression in motor neurons in vivo (Arber et al., 1999, Wichterle et al., 2002)) and this was 
further refined to a 3.6 kbp segment of this 9kbps by human to mouse homology (Nakano et 
al., 2005)). Transgenic mice generated with this 3.6 kbp segment inserted into the reporter 
vector BGZA, which contains a LacZ gene under a human fJ-globin minimal promoter, were
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shown to express |3-Gal in the same regions of the ventral spinal column as for the 9kbp 
segment. Comparing mouse, human and pufferfish {Fugu rubres) revealed a 438bp region 
consisting of a non-contiguous 313bp and 125bp fragment. Zebrafish {Danio rerio) were 
then found to have two identical copies of the 125bp region, but no 313bp region. 
Transgenic analysis showed the 125bp fragment was sufficient to drive LacZ expression in 
the spinal motor neurons and therefore an enhancer (Nakano et al., 2005). The 313bp 
region demonstrated no such function, indicating that the 313bp had no enhancer function 
at this stage. Furthermore disruption of a Hox/Pbxl consensus binding sequence 
(TGATnnAT, where n represents any nucleotide) within the 125bp sequence destroyed the 
enhancer effect (Nakano et al., 2005).
The reverse complement of TGATnnAT (ATTCATCA, where TC is in the location specified by 
nn) occurs within the consensus sequence for the enhancer HNF1_C (ttgtCAATTCATCAGCt, 
where upper case letters represent the core sequence within the enhancer's consensus 
sequence and nn is any nucleotide).
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(A)
agagtggttagctgatgaattgacaaaaactaatcagctttattgggaaacaggtttaaggg
cacggacgtgtcaataacgctcagcctgaccccctcttccattagctxaggcaggctgatta
ga
(B)
tctaatcagcctgcctgagctaatggaagagggggtcaggctgagcgttattgacacgtccg
tgcccttaaacctgtttcccaataaagcm^mttttgtca^miUgctaaccact
ct
(C)
tgaataaatttaagcaggctaattaatatataaactagctcaatttgtcaagttgatttgta
ttttagttaattgtgaaagtaattaccacatggtcaaattaacagctttctggaaatgacca
agcctgaggttttatttccttcctgggtgaagaaaattcatttttccaagctcttgatgHB
BBHaaaagtcataaatctgggtgattggtgcaggcagagtctaaatggcttcatatttca
ttttaggtttaatagaaatattcatgctctgttttaatgaaattaaattgaagggggatggg
get
Figure 28 Sequences investigated for enhancer function taken from Figure E (Nakano et 
al., 2005). (A) 125 bp sequence shown to act as an enhancer. Highlighted in yellow is the 
sequence highly related to the Hox/Pbx consensus binding sequence (TGATnnAT, where 
'n' is any nucleotide), disruption of which was found to destroy the enhancer effect of the 
125bp sequence. (B) the reverse complement of the 125bp sequence shown in A. (C) The 
BIBbp mouse sequence not shown to act as an enhancer at this stage of development. 
Note the repeat of one unit of the Hox/Pbx consensus binding sequence as indicated in (A) 
above in this BIBbp structure.
Figure 29 The expression of (3-galactosidase is detected by blue staining in the spinal 
motor neurons of a transgenic mouse staged at (A) E10.5 whole mount and (B) 11.5 
section of neural tube. Image taken from Fig 5 (Nakano et al., 2005).
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3.4 Aim of chapter
The aim of this part of the project was to develop a positive control by demonstrating that 
reporter vector pl229 could be used successfully to detect if a DNA fragment was an 
enhancer of gene expression. This was to be done by identifying a DNA sequence that had 
been proven to be an enhancer, preferably in chick, but failing that, in another species. If the 
sequence identified was not in chick then the equivalent sequence in chick was to be located 
by a bioinformatics method such as BLAST (Altschul et al., 1990, Johnson et al., 2008). The 
enhancer sequence was to be cloned into a reporter vector and transfected into embryonic 
chick. The technique would be validated if the reporter gene expression could be detected in 
the expected location in the chick.
An additional aim of the experiments described in the chapter was to develop a 
methodology that would allow the chicks to be injected, electroporated and survive for the 
sufficient time to allow reporter gene expression.
RESULTS
3.4.1 Synthesis of the ECR1 -Hb9:pl229 construct.
3.4.1.1 Iden tification of the mouse homologue enhancer sequence in chick.
The location of the Hb9 125 bp enhancer sequence (Nakano et al., 2005) as shown in Figure 
28 was located by BLAST using Mouse genome resources (Altschul et al., 1990) showed the 
location of the 125 bp sequence to be ~7.5kbp bp upstream of the start of Hb9 (Figure 30). 
The ECR Browser (Ovcharenko et al., 2004) was used to compare this region using mouse as 
the base organism and chick and human as the target organisms (stringency; 100 bp length
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70% similarity) to show that the ECR Browser could be used to indicate the location of 
putative enhancers. The ECRs so identified were 344bps in length at 77.6% identity in mouse 
with the chick ECR being slightly shorter at 339 bp (Figure 31).The mouse/chick/human 
results are shown graphically (Figure 32) and the region upstream from the Hb9 TSS with the 
ECR containing the enhancer is identified. Note that there are 8 ECRs upstream of ECR1 in 
human that do not appear in chick (marked * Figure 32). This is a good example of how using 
an evolutionary more distantly organism can highlight important and more highly 
constrained sequences. In this case it serves to highlight the ECR of interest, i.e. the ECR 
containing the 125 bp sequence, but in other circumstances important data could be lost as 
the ECRs highlighted in human may also be important. The downstream ECRs, being 
constrained, are also probably important at a fundamental level. Although these other ECRs 
may have a function in the control of Hb9 or some other gene, as they do not contain the 
125 bp enhancer they are of no interest in this search for a positive control.
The mouse enhancer sequence was further compared against other species (Figure 
33 ). It can be seen how the region, centred at the 344bp ECR in chick, with mouse as 
the base species, has, unsurprisingly, the greatest similarity to rat. In human the ECR 
appears as a discrete element, unlike rat, and has a slightly higher similarity with 
mouse. Frog and chick appear very similar to each other. Of the organisms 
compared here, puffer-fish exhibits the least homology.
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Features flanking this part of subject sequence:
7793 bp at 5' side: motor neuron and pancreas homeobox protein 1 
83323 bp at 3' side: ubiquitin-protein ligase E3C
Score = 231 bits (125), Expect = 8e-59
Identities = 125/125 (100%), Gaps = 0/125 (0%) 
Strand=Plus/Minus
Query AGAGTGGTTAGCTGATGAATTGACAAAAACTAATCAGCTTTATTGGGAAACAGGTTTAAG 60
111 I ! I I M I I I I I M I ! I I I I I I I M I I I II I I I I I I I I I II I I I I I I I I I I I I M I I I
Sbjct 14028526 AGAGTGGTTAGCTGATGAATTGACAAAAACTAATCAGCTTTATTGGGAAACAGGTTTAAG 14028467
Query 61 GGCACGGACGTGTCAATAACGCTCAGCCTGACCCCCTCTTCCATTAGCTAGGCAGGCTGA
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 lit M 1 1 1 1 1
120
Sbjct 14028466 GGCACGGACGTGTCAATAACGCTCAGCCTGACCCCCTCTTCCATTAGCTAGGCAGGCTGA 14028407
Query 121 TTAGA 125
[ M M
Sbjct 14028406
Mill
TTAGA 14028402
Figure 30 BLAST of 125bp region against mouse. The 125 bp sequence is identified as 
'query and the mouse as 'subject'.
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A)
ECR : : Evolutionary-
Conserved Region Mouse [mm8] - Chicken(galGal3j ECR
Type 344 bp, 77.6% identity
chr5: 2 9816686-29817 02 9 [nm8]Location
Alignment
10 20 30 40 50
Mouse AAaaCatGTatTACACtGCGACATTCTGTAaATGAGATAATGATACATAAACCCga-TGA
chicken AAcgCgcGTccTACACcGCGACATTCTGTAcATGAGATAATGATACATAAACCCcccTGA 
4590 4600 4610 4620 4630 4640
60 80 90 100 110
Mouse TcGATGTGACgggCCtGGatGtcttCTCTAAATtAGCtGCtCaCATCGACTGCTaATA-T
I I ! II I I I I II II I I I II I I I I III II I MIMMIMI III IChicken TaGATGTGACaccCCcGG--GatggCTCTAAATgAGCcGCcCgCATCGACTGCTgATAaT 
4650 4660 4670 4680 4690
120 130 140 150 160 170
Mouse tGtGaGTTTATGAAAGCAATTTCGGTGCaAtCgGCGagAGGGTCTtCTtac|
I I I II I I I I I I I I I I I I I I I II I I I I I III lllllll II IChicken gGcGcGTTTATGAAAGCAATTTCGGTGCgAgCaGCGc-AGGGTCTgCTcggTgTAATCAG 
4700 4710 4720 4730 4740 4750
180_______ 190_______ 200_______ 210_______ 220_______ 230________
Mouse
MM 111111III I II I Ml Ml I HIM IIII I III III IIChicken gCTGCtcgGCTAATGGAcGgGG--- CgGGCgGAGaGcTATTGACACtcCgcTGCCCTTA
4760 4770 4780 4790 4800 4810
250_______ 260_______ 270_______ 280_______ 290
Mouse
I 11111111111111111111111 II MM lllllll IIIIIIII Ml I II MlChicken A-CCTGTTTCCCAATAAAGCTGATTgGTTTTTGTCAATTCATCAGCTcACCgCcCTcGCT 
4820 4830 4840 4850 4860 4870
300 310 320 330 340
Mouse GgaAacaaATCAAAGCtGtATTTGtTCAataGAAg-CAACAAGTCaC
I I 1111 1111 I Mill Ml Ml III 11III I IChicken GcgActgcATCAAAGCcGgATTTGcTCAgggGAAatCAACAAGTCgC 
4880 4890 4900 4910 4920
Figure 31 Details from the ECR Browser grab function (base organism, mouse; target 
organism, chick) showing A) the length of the mouse ECR and its percentage similarity to 
the chick sequence and the genomic location of the mouse sequence (mouse, because it 
was the base sequence). B) Indicates the alignment of the ECRs between mouse and chick 
with the murine 125 bp region highlighted in turquoise.
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Figure 33 ECR Browser showing 125bp sequence identified as driving Hb9 expression in 
motor neurons.
125bp aligned against zebrafish (top line). Cross-species homology of ECR showing chicken, 
mouse human, frog and pufferfish. Stringency at default (100bp/70%). lOObp of the 125bp 
are constrained in puffer fish (Fugu).
3.4.2 Designing of primers to amplify ECR1 from whole-chick DNA.
Suitable primers sequences were generated using PrimerB (Rozen and Skaletsky, 2000) 
(release 1.0b) using default settings with the 120bp sequence from chick ( Figure 31) 
marked as source sequence. To provide the optimal primers for the sequence, PrimerB 
selected a 215 bp region (Figure 34 and Figure 35).
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start len tm gc% any 3 ' seq
1 LEFT PRIMER 9 20 58.00 35 .00 6.00 3.00 CGCGTTTATGAAAGCAATTT
RIGHT PRIMER 223 20 59.67 50 . 00 3.00 2.00 CTTGTTGATTTCCCCTGAGC
PRODUCT SIZE: 215, PAIR ANY COMPL: 6 00, PAIR 3' COMPL: 0.00
Figure 34 PrimerB results chick Hb9 ECR showing the forward and reverse primers.
Figure 35 The 215 bp chick sequence to be generated by PCR showing the Forward primer 
(green highlight), Reverse primer (red highlight) as identified by PrimerB and the 120 bp 
putative Hb9 enhancer (turquoise highlight)
3.4.3 Amplification ofHb9's ECR1 DNA sequence.
The primers were synthesized, however amplification by PCR from the whole genomic DNA 
proved difficult and many attempts at a succession of annealing temperatures and 
denaturing, annealing and elongation times were tried, with varying salt concentrations and 
with and without adjunct. The problems in obtaining PCR product were probably due to 
attempting to amplify a very small fragment from genomic DNA and the stochastic nature of 
the initial annealing stages. The 215 bp region was eventually amplified by gradient PCR, as 
specified in Materials and Methods, from whole chick genomic DNA with the TA 
temperature range set from 55°C to 65°C ( Table 10 ). The PCR reaction used was as 
specified in Materials and Methods for 25 pi PCR reaction except that 1.25 pi H20 was
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replaced by DMSO (5% v/v) as an adjunct and 63 ng whole-chick gDNA was used as the 
template .
The PCR reaction product was visualized by agarose gel electrophoresis (Figure 36 A) and 
track 1 (55°C) and track 2 (55.3°C), having produced bands at about the expected size were 
excised, purified, cloned into the pCRII vector, bacteria were transformed and expanded. 
Colonies were subsequently screened by PCR (TA @ 55°C) using the original primers and the 
results visualised by agarose gel electrophoresis (Figure 36 B). The pCRII plasmid from four 
colonies (1,2,A and B) was extracted and purified by plasmid preparation. Sequencing from 
the Sp6 and T7 promoters showed the Hb9 enhancer had been cloned into pCRII, in colonies 
A,B and 1 the Hb9 enhancer was inserted in direct orientation but was reversed in colony 2.
Cell 1 2 3 4 5 6 7 8 9 10 11 12
t/°C 55 55.3 55.8 56.7 57.8 59.3 61 62.4 63.4 63.5 64.8 65
Table 11TA temperature gradient range of 55°C to 65°C of PCR used for Hb9 
amplification from whole-chick gDNA.
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(A)
Gradient temperature CGradient PCR I...........................
55C - 65C
MW 55 55.3 55.8 56.7 57.8 59.3 61 62 4 63 4 63.5 64 8 65
300bp—
(B)
Figure 36 (A) 1.3% agarose gel showing the two bands of approximately the expected 215 
bp that were obtained at 55°C and 55.3°C, by the Hb9 primers previously described, using 
Gradient PCR (temperature range 55°C to 65°C) on whole chick genomic DNA as a 
template. The MW marker is lOObp (Invitrogen) but probably due to the addition of SYBR 
Green to the DNA it ran a little slower than the naked DNA would. The track at 56.7°C was 
to be negative control, there being no gDNA in its mix, however as no band was produced 
at 55.8°C this functionality was negated.
(B) 1.3% agarose gel of the output from 10 colonies from the lOOul-spread plate (1-10) 
and the lOul-spread plate ( A - J) of pCRII plasmids, screened by PCR for inclusion of Hb9 
ECR. All colonies, except colony I, produced a band of approximately the expected size.
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The Hb9 enhancer was serially digested from pCRII for insertion into the pl229 chromogenic 
vector. The first digest was with restriction enzyme Notl, then following ethanol 
precipitation, pelleting and re-suspension in water the linearized plasmid was digested using 
Spel. The reaction was run on a 1.3% agarose gel and the resulting 200bp band, visualised 
with SYBRGreen (Figure 37 A), was excised and the DNA was extracted. The DNA was 
ethanol precipitated and assayed as being 6.6 ng/pl.
The pl229 vector (2|il @ 342ng/pl) was double digested and visualised on 0.8% agarose 
gel. The size shift between digested (Figure 37 C) and undigested pl229 (Figure 37 D) is 
evident. This was excised, and processed to clean it up.
A B c
" * —
^ *rva *
—350bp
Figures? Double digests
(A) The 200bp Hb9-ECR (very faint, arrowed) double digest from pCRII with Notl and Spel 
restriction enzymes.
(B) Molecular weight marker with 350 bp band identified.
(C) Plasmid pl229 double digested by Notl and Spel with the size shift evident when 
compared with
(D) The undigested form.
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3AA Ligation of the Hb9 ECR1 sequence into reporter vector
pl229 to generate the ECR1-Hb9:pl229 construct 
Ligation of the Hb9 enhancer into the pl229 vector was performed. Following initial STET 
PREP verification of 10 colonies for the presence of plasmid (Figure 38 A) and subsequent 
double digest with Notl and Spel) of 4 colonies (Figure 38 B), 2 colonies were purified by 
plasmid prep and sequenced (Figure 39). The sequencing indicated perfect homology 
between the desired and actual sequence.
These two colonies were expanded in overnight culture and the pl229 plasmid was 
extracted and purified and concentrated to 10.6 mg/ml.
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(A)
1kbp 1 23 45 6789 10 1kbp
- -7 kbp
t 11 t
(B)
Figure 38 (A) STET prep output showing the presence of a band running at about 7kbp. 
Circular DNA can be adopt a number of conformations such as supercoiled where it will 
run faster through the gel than it it were an open circular plasmid. This band, which 
perhaps serendipitously runs at ~ 7kbp, indicates the possible presence of the putative 
ECR1-Hb9:pl229 construct.
(B) Double digestion of the Hb9:pl229 construct by Notl and Spel showing the released 
200bp fragment (arrowed) indicating that the enhancer had been cloned into pl229. (0.8% 
agarose gel).
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TGCACTCCCGCGGTGJHHBnGTGTGATNGTATATCTGCAGCAATTCGCCCT
CCGGCTTTGATGCAGTCGCAGCG^H^^H^H^^^^HI^Hj^H
tgctcgH^H^MMBI^Hcgcgaagggcgaattccagcacactggcggccgt'i^BHggatcccccggg
CTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTAGCCTGCAGGTCGAGGAGCGCAGCCTTCCAG
Figure 39 Results from the sequencing from T7 direction of Hb9-ECRl:pl229 Key: Red, 
reverse-complement of reverse primer; Green. Reverse complement of forward primer; 
Turquoise, Reverse complement of ECR sequence, Restriction enzymes sites are annotated 
and also indicated specifically as follows: Notl (puce), Eagl, (puce underlined), Spel (teal).
3.4.5 Injection and transfection of the ECR1 -Hb9:pl229 construct 
into chick tissue.
The techniques used for egg and embryo maintenance, injecting and electroporation were 
developed and refined over the course of the project. To develop the techniques for 
exposing of the embryo, electrode placement, needle shape, size and preparation, injection 
technique, electroporation parameters was varied to give the best results.
The electroporator that was used for this experiment was battery-powered and was rather 
primitive having only two controls; output voltage and pulse length. Each pulse was 
triggered manually by push-button and there was no current control. Many experiments 
were run under differing conditions before electroporation was achieved; the output voltage 
was altered from 15V through to 60V, pulse length changed from 50 msecs to 100 msecs and 
number of pulses was varied from 3 to 5 with the gap between pulses ranging from as fast as 
was manually possible to about one second. Electroporation was achieved at a setting of 
40V upwards but survival was lower at the higher voltages and indeed this 40 volts and 
upwards contrasts with the 15V quoted in other papers (Itasaki et al., 1999, Croteau and
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Kania, 2011, Islam et al., 2012). The best compromise between electroporation success and 
survival was found to be five pulses of 40V each, at random speed and with a pulse length 50 
msecs. At these parameters between 20% and 50% of the embryos survived and showed 
green in the neural tube.
The optimum location of the electrodes in relation to the embryo was found to be important 
and relatively difficult to achieve due in part to the instability of the embryo and its 
substrate. When positioned on either side of the embryo both electrodes had to make good 
electrical contact with the egg yolk. This was done in the opening in the vitelline membrane 
and further assisted at times by the application of a few drops of L15 or PBS. The electrodes 
also had to be oriented so that the plasmid, as it was being attracted to the positive pole 
would travel towards the desired location. This meant attempting to ensure that the neural 
tube was centred between- and parallel to- the electrodes and in the correct plane. When 
positioning the electrodes extreme care had to be exercised to ensure all these parameters 
were achieved and that the embryo was not disturbed too much and also that contact with 
the extra-corporal main blood vessels was avoided.
The gap between the electrodes was ideally set between 3mm and 5mm depending on the 
size and orientation of the embryo. It appeared that at a narrower gap the focus of the 
electrical pulse was too narrow to achieve a good electroporation result. At a wider gap it 
was assumed the voltage drop was too great, also resulting in poor results.
The electrodes initially used were an in-house construction using platinum wire but these 
were later changed to commercially-made gold-plated electrodes.
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The initial, test injections were made using with Fast Green dye dissolved in PBS and the 
GFP-reporter vector. Only when the electroporation was shown to function by the presence 
of GFP positive cells in the targeted area was the transgenic reporter vector (Hb9- 
ECRl:pl229) co-injected with the GFP.
Because the signal from the p!229 chromogenic vector is only expressed in response to 
specific signals within the cell and could only be observed following sacrifice of the embryo, 
a fluorochromic vector was co-injected with the pl229 reporter vector. This GFP-expressing 
produces a signal that is independent of intracellular signalling, is visible within hours, and 
being fluorescent, no processing of the subject is required.
3.4.6 Transfecting the chick embryos with the ECR1-Hb9:pl229 
construct.
The contents of fertilized eggs of fifty-five hours incubation, were placed in individual cling­
film hammocks and the embryos micro-injected with the plasmid mix (GFP - 2 figM ECR1- 
Hb9: pl229 - 3 pg/^l) and electroporated with 5 pulses of 40V at 50 msec pulse length and 
random intervals between pulses. Three embryos were successfully injected.
Following 44 hours in a passively humidified incubator at 37 °C two of the embryos were 
found to express fluorescence in the neural tube (Figure 40 A) and were processed as 
described in the Embryo Staining Protocol. Following 5 hours incubation at 37°C, blue 
staining, co-localised with the GFP fluorescence was observed (Figure 40,B).
The embryos were then processed as per "Harvesting Embryos" in Materials and Methods 
chapter, and 10 micron frozen sections were made. From these it can be seen that only one 
side of the neural tube is GFP-stained showing the integral negative control of this system ( 
Figure 40 C) and that the staining occurs in the motor-column of the neural tube (Figure 40 
D) matching the location in mouse (Figure 29).
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3.4.7 Hb9 antibody staining to identify location of the Hb9 protein
in Chick Neural Tube.
Hb9 antibody staining using M NR2 (University of Iowa) was found to stain the nuclei of the 
neural-tube motor-column (Figure 41). This was the same region that the ECR1-Hb9:pl229 
reporter plasmid construct caused staining ( Figure 40D). The negative control, using no 1° 
antibody is completely blank under fluorescent illumination (Figure 42).
The fact that staining occurred in the equivalent position in the chick to that previously 
demonstrated in the mouse (Figure 29) strongly indicated that this tool had functioned 
correctly in the chick embryo.
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Figure 40 Whole mount (A,B) and 10 micron sections (C,D) of embryonic day 4 chicks 
showing fluorescence (A,C) indicating the location of the electroporation and Hb9- 
enhancer LocZ-driven blue staining (B,D) following successful micro-injection and 
electroporation of the neural tube.
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Figure 41 Hb9 antibody staining is in the motor neuron column. (A) Embryonic day 5 chick 
neural tube (outer edge indicated with blue arrow) stained with MNR11° Antibody 
81.5C10 @ 1:5 (University of Iowa) highlights the motor column (orange arrows). (B) DARI 
staining of the same section indicating the location of the nuclei.
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Figure 42 Negative control of MNR1 antibody in 10 micron section of torso of HH stage 25 
chick. (A) Phase image showing neural tube, notochord and DRG, whilst (B) shows negative 
control fluorescent image of same section.
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3.4.8 Investigation into Transcription Factor Binding Sites found 
within the ECR1 enhancer ofHb9.
The 212bp sequence that had been cloned into the pl229 reporter vector was scanned for 
TFBS using the ECR Browsers link to TRANSFAC professional V10.2 and rVista V2.0.This 
showed that of the 53 TFBSs in the base sequence (Human) and 49 in the second sequence 
(chick) 19 TFs were conserved and aligned between the species. This indicates that this 
group of TFs could be important in the regulation.
Which TFs are driving the reporter gene expression? This still appears to be a nascent area 
with a paucity of specific information on what TF or group of TFs drive Hb9 expression. 
GATA1 (a.k.a. NF-E1) is a transcription factor that binds the regulatory regions of many viral 
and cellular genes (Becker et al., 1994).
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Figure 43. TFBS conserved and aligned between human and chick in the 212bp ECR 
upstream of Hb9(Mnxl) in chick that had been demonstrated to act as an enhancer. TFBS 
conserved between human and chick in the 125 bp enhancer region are indicated by 
arrowed line and appear to form three groups with GATA1 and HNF1_C forming groups 
on their own with the remaining TFBS in the other group. The region Hox/Pbx consensus 
sequence that Nakano disrupted and so destroy the enhancer effect is at the HNF1_C TFBS
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3.5 Discussion
As it had been unknown if an enhancer from a chicken inserted into the pl229 vector would 
function in chick it was necessary to test that it.
The ECR Browser (Ovcharenko et al., 2004) was shown to be a very useful tool in identifying 
the corresponding ECRs between chick and mouse because by using the ECR Browser to 
compare these two genomes the 125bp region that had been identified (Nakano et al.,
2005) as an enhancer of Hb9 in mouse was identified as an ECR in mouse and t the 
equivalent sequence was also shown to be an ECR in chick. The ECR grab function, a feature 
in earlier versions of the ECR Browser, was used to capture the DNA sequence, and flanking 
regions, of the chick ECR and from this generate suitable primers using the PrimerB program 
(Untergasser et al., 2007, Koressaar and Remm, 2007). Although difficulties were 
encountered in PCR-amplification of the ECR sequence from the whole-chick DNA the 
success at the lower TA of 55°C and 55.3°C by gradient PCR would indicate that the 
convention of setting TA at 2°C below TMwas ill-advised and that a greater temperature 
difference, such as a TA 5°C below TM would be more appropriate in this case. However care 
must be taken when lowering the TA as this increases the likelihood of the primers annealing 
to the wrong target (Metzenberg, 2007). Although PrimerB's method for calculating TM is 
sophisticated, such as using the oligo melting temperature formula and the table of 
thermodynamic parameters given in {Breslauer et al., 1986), this is still only an 
approximation of the empirical situation and may vary in accuracy with different DNA and 
primer combinations.
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As it was, the IA in the gradient PCR run that produced the product had a TA of 55.3°C putting 
it only 2.7°C below the lowest TM of the two primers as calculated by PrimerS. What is 
surprising is that two runs had previously been made at 55°C using a conventional PCR 
machine that resulted in no PCR product being produced. This may just random chance or 
might indicate a slight temperature differences between the two machines either of which 
could result in fewer primer-annealing events in the first few PCR iterations. Due to the 
exponential nature of PCR product formation small differences at the start of the cycle can 
result in huge differences after thirty iterations. This can result in sufficient PCR product to 
be easily observed for the reaction that had an adequate number of primer annealing 
events, and in the other case, where there was a low number of primer annealing events, 
too little PCR output to be observable.
The very bright GFP signal produced by the expression vector under its pActin promoter 
indicated that this functioned well in the chick neural tube. The in-built negative control was 
also shown to perform appropriately because only one hemi- section of the neural tube was 
found to GFP-stained indicating that the GFP-expression was not an artifact or of an 
endogenous nature.
The two major unknowns about how the pl229 reporter vector would function in chick 
were answered in this proof-of-concept process. These were whether pl229 would function 
when stimulated by binding of the correct TFs to the enhancer sequence or conversely 
would it be 'leaky' and drive the reporter gene without any stimulation. As previously 
discussed, some minimal promoters are 'leaky' in some tissues/organisms and so an 
appropriate minimal promoter must be selected. Both of these questions were answered 
during the work described in this chapter. The human pglobin promoter was indicated not to 
be leaky in two ways; firstly, empty plasmids that were transfected into chick neural tubes 
produced no signal and secondly and more telling, the reporter-vector-generated blue
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staining was located solely to motor-neurons, matching the location in the mouse as 
anticipated, even though the whole hemi-section of the neural tube was transfected as 
evidenced by the co-transfected GFP-expressing plasmid.
Due to the success of the blue staining produced by the chick Hb9: pl229 ECRl-containing 
construct proved to be very effective because out of four GFP-expressing chick embryos 
three of these were found to have expressed (3gal by showing blue stain upon processing.
Taken together, the results from this proof-of-concept showed that it was a robust positive 
control that had successfully demonstrated that the system functioned in chick.
This then served to instil sufficient confidence to proceed to the next phase in the process - 
testing the system against a putative enhancer from the LSAMP genomic region.
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Chapter 4.
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4 ECR adjacent to the LSAMP gene shown to possess enhancer 
functionality.
As previously described, some non-coding sequences that have been conserved over 
evolutionary time have been shown to act as enhancers of gene expression (Prabhakar et alv 
2006). These ECRs can be exposed by comparing the genomes of different species and 
identifying the non-coding conserved regions. By cloning these sequences into a suitable 
reporter plasmid and transfecting appropriate cells with this reporter construct, the reporter 
vector's signal will be expressed when the ECR sequence has acted as an enhancer.
It was demonstrated in the previous chapter how the Hb9-enhancer pl229-based reporter 
construct (ECR1-Hb9:pl229) functioned successfully in chick, by driving expression of the 
reporter gene LacZ in appropriate locations in the chick motor column. The next step in the 
process was to use the pl229 reporter plasmid to investigate if ECRs adjacent to, and within 
the LSAMP transcription unit, potentially act as enhancers. LAMP, a cell adhesion molecule 
of the IgLON family was selected for investigation due to its possible implication in anxiety 
(Nelovkov et al., 2006, Catania et al., 2008). LSAMP is a longer and more complex gene than 
Hb9. Because of the larger genomic extent of LSAMP the possibilities of where the 
controlling sequences may reside also increases as does the possibility that ECRs associated 
with other genes may be intermingled with those of LSAMP. Because LSAMP has a number 
of isoforms and is active in various tissues at different stages of development the exquisite 
control required to ensure its correct temporal and spatial expression are probably very 
intricate requiring many enhancer and repressor sequences. The search for enhancer 
regions in and around LSAMP is by its nature potentially more complex than searching for 
enhancers in a smaller, simpler, gene.
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4.1 AIM
The aim of this chapter is to select ECRs for testing as putative enhancers; to amplify these 
sequences and insert into a reporter plasmid; to inject these plasmids into the neural tube 
and brain of embryonic chickens and electroporate to generate transfected cells and to test 
if the ECR sequences act as enhancers by driving expression of 6Gal/LacZ within the reporter 
plasmid construct.
4.2 METHODS
4.2.1 Selection of first three ECRs in the genomic region of ISAM P 
in chick.
Following the positive results obtained from the Hb9 enhancer proof-of-concept, the region 
upstream of the short LSAMP genomic sequence, Figure 15, was scanned for ECRs by 
comparing chick (target) against human (base) using the ECR Browser (Ovcharenko et al., 
2004).
LSAMP contains many sequences designated as ECRs, for example between the distal and 
proximal TSSs (Table 11) it can be seen that there are 113 at stringency 100bps/70%. What is 
designated as an ECRs varies with the stringency employed as can also be seen in this table.
Length
specified/bp
Percentage
similarity
BASE:Chicken 
Target: Human
BASE:Human 
Target: Chicken
100 85 39 46
100 70 113 127
350 70 23 28
Table 12 Number of ECRs in LSAMP between proximal and distal TSSs at differing 
stringency. ECR Browser
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Due to the large number of ECRs a decision was made to start with the first three ECRs 
upstream of the proximal LSAMP JSS to see if the methodology would work prior to testing 
many more. These three ECRs were exposed at a stringency of 100bps/80% identity by the 
ECR Browser, this value giving a reasonable number of persistent ECRs The nearest ECR to 
the proximal TSS site, ECR1, was 29 kbp upstream of the TSS, in chick, with ECRs 2 and 3 
further upstream ( Figure 44, Figure 45). The Hb9 ECR had been much closer to the TSS i.e. 
1.7 kbp upstream in chick, 11 kbp in mouse( mu8 database build) and ~7.7 kbp(mu9 
database build) the 29 kbp found for LSAMP was well within the 60kbps distance at which 
the known human p-globin enhancers act(Porcu et al., 1997). ECR1 and ECR3 were still being 
exposed at 95% and lOObp, possibly due to its shorter length ECR2 disappeared at 90% and 
lOObp.
4.2.2 Design of primers to allow for directional cloning 
The ECR sequences plus flanking regions of 100bps were obtained from the ECR Browser and 
using Primer3 suitable primers were obtained for ECR1, ECR2 and ECR3 (Table 23,
Appendix). To allow for directional cloning restriction sites suitable for cutting by Notl 
(GCVGGCCGC) and Spel (AVCTAGT) restriction enzymes were appended . Because of the 
proximity of the restriction enzyme cleavage sites (marked by v) to the ends of the DNA 
sequences an extra four nucleotides, complementary to the DNA, were appended to the 5' 
end of the primers to allow for efficient restriction enzyme cutting. These extra nucleotides 
were selected to bind to the DNA sequences where possible but in the ECR2 reverse primer 
this would have resulted in a hairpin structure and the sequence was modified to avoid this 
(Table 23).
The DNA of all three ECRs was amplified by PCR as previously described in Materials and 
Methods, with TA=58°C. Following DNA purification by phase-lock gel the PCR product was 
double digested with Notl and Spel restriction enzymes (Fermentas FastDigest). The digested
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products were isolated by 1.8% gel electrophoresis and visualised by SyBR green fluorescent 
nucleic stain and found to be the expected sizes (Figure 47). The PCR product was then 
excised from the gel, glass-wool fractured, ethanol precipitated and re-suspended in water. 
Ligation into the pl229 reporter vector that had also been double digested with Notl and 
Spel (Figure 48) resulted in the desired ECRx-/.5/4/WP:pl229 constructs (where x = 1,2 or 3). 
These were transformed into E coZ/JOPlOF' (ECRl-L5y4MP:pl229) or DH5a (ECR2- 
LSAMPiplllS, ECR3-LS/\/WP:pl229) and the population expanded overnight and initial 
selection was made by spread plate. As blue/white screening is not supported by the pl229 
plasmid, colonies were chosen by their size, isolation from neighbours and their lack of 
satellite colonies. A scraping of the selected colonies was PCR-screened using the primers 
originally used to amplify the strands. The PCR output was then run through gel 
electrophoresis and a number of colonies from each ECRx-Z.5A/WP:pl229 construct were 
then selected, based on the appropriate molecular weight and the intensity of SyBR green 
signal from the band. Selected colonies were then expanded overnight and the plasmids 
extracted using a plasmid prep kit. Clones for plasmids containing ECR1 (clones R5 and 
ABM6), ECR2 (clones 5 and 8), ECR3 (clones F and I) were sequenced from the direction of 
both the T7 and T3 primers within the pl229 plasmid. All of the sequenced ECRx- 
LSAMP:pl229 plasmids were found to have the correct ECR inserted in the desired direction, 
i.e. from T7 promoter (Figure 77, Figure 78). The results obtained from the sequencing were 
of high quality, with only one nucleotide difference in the ECR sequences. If a higher fidelity 
had been required multiple sequencing passes would have been ordered. Many researchers 
have three sequencing runs as the default. The sequencing vendors also offered higher 
fidelity sequencing, at extra cost, but probably because of the short lengths of DNA involved, 
the basic service was found to be adequate. Sequencing technologies have continued to 
improve (Hall, 2007) and these massively parallel methods offer a high quality service at an 
affordable price.
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The transformed bacteria for each of the constructs were expanded overnight in LB broth 
with 50 pg/ pi ampicillin at 37°C in a shaking incubator and endotoxin-free plasmid-preps 
were made. As a final concentration of 2 - 6ug/pl was specified in the electroporation 
protocol the ECRx-LSA/WP:pl229 constructs were concentrated by ethanol precipitation and 
re-dissolved in PBS plus ImM Mg2+. They were then assayed to check concentration and 
A260/280pm ratio (Table 12).
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Figure 44 First 3 LSAMP ECRs. ECR Browser output for the first three LSAMP ECRs, showing 
(A) ECRs in the region upstream from Human LSAMP (RefSeq entry); Comparison made 
using Human as base organism and macaque, mouse, opossum, chick and frog as target 
organisms, using a stringency of 100bp/80%. As can be seen sequence similarity decreases 
with evolutionary distance. (B) Enlarged section showing the three ECRs in greater detail. 
The three selected ECRs are marked 1,2 and 3.
NOTE1: Due to an artifact of the system, although the pink ECR marker does appear, the 
vertical conservation plot for ECR2 does not appear in (A), but only emerges upon 
zooming-in as shown in (B).
NOTE2: The gene BZWILI, official name BZW1P2 basic leucine zipper and W2 domains 1 
pseudogene 2, is a pseudogene and therefore does not code for a protein (Muzny et al., 
2006).
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Figure 45 First three ECRs in chick. ECR Browser output showing (orientation flipped due 
to LSAMP being insertion in opposite direction between chicken and human), ECRs in the 
region upstream from chick LSAMP (RefSeq entry); Chick was used as the base organism 
and human as target organism. ECRs are marked 1,2 and 3 and were identified at 
100bp/80% stringency. The distance (bp) that ECR 1 is upstream of LSAMP and the gap 
between other ECRs are shown. The short LSAMP isoforms gll/gl9 are ~286,000 bp - see 
Figure 46
128
3 1
LSAMP g 19 - 2S6 kbps
chLSAMP ECRsI 2 3 
350.0 kb5kbps 2
Figure 46 Distance map of ECRs from gll/gl9 LSAMP isoform
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Figure 47 Amplification of ECR1, ECR2 and ECR3 from whole genomic Chick DNA. 1.8% 
agarose gel showing the (arrowed) amplified DNA fragments for ECR1 (expected size 
SOObp), ECR2 (expected size (200 bp), ECR3 (expected size 380bp).The negative control 
track (-ve) is empty for all ECRs. The 600bp line is identified on molecular weight marker 
track, each band below this is separated by lOObp. SyBR green was mixed with all samples 
prior to loading on gel resulting in the fragments running slower in the gel than they would 
without the SyBR green.
pi 229
Undigested Digested
Figure 48 pl229 showing size shift. pl229 double digested with Notl and Spel (track 
marked 'Digested') showing size shift against undigested pl229 (track marked 
'Undigested'). This size shift indicates that at least one of the restriction enzymes had 
functioned correctly.
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Plasmid Name Concentration
(Hg/pl)
Purity
(A260/ A 280 ratio)
ECRl-iSA/WP:pl229 6.7 1.62
ECR2-£SA/WP:pl229 11 1.63
ECR3-£SA/WP:pl229 11 1.62
Table 13 Concentration and purity of the ECRx-Z.S4MP:pl229 transgenic constructs. A 
minimum (A260/ A 280 ratio) of 1.6 is required
4.3 Injecting and transfection
4.3.1 Plasmid mix preparation, injection and electroporation.
The plasmid was mixed with the eGFP vector and Fast Green dye as previously described to 
give a final ECRx-LSA/V7P:pl229 of 2 - 6 pg/pl. and NT of embryos were injected and 
transfected by electroporation ( eight fast, manual pulses of 60V with electrode gap of 3-4 
mm). The final concentration of the ECR and GFP-containing plasmid mixes varied in 
different runs (Table 14) in the transfection procedures run for this chapter.
ECR Range of ECR Plasmid 
final [pg/pl]
Ratio ECR:GFP plasmids 
range
1 1.7-10.0 1.3:1 - 4.5:1
2 3.7-4.5 1.9:1-7.5:1
3 1.9-7.3 1.8:1-10:1
Blue staining at 4.4 2:1
Table 14 The range of the final concentration of p!229 plasmid containing ECR1, ECR2 and 
ECR3 used in the various transfections. The ratio of the ECR-containing plasmid and the 
GFP-expressing plasmid also shown. Blue staining was achieved at a final concentration of 
4.4 pg/pl of the ECRl-containing plasmid at a ratio of 2:1 with the GFP-containing 
plasmid.
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4.4 RESULTS
Following incubation, embryos which were successfully electroporated as evidenced by GFP 
staining (n=66) were processed to develop the chromogenic staining (Table 13). GFP staining 
of NT and co-localised 6-gal (Z.ocZ)-derived blue staining were observed in whole-mount 
embryos (Figure 49) and NT sections (Figure 50) for ECR3-LS/4MP:pl229 (n=10). As with Hb9, 
only a subset of ceils expressing GFP also stained blue (Figure 49) confirming that the human 
|3-globin promoter was not leaky. The inbuilt negative control for electroporation is evident 
in that only one side of the NT exhibits fluorescence (Figure 50) and that the staining is as a 
result of the plasmids and not due to endogenous expression. While 29 embryos were 
successfully electroporated with ECRl-containing plasmid, as evidenced by GFP-staining, no 
blue staining was observed and ECR2-LSAMP testing was abandoned as no embryos were 
successfully electroporated.
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Figure 49 Whole mount E4 chick embryos showing (A) GFP expression. (B) Composite 
image of GFP and (3gal expression as a result of ECR3, and (C) (3gal expression as a result of 
ECR3 producing the blue staining of a sub-population cells in the neural tube.
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Figure 50 Sections (10 microns) of E4 chick NT showing GFP staining (A) composite 
image showing GFP and (3gal co-localised (B) Pgal expression (C).
ECR3 was shown to be an enhancer for LSAMP with 27% of the embryos that expressed GFP 
also expressing 6-gal (LacZ) (Table 13).
The percentage of GFP-expressing chicks also expressing Pgal increased with post-injection 
incubation time, increasing from 22% at 48 hours, through 33% at 72 hours and to 40% at 96 
hours post-injection, although too few embryos were available at 96 hours for the result to 
be significant (Table 13). When post-injection incubation was allowed to proceed for 96 
hours, dating the embryo as E6, the blue staining became more widespread. Both these 
results are consistent with the possibility that the expression of LSAMP increases under the 
influence of this enhancer and becomes more extensive in the neural tube as development 
progresses, this may be concomitant with an accumulation of 6gal (Figure 52).
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Conversely none of the GFP-expressing embryos transfected with ECRl-LS>4MP:pl229 (n=29) 
produced any blue-stained cells indicating that ECR1 may be a repressor or that it was not 
activated at that stage of development, or that it does not possess a regulatory function. If 
ECR1 was an active enhancer it would be expected that about 7 of the ECRl-transfected 
embryos would also express 8-gal based on the GFP-to 6gal ratio of the ECR3-containing 
plasmid where 10 out of 37 were blue.
4.4.1 Transfection of chick Brain tissue using ECR3-LSAMP:pl229 
LSAMP was reported to be expressed in the anterior midbrain from stage 14 (Kimura et al., 
2001) so having established that this system functioned in the neural tube and was able to 
detect and report on the activation of enhancers an investigation into the brain was made to 
see if the NT success would be repeated.
Forebrain, Midbrain and Hindbrain regions were injected with ECR3-LSy4MP:pl229 at HH 
stages 10-12 (n=10). The GFP-staining in the brain was found to be positive and widespread 
indicating that the micro-injection and electroporation methodology functioned efficiently 
and that investigation of enhancer activity in the brain would be feasible using this system. 
No blue staining, however, was observed in the brain (Figure 53).
The lack of 6-go/-derived blue staining may either be due to lack of activation of the 
enhancer in the brain tissue at this developmental stage or too low a concentration of the 
ECR3-LSAMP:pl229 construct due to the large lumen in the brain at this age. To ameliorate 
this, the plasmid-concentration was increased and the bolus was deposited immediately 
adjacent to the target tissue but to no avail so ECR3-LSAMP may not act as an enhancer at 
this stage or in this tissue.
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ECR Location
of
Injection
H.H.
Stage
when
Injected
Hours
incubated
post-injection
H.H.
Stage
when
Harvested
GFP
+ve
embryos
fSGal
+ve
embryos
% blue embryos
of those that
were GFP+ve
ECR3 NT 14 48 23 23 5 22
72 25 9 3 33
96 28 5 2 40
Both 72+96 25 + 28 14 5 36
37 10 27
ECR3 B 11 48 23 4 0 0
72 25 6 nV 0
■■I jph- 10 0 0
ECR1 NT 14 48 23 7 sir 0
72 25
orsiCM 0
Total NT 29 | 0 0
Table 15 Summary of the results of the embryos injected with ECRl-LSAMP:pl229 and 
ECR3-LSA/WP:pl229 reporter indicating the location (NT - neural tube, B - brain) the 
Hamburger-Hamilton stage, the number of embryos expressing GFP and pgal and 
percentage of the GFP-expressing embryos that also expressed pgal resulting in blue 
staining.
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ECR3 NT
Number of GFP positive 
embryos that are f) Gal positive
ECR3 Brain
Number of GFP positive 
embryos that are 0 Gal positive
' aD 48 7
Hours post injection Hours Post motion
Figure 51 (A) Expression of GFP and ECR3-LSAMP-derived P-gal staining in chick neural tube by post-injection 
time and (B) GFP staining in brain.
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Figure 52 ECRB-driven blue staining at 96 hours post injection in sequence of 10 pm section 
taken from the neural tube in an anterior to caudal direction. Sections are bright field 
view of HH Stage 28 embryo NT (dorsal at top right) transfected with ECRB-containing 
pl229 reporter vector showing extensive blue staining 96 hours incubation post injection.
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Figure 53 GFP expression in brain region of chick embryos at 48 hours post-injection (HH 
stage 23). Image of HH stage 23 injected at HH stage 10 in midbrain hindbrain region with 
ECR3-containing pl229 plasmid co-injected with GFP-expressing plasmid. No blue staining 
was visible following processing.
LAMP antibody staining was undertaken to show the location of LAMP expression. If, as 
expected, ECR3-LSAMP drives LAMP expression the blue staining should be co-located with 
the antibody-driven staining.
LAMP antibody-staining of an E6 chick's neural tube showed the LAMP-expressing region to 
be in the region of the commissural axons and not so highly expressed where the Pgal 
expression had been indicated Figure 54. The (3-gal is expressed in the soma of the neurons 
and the LAMP expressing axons of these developing neurons come into close proximity at 
the commissure as would growth cones of developing axons at the moment resulting in this 
obvious antibody staining. The fact that LAMP is a membrane protein may explain the 
pattern of staining due to the relative amount of membrane in the axons compared to the 
lower amount in the soma.
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Figure 54 E4 chick NT sections. (A) ECR3-/.SA/WP-driven Pgal staining (B) LSAMP antibody 
staining very evident at commissure.(C) Diagram of neural tube indicating cell bodies of 
commissural neurons and their axons.
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4.5 Transcription factor binding sites located within ECR1, ECR2
and ECR3 of the LSAMP gene.
Upon analysis of the transcription factor binding sites within the ECRs it was found that ECR2 
had only four conserved TFBSs in 2 groups (Figure 55) of which only two (PAX3, MEISl-using 
simplified names), were in the FANTOM4 database. No interactions between them were 
indicated.
Within the ECRl-sequence there were 32 conserved TFBSs in about 9 groups (Figure 56) and 
within the ECR3-sequence there were 33 conserved TFBSs in about 10 groups (Figure 57) 
indicating that ECR1 is as complex as ECR3 and some effect could be expected from it. As 
many of these TFBSs share much of the same motif it is probable that the number of groups 
is of higher significance than number of individual TFBSs. With ECR1 it is interesting to note 
that there are two TBP (TATA box binding protein) binding sequences. TBP is usually found in 
the promoter region 25bp upstream of the TSS.
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Figure 55 ECR2-LSAMP: 4 conserved TFBSs showing their relative positions, overlapping to 
form 2 groups. Base organism Human, target organism Chick. (TRANSFAC Professional 
V10.2 library, analysed by rVISTA V2.0 (Loots and Ovcharenko, 2004) accessed through 
ECR Browser)
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Figure 56 ECR1-LSAMP: 32 conserved TFBSs showing their relative positions and 
overlapping to produce ~9 groups. Base organism Human, target organism Chick. 
(TRANSFAC Professional V10.2 library, analysed by rVISTA V2.0 (Loots and Ovcharenko, 
2004) accessed through ECR Browser)
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Figure 57 ECR3-L5AMP : 33 conserved TFBS showing their relative positions and
overlapping to form ~10 groups. Base organism Human, target organism Chick. (TRANSFAC
Professional V10.2 library, analysed by rVISTA V2.0 (Loots and Ovcharenko, 2004)
accessed through ECR Browser)
143
4.6 Discussion
During the work done to complete this chapter the embryo-handling, injecting and 
electroporation methodologies were refined and improved. Although only a 21% success 
rate of injections (n=465) to GFP-expressing embryos (n=99) using the current battery- 
powered eiectroporator was achieved it was being proposed that a newer electroporator 
should be obtained which would hopefully provide better results. The current electroporator 
had no pulse rate facility or over-current protection and the voltage setting (40V-60V) that 
we had to use to achieve transfection was higher than the norm of 20V-25V (Itasaki et alv 
1999) possibly leading to damage of the embryo.
This system was shown to be able to identify ECR3-LSAMP as an enhancer of gene 
expression and to differentiate between a functional enhancer and ECRl-iSAMP which was 
not shown to be an enhancer and at this stage in development in this particular tissue.
Of interest was the fact that only some of the embryos that had been successfully 
electroporated (as indicated by the GFP staining) also stained blue. It is unlikely that this 
difference was a result of differential expression of TFs by the embryos because others 
processed at the same stage of development stained blue. If only a subset of the neurons 
activated the enhancer and none of these particular cells were successfully electroporated in 
the pGal-negative cells, this may explain the observed result. An alternative explanation 
might be that blue was expressed but at such a low level that it was not observed, a 
fluorescent reporter may prove more detectable.
The final concentration of the ECR-containing plasmid nor the ratio of the ECR and GFP- 
containing plasmids did not seem to be a contributory factor as the ranges tested
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overlapped that of the transfection that resulted in the ECR3-containing plasmid producing 
blue embryos (Table 14).
A variable not fully catered for here is the amount of plasmid that was injected and/or 
remained in the neural tube at the time of electroporation. As the neural tube closes up in 
line with increasing development age it was attempted to ensure that all the embryos were 
at the same HH stage at time of injection. As it was impossible to obtain eggs that had been 
fertilized and held in exactly the same conditions until injection, this was impossible to 
achieve and so embryos at a range of development stages were found in each batch of 
injections. A further complication was that the variations in development stages became 
more pronounced the longer the fertilized eggs were held in cold-storage prior to injection. 
Another issue was that, at times, there was leakage of the plasmid some of the injected 
bolus naturally leaked from the neural tube, and although speedy working helped 
ameliorate this. Taken together, the size of the neural-tube's lumen and the amount of 
leakage would have caused variations in the amount of plasmid available for the 
electroporation stage.
Evidence would indicate that ECR3-LSAMP acts as an enhancer of LSAMP in the neural tube 
of E4 to E6 chicks, but no indication that it was acting as an enhancer in the brain at E4/E5 
was observed. There are several possible reasons for this such as the avian equivalent of the 
limbic-system had not yet developed or that expression of the reporter gene was insufficient 
to produce observable staining.
There is no evidence to support ECR1-LSAMP as an enhancer at this stage of development in 
the neural tube. Further testing for repressor function would be informative.
Although ECR2-LSAMP had been tested on only a few embryos (n=30), no GFP-positive 
results were obtained probably due to a failure of electroporation.
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Upon analysis of the transcription factor binding sites within the ECRs it was found that 
ECR2-LSAMP had only four conserved TFBSs in 2 groups {Figure 55). Because TFBSs and their 
associated TFs work in a co-operative manner, ECR2-LSAMP may not be a very significant 
moderator of gene expression on its own and probably should not have been be tested in 
isolation i.e. the plasmid should have incorporated at least one of the other ECRs. 
Investigation into ECR2-LSAMP this was dropped as the number of TFBS was so low.
Further testing of ECR2-LSAMP in conjunction with other ECRs may indicate if it possesses a 
moderating function, but this was not undertaken. It may be, for example, that ECR2-LSAMP 
is a repressor of ECR3-/.S>A/WP and if both ECR2-LSAMP and ECR3-LSAMP had been 
incorporated into the reporter construct the response from ECR3-LSAMP may have been 
reduced.
Why ECR3-LSAMP drove expression and ECR1-LSAMP did not is unknown. Naturally it is the 
population of TFs that populate the TFBSs that ultimately decide if a sequence has enhancer 
or indeed repressor functionality. ECRs 1 and 3 both had TFBSs for 9 and 10 groups 
respectively whereas ECR2-LSAMP had binding sites for 2 groups. This may mean that ECR2- 
LSAMP has very specific controls or that its effect is minimal. However, this does not explain 
why ECR3-LSAMP functioned as an enhancer and ECR1-LSAMP did not which must be related 
to the TFBSs in the ECR and the specific population of TFs being expressed at this stage by 
the cell.
While ECR3-LSAMP has been demonstrated to be an enhancer the function of the other two 
ECRs is as yet unknown. This system does not identify repressor function and so it is possible 
that ECR1-LSAMP and ECR2-LSAMP are repressors, or not active at this stage of 
development or have no regulatory function.
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Although the evidence indicates that enhancers are orientation independent these three 
ECRs were inserted into the into the reporter vector in the same orientation as they are in 
the genome. Orientation independence was not tested for these three ECRs however results 
for the ECRs subsequently selected (Chapter 5) support the argument that enhancers are 
indeed orientation independent.
The results presented in this chapter show that the system was suitable for analysing ECRs 
for enhancer function as indicated by the results obtained for E.CR3-LSAMP.
147
Chapter 5
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5 Selection of additional LSAMP ECRs
The previous chapter described how the ECR designated as ECR3-LSAMP was shown to drive 
Pgal expression. Having established that the tool worked, further ECRs needed to be 
investigated for enhancer activity in order to establish if ECRs could be rapidly screened 
using the chicken as a model.
Enhancers of gene expression are understood to be location independent (Banerji et al., 
1981) however it would seem to be reasonable to expect that at least some of the control 
would be close to the target regions. For selection of the next tranche of ECRs the genomic 
region was divided into three regions; upstream of the g9 TSS to next gene IGSF11 (Group 1), 
between the g9 and gll/gl9 TSS (Group 2), within the gll/gl9 transcription unit (Group 3). 
The three original ECRs {ECR1-LSAMP, ECR2-LSAMP and ECR3-LSAMP) were located 
upstream of the gll/gl9 TSS and so form part of the new 'Group 2' (Table 14,Figure 58).
5.1 LSAMP Expression profile
As indicated in Chapter 1, during early embryogenesis LAMP expression was found to be 
active by HH stage 10 in the anterior region of the neural tube However at stage 14, the 
expression was limited to most of the neural crest ceils, the anterior midbrain region and the 
notochord. The notochord expression was absent at stage 25 but expression had moved to 
the floor plate and the lumbar region of the motor neuron columns. At the later stages of 
development, expression in motoneuron columns was seen at all levels of the spinal cord 
(Kimura et al., 2001).
5.2 AIM
The aim of this chapter is to continue to test the ability of this model to rapidly screen for 
enhancer activity in ECRs in the LSAMP gene's genomic region.
5.3 METHODS
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5.3.1 Selection of the additional ECRs in the chick LSAMP's 
genomic region.
Initial identification of suitable ECRs was based on obtaining sufficient ECRs, using the ECR 
Browser, to provide a representative sample from these three regions by varying the 
stringency of selection (Table 14). The 16 ECRs thus selected were reduced to 8 by selecting 
those ECRs that were the longest and contained the highest number of discrete groups of 
TFBSs whilst ensuring there was representation from each group (Table 14). This resulted in 
the following list of ECRs:Group 1 - G1E2, GlE3;Group 2 - G2E4,G2E5,G2E6; Group 3 - 
G3E3,G3E4,G3E5 (Figure 58,Table 15). The numbering convention for the ECRs within the 
groups used the proximal TSS as the reference point with the ECR number increasing from 
this point, upstream and downstream.
The ECR regions were expanded by PCR from whole-chick DNA as previously described in 
Materials and Methods, and DNA regions were TA cloned into pCRII, expanded overnight 
and screened for putative enhancer sequence. Positive clones were expanded and digested 
to release the DNA fragment which was then ligated into pl229.
Because enhancers are understood to be orientation-independent as well as location- 
independent (Banerji et al., 1981), directional cloning was not undertaken for these ECRs. To 
obtain the expanded population of ECR sequences all that was required to R.E. digest them 
from pCRII's Notl and Spel restriction sites. A benefit of this was that the process of 
amplifying the putative enhancer region was simplified by not having to clone in suitable 
restriction enzyme sites.
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Region Group Location Number of ECRs at specified stringency
100bp/
70%
350bp/
70%
350bp/
75%
350bp
/79%
350bp/
80%
Total region IGSF11 
to end of gl9/gll
(ALL)
1,2,3
chrl:84259128-
85558083
IGSF11 to g9 isoform 1 chrl:84259128-
84587321
29 4 3 0
g9 to start of 
gll/gl9
2 chrl:84587321-
85272240
113 24 12 7 6
gl9 isoform
(refseq)
3 chrl:85271704-
85558083
50 13 6 0
Table 16 Genomic extent of ECR groups (all groups, top row) and number of ECRs (in
bold/white box, where initial selection made) at various stringencies. Group 1 ECRs 
selected at a stringency of 350bps/70% similarity, Group 2 at 350bps/80% similarity 
and Group 3 at 350bps/70% similarity.
151
(G3E3)
G1E3
G1E2
(G2E6) ECR3
(ECR2)
IGSF11
TSS'
4 Group 1
G2E5
(G2E4)
■ GAP43LSAMP - long
LSAMPIGSF11 to GAP43 
1400.0 kb
Group 2
Figure 58 Isoforms of chicken LSAMP.
All isoforms of chicken LSAMP showing the location of the proximal transcription start 
site (EXON1 TSS) and upstream transcription start site (TSS'). Double-headed arrows 
indicate the genomic region Groupl, GroupZ and Groups. The location of the original 
ECRs ( ECR1-ECR3, shown with old nomenclature) and the second tranche of 8 ECRs 
(GxEy). V indicates the Group number (1, upstream of distal TSS; G2 between the 
distal and proximal TSSs; 3 within the transcription unit of the gll/gl9 isoforms) and 
V indicates the ECR number. ECRs resulting in no |3gal expression are shown in round 
brackets. No GFP was obtained when GECR4 (G2E4) was used. Central line is 1.2 Mbp.
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Table 17 ECRs initially selected over complete LSAMP test region with final selection of 
ECRs shown by name (GxEy). Location of ECRs in relation to the genome in chicken, length 
of ECR shown and percentage identity between chick (base organism) and human . 
Original three ECRs (ECR1,2 and 3) also shown.
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5.4 RESULTS
5.4.1 Injections and Transfections into chick Neural Tube
The neural tube (n=132) and brain (n=32) of chick embryos at HH stages 10 through 14 were 
co-injected using the new LSAMP ECRs (GxEy) subsequently electroporated. The GFP 
expression that was observed in many of the embryos highlighted the regions of the 
embryos that were successfully injected and electroporated. Co-expression by the ECR- 
containing reporter plasmid was visualised as blue staining alongside the GFP expression and 
this was observed in the neural tube for 5 ECRs (G1E2, G1E3, G2E5, G3E4, G3E5) and 
included at least one ECR from each group. Blue staining was not observed in embryos 
injected with plasmids containing the 3ECRs (G2E4, G2E6, G3E3) (Table 16).
5.4.2 Sectioning the Chick Neural Tube to investigate location of 
PGal-derived blue stain.
To investigate if the individual ECRs were activated by different sub-populations of cells that 
could be identified by their location or migratory paths, cryostat sections of the blue-staining 
embryos were analysed. To assist orientation a diagram of the neural tube morphology is 
shown below in Figure 59.
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ECR NAME 
(GX,ECRy)
ECR
Length
/bp
Orientation
Location
Inj
Cone
ug/yi
Hours
Post
Inj action
Embryos 
Alive &
Transfected
Embryos/
Active
enhancer
% Transfected 
Embryos with 
enhancer
1,2 307 Fwd NT 5.32 48 4 1 25
1,3 366 Rev NT 2.3 48 14 8 57
2,1 (ECR1) 486 Fwd NT 3.2 48 7 0 0
NT 72 22 0 0
2,2 (ECR2) 205 Fwd NT 4 48 3 0 0
2,3 (ECR3) 380 Fwd NT 4.4 48 23 5 22
NT 72 9 3 33
NT 96 5 2 40
Brain 72 3 0 0
2,4 509 Rev NT 5.05 48 2 0 0
(No GFP)
NT 72 6 (No GFP) 0 0
Brain 72 2 (No GFP) 0 0
2,5 612 Rev NT 3.9 48 7 1 14
NT 72 8 3 37
2,6 459 Fwd NT 3.0 72 6 0 0
3,3 385 Fwd NT 5.0 72 7 0 0
Brain 72 4 0 0
3,4 318 Fwd NT 2.2 48 7 4 57
Brain 72 3 0 0
3,5 403 Fwd NT 2.88 72 8 6 75
Table 18 Summary of data for injections of the 8 ECRs into neural tube (NT) and brain 
showing ECR NAME (e.g. G1E2), length of ECR, injection concentration of pl229-based 
transgenic reporter vector, time incubated post injection, embryos alive and successfully 
transfected, embryos alive and transfected successfully at time of harvesting (48hrs or 72 
hrs post injection), embryos containing active enhancer and so staining blue, percentage 
of embryos successfully transfected that contained an active enhancer. Original 3 ECRs 
included for clarity.
155
Figure 59 HH Stage 25 chick neural tube showing lumen of neural tube, ventral zone (VZ), 
intermediate zone (IZ), Medial Zone (MZ), Motor Column (MC) and Floor plate (FP).
5.4.3 Co-expression ofGFP and LacZ/pGal derived Blue Staining 
Blue staining in the NT of the embryos was driven by at least one ECR from each of the three 
groups. G1E2, G1E3, G2E3 (ECR3) from previous chapter, G2E5, G3E4 and G3E5 all produced 
blue staining (Table 16).
The whole-mount torso of the embryo injected into the central canal of the with G1E3 in 
Figure 60 is representative of the blue-stained embryos and shows the regions with the GFP 
expression Figure 60A highlighting the areas injected and electroporated and the 
corresponding blue staining in Figure 60B indicates the regions the reporter vector produced 
ECR-driven LacZ.
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5.4.4 LSAMPECRG1E3
Of the 16 embryos injected with G1E3,88% (n=14) were expressed GFP and of these 57% 
(n=8) also exhibited blue staining due to (3gal expression. A representative whole-mount 
embryo, in dorsal view, is shown in Figure 60. In order to analyse the cellular distribution 
across the neural tube 10 micron sections were made with differing expression patterns 
being observed.
In the section shown in Figure 61 GFP is expressed as a streak of highly localised staining 
about halfway down the dorso-ventral axis and running in a lateral direction. There are some 
fainter streaks more ventral than and dorsal this and there is a more diffuse arc of blue the 
dorsal end which could be neural crest cells. The amount of GFP staining evident is far 
greater than the amount of blue indicating either that the G1E3 enhancer becomes activated 
only in the stained subset of cells or, what is more probable, the LSAMP is not fully 
expressed at this stage, HH 23, of development.
The next section, shown in Figure 62, shows a fainter, less definite, streaked configuration 
that ranges from the dorsal (surface area) to as deep within the tissue as the GFP 
fluorescence is evident. An even more diffuse expression pattern is also apparent (Figure 63) 
although streaking is also discernible.
In all cases the blue staining is localised to the neural tube although GFP staining occurs in 
other areas such as the commissural neurons and the DRG which is especially evident in 
Figure 63. The DRG cells come from transfected neural crest cells that delaminate and 
migrate to form the DRGs. This indicates that these areas have been transfected but the 
G1E3 ECR is not being activated as an enhancer in this tissue at this time.
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Figure 60 G1E3 HH stage 23 chick injected into Neural Tube at HH stage 14 with GFP
plasmid and GlE3-containing pl229 reporter vector electroporated and incubated for 
48 hours. (A,B) Overall view of whole-mount embryo (caudal, left; rostral, right; limb 
buds identified with asterisks in(B)). (C,D) Rotated and cropped images of A and B 
respectively with the extent of the NT region in C and D is indicated by arrow heads in 
B. (A,C) Successful injection and electroporation visualised by green fluorescence. 
(B,D) blue chromogenic staining indicates that the ECR G1E3 functions as an enhancer.
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A B C
Figure 61 G1E3 10 micron section of E4 (HH stage 23) chick neural tube co-injected and 
electroporated at HH stage 14 chick with GFP plasmid and GlE3-containing pl229 plasmid 
construct, electroporated and incubated for 48 hours showing (A) intense staining 
(arrowed) but (B) with GFP intensity at similar levels to regions of faint, or even no visible 
blue indicating the specificity of the ECR.(C) Anti-GFP staining matches the GFP staining, 
and in this case the red fluorescent staining is less streaky than the green in image B.
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A B
Figure 62 10 micron section of E4 (HH stage 24) chick neural tube co-injected and 
electroporated at HH stage 14 chick with GFP plasmid and GlE3-containing plasmid, 
electroporated and incubated for 48 hours. (A) Successful injection and electroporation 
visualised by green fluorescence. (B) Blue chromogenic staining evident in dorsal region of 
NT indicates that the ECR functioned as an enhancer at this stage. The streak-like staining 
pattern may indicate that these are radial glia.
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A B
Figure 63 G1E3 Emb4R SIS C. Streaks of GFP partially correspond to diffuse blue staining.
The dorsal root ganglion (DRG) is well labelled with GFP but with no sign of blue thus 
indicating the specificity of the ECR.
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5.4.5 LSAMPECRG2E5
With G2E5, 88% (n=15) of the 17 embryos injected expressed GFP, however only 27% (n=4) 
also expressed pgal driven blue staining.
Electroporation was successful as evidenced by the extensive GFP staining in the whole 
mount (Figure 64 A) but the blue staining appears fainter than would be expected from the 
example of G1E3 (Figure 63). This may be because G2E5 is activated in a different, and 
perhaps more discrete, subset of cells. The blue staining can be seen to be very intense in 
section and visible in dorsal medial and lateral regions (Figure 65 A,D), although GFP is 
visible throughout the hemi-section (Figure 65 C, E) indicating the success of the 
electroporation with the specificity of the blue staining indicating the preciseness of the 
G2E5 activity. GFP stained cell are also visible in marginal zone (Figure 65 B, E), where their 
orientation appears to be dorsal-ventral and there is corresponding blue staining within this 
region indicating that G2E5 is activated as an enhancer (Figure 65 D,G). The boxed LacZ- 
expressing region enlarged from Figure 65B shows the most dorsal blue staining (dosed 
arrow) and the most intense blue (open arrows) (Figure 65 D) and GFP staining (Figure 65 E) 
and bright-field image (Figure 65 D) and GFP fluorescent (Figure 65 E) are shown as merged 
(Figure 65 F). The merged image (Figure 65 F) shows the co-localisation of the GFP 
fluorescence and the chromogenic blue staining. The strongest blue and GFP signals appear 
to be co-localised and no quenching of the GFP by the blue is observed ( Figure 65 D,E,F) 
whereas the blue-fluorescent DAPI signal (Figure 65 G) appears quenched or masked 
indicating that the blue staining could be within the cell bodies.
In a separate embryo, as shown as a transverse plane piece of trunk in Figure 66, although 
the whole hemi-section of the neural tube and the DRG have been transfected as evidenced 
by the GFP only a single very strong blue band was generated in the dorsal region (arrowed 
in Figure 66 A). This again may show the early stage of LSAMP expression. In this case the
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blue staining appears to be quenching or masking the GFP (arrowed in Figure 66 B) perhaps 
indicating that the blue staining is nearer the surface than the green fluorescence.
A B
Figure 64 G2E5 images of HH stage 23 chick injected into Neural Tube at HH stage 14 with 
GFP plasmid and G2E5-containing pl229 transgenic plasmid construct and electroporated 
and incubated for 48 hours. (A,) Successful injection and electroporation visualised by 
green fluorescence. (B,) blue chromogenic staining indicates that the ECR functions as an 
enhancer.
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A B C
D E F
G
Figure 65 G2E5 Emb C T2 SI4 C. Blue staining visible in dorsal region only (A,D) although 
GFP is visible throughout hemi-section (B E). GFP stained cell visible in marginal zone 
(arrowed as MZ) (B E), orientation appears to be dorsal-ventral and the corresponding 
blue staining can be seen (D and G). Boxed LacZ-expressing region enlarged from above (B) 
showing the most intense blue (D) ( Black and open arrows) and GFP staining (E) co­
localised . This co-localisation is shown in Image F, a merging of images D and E; the GFP 
and chromogenic blue staining can be seen in the MZ as indicated by pale blue and dark 
blue arrows. The DAPI signal (G) appears quenched or masked (pink open arrows) by the 
blue chromogenic stain.
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A B
Figure 66 (A & B) Cross section view of piece of trunk showing discrete blue staining 
(arrowed). (B) The DRG is marked as is the electroporated "control side of neural tube".
5A. 6 LSAMP ECR G3E5
In some of the early sections GFP expression appeared to be poor and also what seemed to 
be the blue stain quenching the GFP. In an attempt to enhance the detection of the GFP 
signal, the sections were treated with GFP antibody and a secondary red-fluorescent stain. 
The results were disappointing in this instance with the original GFP signal being as strong, if 
not stronger, than the GFP antibody results (Figure 68 A (GFP), B (GFP antibody).
The blue staining in the whole mount image (Figure 67 B) is clumped and very intense. This 
intensity is reflected in section Figure 68 C but also probably by the dorsal location of the 
stained section. The blue staining is very localised although the GFP staining (Figure 68 A) 
and GFP antibody staining (Figure 68 B) indicate that the whole depth of the section was
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successfully transfected, therefore the lack of blue staining was not due to restricted 
transfection.
To see if the staining patterns are co-tocalised overlays of the section images (Adobe 
Photoshop CS6) were made. The green, GPP image and the red, GFP antibody-stained 
images, Figure 68 A and B, were automatically aligned using Adobe Photoshop CS6 Auto- 
Align facility to produce Figure 69 C. The images containing the blue staining had to be 
manually aligned due to the blue image and the GFP and GFP-antibody images being less 
than the minimum 40% overlap required.
The overlay image shows that although there is extensive co-localisation of the GFP 
fluorescence and the red fluorescent GFP antibody indicator this co-localisation is not 
uniform (Figure 69 C) as indicated by the green (GFP fluorescence only), red (GFP antibody 
only) and yellow (co-localisation of GFP fluorescence and GFP antibody).
In a separate embryo, also positive for blue staining, the expression pattern was observed 
ventrally in both the ventricular zone (VZ) the intermediate zone (IZ), and medial to the 
motor column (MC) (Figure 70). The expression pattern here contrasts with the previous 
embryo where the expression was dorsal. This difference in the enhancer expression pattern 
between the two embryos shows that this enhancer probably drives expression from the 
dorsal to ventral regions of the NT.
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vl<f
Figure 67 G3E5 images of HH stage 24 chick injected into Neural Tube at HH stage 14 with 
GFP plasmid (A,B) E/G3E5pl229:i5A/WP transgenic plasmid construct and electroporated 
and incubated for 48 hours. (A) Successful injection and electroporation visualised by 
green fluorescence. (B,) blue chromogenic staining indicates that the ECRs functions as an 
enhancer.
A B C
Figure 68 (G3E5 Emb B SI A1 A) Comparison of 10 micron section of HH Stage 24 (E4) 
chick neural tube stained using three methods. (A) electroporation success indicator 
indicated by green fluorescent staining (B) GFP antibody staining indicating location of 
the GFP (C) blue chromogenic staining indicates that the G3E5 ECRs functions as an 
enhancer.
(A,B) GFP visible throughout Ventral zone, intermediate zone and motor column but blue 
staining mainly confined to dorsal region (yellow arrows). Note too that the intensity of 
blue staining (C) does not correlate to the intensity of the GFP staining (red or white 
arrow head (A,B)).
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cA B
Figure 69 (G3E5 Emb B SI A1 A) Comparison by overlay of 10 micron section of HH Stage 
23 (E4) chick neural tube stained using three methods. (A) Electroporation success 
indicator indicated by GFP antibody stain indicated by red florescence and blue 
chromogenic staining indicates that the G3E5 ECRs functions as an enhancer.
(B) GFP staining indicating location of the GFP and same blue chromogenic staining 
indicating that the G3E5 ECRs functions as an enhancer. (C) GFP (green fluorescence) and 
GFP antibody (red fluorescence) images overlaid to produce yellow colour where GFP 
fluorescence and red (GFP antibody indication) fluorescence coincide.
(A,B/C) GFP visible throughout Ventral zone, intermediate zone and motor column but 
blue staining (A,B) mainly confined to dorsal region ( arrows). Note too that the intensity 
of blue staining is very localised.
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A B C D
Figure 70 G3E5 Dots of blue staining are visible ventrally in the VZ and the IZ (A). 
Subsequent images show nuclei stained with DAPI (B), anti-GFP Ab with Alexa 2° Ab (C) 
and GFP fluorescence from the transfecting GFP (D).
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5.4.7 LSAMP ECRs G1E2 and G3E4
Both the ECRs G1E2 (Figure 71) and G3E4 (Figure 72) were shown to be active in neural tube 
tissue at this stage of development with G1E2 appearing to be more prolific than G3E4„ This 
may, once again, indicate differential activation of the ECRs in either or both a temporal or 
location-dependent manner.
A B
Figure 71G1E2 Images of HH stage 14 chick injected into Neural Tube with GFP plasmid 
and (A,B) E/GlE2pl229:L5AMP transgenic plasmid construct and electroporated and 
incubated for 48 hours. (A,) Successful injection and electroporation visualised by green 
fluorescence. (B,) blue chromogenic staining indicates that the ECR functions as an 
enhancer.
A B
Figure 72 G3E4 Images of HH stage 14 chick injected into Neural Tube with GFP plasmid 
and (A,B) E/G3E4pl229:LSA/WP transgenic plasmid construct and electroporated and 
incubated for 48 hours. (A,) Successful injection and electroporation visualised by green 
fluorescence. (B,) blue chromogenic staining indicates that the ECR functions as an 
enhancer.
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5.5 LSAMP ECRs with no evidence of activity
No blue staining was observed from the following ECRs; G2E1, G2E6 and G3E3, although GFP 
expression was present.
5.5.1 LSAMP ECRG2E1
An example, G2E1, is shown in Figure 73 where it can be seen that although the GFP 
expression is strong no corresponding blue stain is observed.
A B
Figure 73 G2E1 HH stage 14 chick co- injected into Neural Tube with GFP plasmid and 
G2E1-L5AMP containing pl229 transgenic plasmid construct and electroporated and 
incubated for 48 hours. (A) Successful injection and electroporation visualised by green 
fluorescence. (B) lack of blue chromogenic staining indicates that the ECR did not function 
as an enhancer at this stage.
5.5.2 No GFP or LacZ-driven Blue Staining produced by LSAMP 
ECR G2E4
For one ECR, G2E4, no GFP or blue staining was observed. The G2E4 ECR appeared to 
quench the expression from the GFP plasmid although 23 embryos were injected into the NT 
and 6 were injected into the brain with plasmid containing this ECR. The reason for this is 
unknown, although it may have been due to a bad plasmid-prep as due to time constraints 
only one of these was run.
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5.5.3 Amount of Blue Staining increased with embryo's age 
Embryos that expressed GFP were initially incubated for 48 hours (n=34) prior to staining but 
as viability improved and in order to see if staining continued and might increase in line with 
development stage the post-injection incubation time was extended to 72 hours (n=35) for 
two ECRs, because LSAMP expression is known to increase as the embryo develops. The 
percentage of the embryos that stained blue varied between enhancers, G3E5 (n=8) 
achieved 75% whereas G1E2 (n=4) only achieved 25% (Table 16) perhaps indicating the 
different activation pattern of the two ECRs.
5.5.4 Ratio of Blue-stained embryos to GFP-stained embryos 
increases with post-transfection incubation time.
Although the numbers of embryos the were blue- and GFP- stained is a factor of the 
numbers processed and harvested at a particular time-point (e.g. 48 hours incubation), with 
the neural tube injections the proportion of embryos displaying blue staining increased with 
incubation time which is in-line with the expected increase in LSAMP expression over time at 
later embryonic stages (Figure 74).
As most of the embryos from the ECRs investigated in this chapter were all harvested at the 
same development stage ECR3-LSAMP (G2E3) from the previous chapter was used for 
comparison with G2E5 as embryos for both of these were harvested at, at least, two 
different development stages (Figure 74 C). The increase in blue was also found when ail the 
blue-stained ECRs tested were analysed (Figure 74 D).
(A) (B)
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G2E3(ECR3)
Hours post-injection Hours post-injection
(C) (D)
All New ECRs
o-
96hrs 120 hrs
Hours developed
IZZ196 hrs 
H120 hrs
Figure 74 Percentage of embryos that stain blue increase with incubation time. (A,B) The
absolute number of GFP-stained embryos that also stained blue depending on the number
of embryos processed at that time. (C) The percentage of GFP positive embryos that are
blue increases. (D) This also holds for all the ECRs tested in this chapter.
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5.5.5 Injection and transfections into Brain by a subset of the new 
LSAMP ECRs failed to produce any LacZ/fGal derived blue 
staining.
Applying the same rationale and methodology as described in the previous chapter 
injections were carried out into the brain using the following ECRs; G2E4, G3E3, G3E4.
Once again the GFP-staining in the brain was found to be extensive indicating that the 
procedure functioned efficiently and that exploration of enhancer activity in the brain would 
be practical using this system. Even where GFP staining was strong no (SGal-derived blue 
staining was perceived in the brain as described in previous chapter.
Although 26 injections and electroporations were made in this chapter into the brain using, 
G3E3 and G3E4, the survival and success rate was poor with only 7 embryos in total being 
GFP positive and surviving to harvest. This does not include G2E4 which was problematic 
and did not express GFP even in the NT. No expression of blue was observed in any of 
embryos (Table 17).
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ECR H.H.
Stage
Injection
No.
Injected
Hours
incubated
post­
injection
No.
Surviving
%
surviving
H.H.
Stage
Harvest
GFP | PGal % blue
of
those
GFP+ve
G2E4* 13/14 6 72 4 66 25 0 o 0
G3E3 12 13 72 7 58 25 4 0
G3E4 14 13 72 4 31 25 3 0
Lr'„ l:
Total 32 15 47 7 0
Total -
G2E4
omitted
26 11 42 7 ° 0
Table 19 Summary of data for injection into brain at various HH stages showing number 
of embryos injected that expressed GFP. None of these expressed blue staining. *G2E4 did 
not express GFP.
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5.5.6 Transcription Factor Binding Site located within the new 
LSAMPECRs.
A large number of TFBS were found to be conserved in the ECRs and are shown in Table 24 
in the Appendix. The most interesting perhaps are the TFBSs that appear in the ECRs that did 
not drive expression. These are marked by salmon-pink rows and the negative ECRs are 
shown in red columns. The following group of ECRs, lEFIJOCZ, LEF1_Q2_01 and LEFIBJDl 
appeared in G2E4, G2E6 and also in G2E1 (ECR1-LSA/WP). Lymphoid enhancer-binding factor 
1 appears to be involved in the negative control of lnterleukin-4 LEF-1 {Hebenstreit et al., 
2008) but it is also active in positive control (van Genderen et al., 1994).Further investigation 
into this group of TFBSs and the LEF1 transcription factor may prove productive.
5.5.7 Analysis of Blue Staining by Heatmap Diagram of transfected 
hemi-section of chick Neural Tube.
An analysis of the regions of blue-stained cells was undertaken. The hemi-section of the NT 
was divided into 8 sections (4 medial and 4 lateral) and scored for any occurrence of blue 
(Figure 75). The results showed that the most dorsal of the medial sectors contained blue 
staining most frequently and that the number of stained sectors reduced in a lateral and 
ventral manner (Table 18, Figure 76)
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12
Medial
3
4
Lateral
Figure 75 Diagram of NT hemi-section as used to enumerate sections containing LacZ- 
driven blue. If a section contained any blue it was marked as positive.
G1E3
n=18
(%)
G2E3
n=18
(%)
G2E5 n=21
(%)
G3E5
n=25
(%)
TOTAL
n=82
(%)
Col/Row M L M L M L M L M L
1 100 66.7 88.9 61.1 95.2 42.9 92 24 93.9 46.3
2 55.6 55.6 33.3 83.3 0 0 0 0 19.5 30.5
3 50 27.8 50 72.2 0 0 20 8 28 24.4
4 11.1 16.7 44.4 22.2 0 0 4 4 13.4 9.8
Table 20 Percentage of GFP-stained sections that expressed 
blue staining (M = medial, L = lateral) All sections that were 
analysed were GFP positive throughout.
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G1E3
Ventral
G2E3
Ventral
G2E5
Blue iq 
stained 
sections 5
/MedMi
Dorsal
Ventral
G3E5
Ventral
Figure 76 Heatmap of blue staining in the NT. The hemi-section of the NT was divided into 
8 sections (4 medial and 4 lateral). If a sector included any blue stain it was counted in.
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In a small number of cases (G2E3 (ECR3)) and G3E5) blue staining was observed ventrally in 
both the ventricular zone (VZ) the intermediate zone (IZ), and medial to the motor column 
(MC) Figure 70. These cells may be migrating neurons.
5.6 Transcription Factor classes in all ECRs
Within the ECRs tested in this thesis for enhancer activity 211 different conserved TFBSs 
were identified (Table 27). These 211 TFBSs can be grouped into about 31 classes (Table 28). 
The class for one of these TFBSs, COMP1 was not identified and there are three TFBS that 
refer to PolyA sequences although it is moot if they are TFBS as they are not in the 
TRANSFAC Professional database (Matys et al., 2006), however they are included in these 
data.
Of the 211 different TFBS 55% (n=117) were found only in the ECRs that drove Latlj pGai 
expression, 31% (n=67) were found only in the ECRs that did not drive such expression and 
13% (27) were found in both categories (Figure 77).
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Figure 77 Number of the 211 discrete TFBS, shown by class, in all LSAMP-re\ated ECRs tested in this thesis.
Key: E = TFBSs located in ECRs shown to have only enhancer activity
B = TFBSs located in ECRs that had both enhancer and no enhancer activity in this tissue 
and at this stage of development
N = TFBSs located in ECRs that only showed no enhancer activity in this tissue and at 
this stage of development
The HOX class of TFBSs was the most highly represented at 25% (n=53) of the total TFBSs but 
these were spread fairly evenly between the different categories of ECR; 9.5% (n=20) were 
in ECRs that only drove LacZ/$Ga\ expression, 8.5% (n=18) were found only in the ECRs that 
did not drive such expression and 7.1% (n=15) were found in both categories. The BZIP TFBS 
class came in a close second with 9% (n=19) being in ECRs that only drove LocZ/(3Gal 
expression, 3.3% (n=7) were found only in the ECRs that did not drive such expression and 
1.4% (n=3) were found in both categories, but were less evenly distributed between the 
categories.
Of the 33 TFBS classes 27% (n=9) were found only in the ECRs that drove LacZ/ (3Gal 
expression. Of these two classes stood out; the E2F class at 36% (n=12) contained the
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greatest number of individual TFBSs with the HISTONE class being second at 21% (n=7). 
Conversely 18% (n=6) of the TFBS classes were found in only in ECRs that did not drive 
expression. The HMG class contained the highest number of TFBSs 1.9% (n=4) with the PolyA 
group containing 1.4% (n-3) of all TFBs.
5.7 DISCUSSION
Following generation of the reporter plasmids, injection and electroporation was performed 
as previously described with injection in chick embryo neural tube and also brain at HH stage 
10 to HH stage 14. Five of the eight ECRs produced blue staining following injections into 
the NT as had ECR3 {G2E3) (Table 16). Of the 32 injections made using the new tranche of 
ECRs into the brain, a low number of 8 (25%) were GFP positive however no (Sgal-derived 
blue staining was produced. This was not entirely unexpected because 5 of the GFP positive 
injections were co-injected with a G3E3-containing pl229 which had failed to produced blue 
in the NT, and so may be a repressor and therefore only 3 of the GFP positive injections 
contained an ECR, G3E4, that resulted in Pgal derived blue staining in the neural tube.
The ECRs that functioned as enhancers in the neural tube varied in robustness, with rates 
ranging from 14% to 75% of the transfected embryos expressing (3gal. Most of the embryos 
were harvested following 48 hours incubation except for G2E5 where harvesting occurred at 
both 48 hours (Stage 23) (n=7) and 72 hours (Stage 25) (n-8) post-incubation. G2E3 (ECRS) 
GFP positive embryos had been harvested at 48 hrs (n=23), 72 hrs (n=9) and 96 hrs (n=5) 
post incubation.
Of the embryos that were GFP positive for G2E3(ECR3) at 48 hours post*-injection(n=23) and 
72 hours post-injection(n=9) and for G2E5 (48 hrs PI ,n=7 and 72 hrs PI n=8), 3gal- 
expressing embryos increasing from 20% of those that were also GFP-stained (n= 6 of 30) at 
48hrs (HH stage 23) to 35% (n=6 of 17 ) at 72 hour HH Stage 25) indicating that this ECR
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may become more active in line with increased incubation time as had been found with 
ECR3. This increase in activity in the neural tube is in line with Kimura's findings that at later 
stages of development expression of LAMP was seen at all levels the spinal cord (Kimura et 
al., 2001). The exact development stage is not specified in Kimura's report, from the context 
of the paper it seems that this is sometime after HH stage 25 which is at a more advanced 
stage than most of the staining described in this project occurred.
5.7.1 ECR Orientation or length did not affect enhancer activation 
Enhancers are orientation independent (Banerji et al., 1981) and this was borne out by the 
fact that the forward orientation G1E2,G2E3,G3E4,G3E5 and the reverse orientation G1E3 
and G2E5 all drove LacZ and so produced blue embryos. Ideally some enhancers would have 
been tested in both orientations to establish this beyond doubt.
The length of the ECR had no specific effect on the activation of the reporter vector (Table 
16). Both the shortest ECR, the 307 bp G1E2, and the longest ECR, the 612 bp G2E5, activated 
the reporter vector. Bracketed by these lengths were eight other ECRs, four of which 
activated the reporter vector and four that did not.
The combination of ECR length and the ECR orientation also appears to have no effect 
because both G1E2 which is 307 bp and in forward orientation and G1E3 which is 366 bp and 
in reverse orientation both activate the reporter vector, and at the other extreme, G2E5 at 
612 bp in reverse orientation, as has already been noted, does activate the reporter vector 
whereas G2E6, the second longest ECR, apart from the questionable G2E4, is 318 bp and 
does not cause activation of the enhancer (Table 16).
182
5.72 Certain ECR classes may indicate greater likelihood of 
enhancer activity.
In the ECRs that were found only in the group that drove tacZ/fJGal expression the TFBS for 
both the E2F (n=12) and the HISTONE (n=7) IF classes contained the greatest number of 
individual TFBSs . On the contrary the HMG class contained the highest number of TFBSs 
(n=4) in the group that was shown not to drive reporter activity.
When investigating future ECRs for enhancer activity these data would suggest that the 
presence of TFBSs for the E2F and HISTONE classes of TFs should be a positive selection 
criterion whereas the presence of the HMG TF class should be a negative criterion.
5.7.3 Lower levels of Plasmid concentration may be effective 
Injection concentration of the reporter vector had been recommended at up to 6 pg/pl per 
plasmid, but this was not always achieved. The highest concentration of 5.32 pg/pl (G1E2) 
and the lowest concentration of 2.2 pg/pl (G3E4) both activated the reporter vector so it is 
probable that this lower value could be used for all experiments and being less viscous 
would be easier to inject. Dilution tests could be run to determine the lowest concentration 
of plasmid that would produce consistent results.
5.7.4 GFP may have been quenched by one ECR.
For some unknown reason the GFP expression from the GFP-expression plasmid appeared 
to be quenched by the pl229 reporter vector that contained the G2E4 ECR. This GFP is 
expressed under the ubiquitous (3-actin promoter and so it appeared unusual that it should 
be quenched. Could the pl229 plasmid be absorbing all the transcription factors required by 
P-actin core promoter in the GFP-expressing vector? Probably not. Another possibilty is 
that some toxin was introduced by the G2E4:pl229 construct. A more mundane possibility 
is that the transfection failed for this ECR although as 29 embryos were injected, in two
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separate experiments, using two different mixes of plasmid and GFP-expressing plasmid this 
would appear to be unlikely. Another possibility is that although two plasmid preparations 
were run for the pl229 plasmid containing the G2E4 insert, only one produced any output 
and a new overnight expansion had to be run. It is possible that there was a problem with 
the second plasmid preparation although at the time there was nothing to indicate this. The 
sequencing of the pl229 plasmid with the G2E4 insert produced the expected output. If this 
was to be pursued further, new endotoxin-free plasmid prep should be made of 
G2E4:pl229. If this quenches the GFP then further investigation should take place, for 
example, co-injecting the G2E4:pl229 plasmid with another pl229/GFP mix that is known to 
function and observe if quenching still occurs. In this case an investigation into the TFBSs in 
the G2E4 and the GFP-expressing plasmid
5.7.5 Expression pattern is initially higher in Dorsal region but 
becomes more extensive with age
The analysis of the regions of blue-stained cells showed that the most dorsal of the medial 
sectors contained blue staining most frequently and that the number of stained sectors 
reduced in a lateral and ventral manner (Table 18, Figure 76). If the cells being 
electroporated originate from the ventral zone (VZ) and migrate laterally into the 
intermediate zone (IZ) this medial-lateral gradient would alter in a temporal manner as the 
cells migrate their numbers would increase laterally and decrease medially. In a small 
number of cases (G2E3 (ECR3)) and G3E5) blue staining was observed ventrally in both the 
ventricular zone (VZ) the intermediate zone (IZ), and medial to the motor column (MC) 
Figure 70. These cells may be migrating neurons and axons.
G1E3 showed a gradual reduction in expression both laterally and ventrally compared with 
G2E5. G2E5 was confined to the dorsal region whereas G3E5 had high expression dorso-
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medially; however expression dorso-laterally was less than would have been expected from 
the other two examples G1E3 and G2E3. G3E5 also exhibited some expression ventrally.
This variance in expression pattern could be as a result of the enhancers being activated in 
differing sub-populations of cells or it could be as a result of inconsistent transfection or 
even of greater transfection success in the ventral region of the G2E5-injected embryos. 
Another possibility for this variation is that it could be as a result of different maturation 
stages of various cells and that had the staining been allowed to carry on past HH stage 25 
an increasing proportion of the cells may have expressed (3gal or as a result more success .
5.7.6 Transfected Region
Of note was the difference in the extent of the GFP expression in the neural tube between 
the Hb9 proof-of-concept transfection as against the GFP expression for the ECR 
transfections. When the injection and electroporation was carried out using the Hb9 
enhancer (Chapter 3) the GFP signal was strongly visible throughout the complete hemi- 
section and within the floor-plate (FP, c.f. diagram Figure 59), however when the same 
protocol was followed for the LSAMP ECRs the GFP signal in some cases did not appear to 
reach full ventral extent and in no instance was the floor plate GFP-stained. This led to the 
concern that some of the cells that could expresses (3-Gal were not transfected.
On closer inspection there did not appear to be a full correlation between the intensity, or in 
some cases, the presence of GFP and the blue staining. In Figure 68(A,B) the GFP is visible 
throughout the hemi-section. GFP expression is faint in the dorsal region where the |3Gal 
expression is strongest and is very strong ventrally where the (3gal expression is virtually 
non-existent. The GFP antibody staining (red) shows a slightly different pattern of expression 
than the green GFP but this may be a result of GFP at a deeper level than where the 
antibody has bound indicating that the antibody is more sensitive.
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In section, most of the neural tubes were found to have blue-stained cells at the roof 
plate/neural tube junction (Figure 62). G2E5 was shown to drive expression here too (Figure 
65) and G3E5 has an especially large expanse in this region (Figure 68 C).
5.7.7 No blue observed following injections into Brain
This low survival and success rate is possibly an operator-effect due learning how to inject 
into and electroporate the brain (Table 17).
Although LSAMP is expressed in the anterior mid-brain at HH stage 14 (Kimura et al., 2001) it 
may be that these particular enhancers (G3E3 (n=4), G3E4 (n=3)) may not be activated in 
these cells at this time, or that the LSAMP expression window was too brief to trigger the 
fJGal expression in sufficient quantities to be detectable. Another possibility is that although 
the GFP staining was intense, indicating that transfection had been successful, due to the 
large lumen the concentration of the enhancer was insufficient to result in observable blue 
staining. Whether these enhancers are active or not in the brain has not been proven due to 
the small number of transfected embryos achieved.
It must also be noted that there was a very high mortality rate associated with these 
injections into the brain with only a low number 8 of 32 injected, i.e. 25%, surviving and 
expressing GFP as compared to the high number of 65 of 132 i.e. 49% achieved with neural 
tube injections. While it is understandable that piercing the embryonic brain tissue with a 
relatively large hypodermic needle would present an enormous insult to this highly complex 
organ and so lead to death, the total lack of success in achieving blue staining may be a 
product of the bent rod electrodes failing to concentrate the electric charge sufficiently to 
focus the effect of the transfection to provide sufficient fi-gal expression. Of course there is 
always the possibility that none of the putative enhancers were activated by the 
electroporated cells at this particular stage in development.
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Some of the ECRs were shown to drive expression in cells of the chick embryonic neural 
tube. The LacZ driven blue staining varied between ECRs but also between embryos injected 
with the same ECRs. Migration appeared to result in blue-staining cells being found more 
laterally as a function of time. So far no correlation between TFBS and the ECRs that drove 
LacZ expression has been established
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Chapter 6
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6 General Discussion
One of the major ways employed by eukaryotic cells to control gene expression is by the 
action of the regulatory sequences known as enhancers and repressors. An understanding of 
the spatial and temporal activation of these sequences would help our understanding of 
gene control. Furthermore polymorphisms in these control regions have been associated 
with disease and a way to rapidly identify if these polymorphisms were affecting gene 
expression would be a useful diagnostic tool. In order to attempt to rapidly identify when 
and where enhancers are being activated a chick-based model was proposed. Using the ECR 
Browser, putative enhancer sequences were identified by cross-species comparison of the 
genomes to expose evolutionary conserved regions. By cloning an ECR into a suitable 
reporter vector and transfecting cells in-vivo, the activation of the enhancer by the cell can 
be detected. Following a successful proof-of-concept run using the Hb9 gene, LSAMP was 
selected as the first gene to investigate because of its role in development and its 
implication in mental health disorders and cancer. A number of ECRs were examined and six 
of these were shown to be enhancers.
6.1 Advantages of this chick-based model and the positive results 
achieved.
This method has been demonstrated to function successfully by using ECRs located near the 
LSAMP gene to identify activated enhancers. These enhancers were shown to be active in 
the same region as LAMP is normally found, indicating that these enhancers are probably 
involved with LSAMP expression.
This is a cheap and relatively rapid method with results being available following several 
hours of embryos staining, in which little operator involvement is required.
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The GEISHA (Gallus Expression in-situ analysis) database is being built by means of whole 
mount in-situ hybridisation using chick embryos (Bell et alv 2004). The protocols they use 
detect mRNA and microRNA is quite rapid, and they have built a database showing the 
expression pattern of many genes, but not LSAMP. The genes have been categorised into 
gene families and what could be of use in the future is their data on the temporal and spatial 
expression of transcription factors.
The VISTA enhancer database (Vise! et al., 2007) experimentally validate human and mouse 
ECRs in transgenic mice and as of early May 2012 they had tested 1729 sequences, 891 of 
which exhibited enhancer activity. Similar to the method used in this work the ECRs are 
selected on cross-species conservation and they also use putative enhancer markers. As the 
VISTA system uses mice that are harvested at E11.5 the murine-based system is intrinsically 
slower than the chick-based system as the equivalent chick age is ~E3.5 (Schneider and 
Norton, 1979). It may appear that because chick is more distant evolutionary from human 
as chick/human they had the last common ancestor at ~300MYA and human/mouse was 
,v100 MYA. Due to the rate of genomic divergence for chick being estimated at 0.16 per 
million years and that of mouse being 0.9 per million years it is concluded that the 
organisation of the human genome is closer to the chick than the mouse (Burt et al., 1999).
In the ECR Browser, by comparing chick with human gives the advantage that due to the 
evolutionary distance and yet stasis between the two species, primitive control regions are 
identified. As these regions are conserved between the species, using this tool to investigate 
within these regions is likely to prove most useful.
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6.2 IgLONs and LSAMP continue to be implicated in disorders and 
disease
Data revealing the relationship between IgLON polymorphisms and disease continue to be 
discovered with polymorphisms in CEPU1/NTM having been implicated by association with 
lower intelligence and with late-onset Alzheimer's disease (Pan et al., 2011). And various 
polymorphisms in NEGRI, the gene that codes for Kilon, having been associated with obesity 
(Elks et al., 2010, Renstrom et a!., 2009, Bauer et al., 2009) and a specific polymorphism 
(rs2815752) in NEGRI was associated with higher waist circumference, but also, 
unexpectedly, with lower body mass index (Haupt et al., 2010).
New evidence, has emerged, indicating that a 2.1 Mb region in 3ql3.31 that contains 
LSAMP was frequently deleted in osteosarcomas (Kresse et al., 2009). This indicates that 
LSAMP may have a role as a potential tumour suppressor gene in osteosarcomas.
Further evidence supporting LSAMP's role as a potential tumour suppressor gene in 
osteosarcomas was provided by the fact that a deletion localized to a region within the 
LSAMP was identified, along with mutations in other regions, as being present in 6 out of 11 
osteosarcomas investigated (Yen et al., 2009). It was found that the deletion of LSAMP 
promoted proliferation of normal osteoblasts by regulation of apoptotic and cell-cycle 
transcripts and also VEGF receptor 1 (Pasic et al., 2010).
Additionally, a SNP-array analysis on 300 diagnostic and 41 adult and pediatric leukemia 
samples, identified, along with other aberrations, a recurrent minimal deletion region at 
3ql3.31, a expanse containing only LSAMP (Kuhn et al., 2012).
A novel functional relationship between LAMP, glucocorticoid receptors, and cognitive 
functioning has been identified (Qiu et al., 2010). This was achieved by comparing wt mice 
and Lsamp^ mice for spatial memory performance, hippocampal synaptic plasticity, and
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stress-related responses. The Lsampw mice exhibited a pronounced decrease in spatial 
memory acquisition and reduced hippocampal CA1 region long-term potentiation over the 
w/t controls. Reduced expression of mineralocorticoid receptor (MR) transcripts in the 
hippocampus and reduction in the corticosterone-induced, MR-mediated non-genomic 
modulatory effects on CA1 synaptic transmission were also observed.
Knock-out mouse models are in agreement with earlier findings (Catania et al., 2008) that 
show lower anxiety in /.samp-deficient mice and furthermore show a decrease in agonistic 
behaviour (Innos et al., 2011). LsampMmice were also found to be less able to adapt to 
novel stressful environments and interact in a socially norma! way (Innos et al., 2012).
Polymorphisms in LSAMP have also been implicated in major depressive disorder and panic 
disorder in humans (Koido et al., 2012). The LSAMP genomic region of 591 patients suffering 
from major depressive disorder or panic disorder was compared against 384 healthy 
volunteers and 21 SNPs were identified. None of these SNPs were located in any of the ECRs 
investigated in this thesis. Only one of these SNPs, rs9830559, was found to be in an ECR 
(Location, Human genome build 19 ; chr3:115595803-115596470 Chick genome build 3 ; 
chrl:85514662-85515326) when chick was compared against human at stringency of 
100bp/70% identity.
6.3 Limitations and Caveats
Because enhancers and repressors sequences need not be located near the gene they are 
moderating there is no guarantee that these sequences are affecting the nearest gene. 
Although the expression pattern of the blue staining matched that expected of LSAMP this is 
still circumstantial and is not a complete guarantee.
There are many different breeds of chicken and although the white Leghorn is used most 
often in reproductive studies (Bahr, 2008) and was used during this thesis it is not identical
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to UCD 001 whose genome has been, incompletely, sequenced {Lee et al., 2003). The release 
2.1 (May 2006) of the chicken genome was throughout this work. The origin of the whole- 
genomic chick DNA used experimentally is unknown. These potential differences between 
the documented genome, the chick DNA from which the ECRs were copied and the actual 
breed of chick embryos used leads to the possibility of dissimilarities, the extent of which is 
unidentified.
An even greater source of difference is that chickens are evidently not humans. We diverged 
from our common ancestor about 310 million years ago and although many of the basic 
systems will be similar there will be many differences. This means that anything discovered 
in the chick model, as with ail models, will only be an indication of what happens in other 
organisms. The greater the difference in evolutionary time between the model and organism 
under investigation, typically, the greater the variances will be.
This method, so far, has used cross-species comparison to find evolutionary conserved 
regions under the assumption that they are putative enhancers. However, this would thus 
miss enhancers that are human-specific or are rapidly evolving which by their nature are not 
conserved. Using input from a predictive bioinformatics methodology such as (Arunachalam 
et al., 2010, Fernandez and Miranda-Saavedra, 2012) could be used to predict enhancer 
sequences and our system could then be used to test the bioinformatics prediction.
The LSAMP gene, although important and interesting, proved a challenging candidate to 
start this investigation due to its large size and complexity, and a smaller simpler gene would 
probably have been more appropriate although positive results were obtained from LSAMP.
So far expression of LSAMP has not been detected in the brain using this method, but as the 
GFP fluorescence indicates transfection is effective this shows that there is no fundamental 
defect in the transfection process.
193
6.4 Enhancements made to the methodology during the course of 
the work
Knowledge gained from early experiments and availability of new equipment allowed the 
methodology to be improved. Due to the high percentage yolks breaking when transferring 
the fertilized eggs into the hammock, "windowing" of the eggs replaced "hammocking" . To 
reduce the risk of egg shell breakage when removing standard Sellotape, Magic Scotch Tape 
was used instead. Both of these changes reduced the amount of loss due breakage.
When finance became available a mains powered electroporator was purchased to replace 
the old, battery powered one. This had more facilities and gave greater control to the 
operator. An active-humidity incubator was also purchased to replace the passive-humidity 
incubator allowing for the incubation process to approach nearer to the natural conditions.
6.5 Proposed Future Experiments and Directions
The blue, pgal driven chromagenic staining although widely used in this context, possibly 
due to its permanency has the major disadvantages that it is not visible before the staining 
process and that the staining process is lethal to the embryos. If the pl229 plasmid was 
altered to express a fluorescent marker instead of LacZ the expression could be detected 
while the embryos were still alive allowing the decision at what stage to dissect the embryo 
to be better informed. Because there would be no stain-development phase the processing 
time would also be reduced thus allowing results to be obtained more rapidly.
It is unknown if some of the ECRs cloned into the reporter vector were repressors or instead 
were enhancers that were activated at too low a level to drive the LacZ sufficiently to result 
in staining, or simply aren't regulatory sequences. One way to increase expression is to 
clone multiple copies of the enhancer sequence into the reporter vector. In one series of 
experiments up to four identical copies of an enhancer sequence has been shown to
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increase expression, beyond that, expression is adversely affected (Kumar et al., 1986). 
Nakano used three copies of the enhancer sequences to increase reporter gene expression 
(Nakano et al., 2005).
Some enhancers work in co-operation to increase expression and some will only function in 
the presence of another (Maekawa et al., 1989). In order to test if the enhancers act co­
operatively to stimulate promoter activity and to ascertain if some of the ECRs that did not 
drive reporter expression when alone would function in the presence of another, I would 
propose that multiple ECRs be cloned in combination, in a step-wise manner, into the 
reporter vector. An increase in reporter expression would indicate that co-operation 
between the ECRs has occurred whereas decreased or complete quenching of reporter 
expression could indicate that most recent ECR added has a repressor function.
The amount of literature on TFs is growing and the FANTOM consortium have gathered 
existing and de-novo data into the FANTOM4 EDGE database (Ravasi et al., 2010). The data 
on TFs is collected from the following sources; Evolutionary conserved TFBS from sources 
that include JASPAR and TRANSFAC, results from miRNAs used to target transcript 
predictions from the EIMMO prediction server (Wang and El Naqa, 2008), published protein: 
DNA interactions, published TF:TF interactions from various sources such as the Database of 
Interacting Proteins -DIP (Xenarios et al., 2000), Biomolecular Interaction Network 
Database- BIND (Bader and Hogue, 2000)and Human Protein Reference Database - HPRD 
(Prasad et al., 2009), in-house and published ChlP-chip data and published ChIP-seq data and 
in-house siRNA knock-out and miRNA over-expression on THP-1 cell-line. Filtering is 
available to produce, for example, a list of TFs of which there is experimental support. Using 
this database could be used to help interpret the TFs and TFBS bindings that moderate the 
activation of the enhancers/repressors.
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Interpretation of the current systems results are qualitative and very subjective as it does 
not quantify the results which are subject to multiple variables such as the success of the 
electroporation, the subset of cells transfected, the developmental stage of the embryo, the 
developmental rate. In order to use this system effectively it would be important to quantify 
the level at which the reporter gene is driven otherwise much information on the co- 
operativity of enhancers and the effect of repressors could not easily be captured. There are 
various assays, such as western blotting that can be used to quantify protein expression but 
these are not rapid systems. A quicker method is to use a static and variable fluorescent 
assay such as a dual-luciferase reporter (Alcaraz-Perez et al., 2008). In this system a control 
luciferase, of one colour, can be driven by a constitutive promoter and another luciferase, of 
different colour, can be driven by a promoter under control of the ECRs under test. By 
normalising the signals from experiments using differing combinations of ECRs on the 
control luciferase the effect of the various enhancers/repressors could be quantified (Ray 
and Gambhir, 2007, Fortes and Razquin, 2009). Another method would entail replacing the 
constitutive promoter with a promoter under the control of a single enhancer or a different 
combination of enhancers to those controlling the other luciferase's promoter.
The promoter sequence in the pl229 reporter vector is a human p-globin minimal promoter, 
and although it has been demonstrated in this work that it functions, the use of plasmids 
containing the reporter gene under the control of the native promoter sequence should 
provide a more intrinsic response to the putative enhancer sequence. In this way the 
generated signal would be more quantitative because the native promoter should respond 
to the enhancer/repressor sequences innately. It would also be expected that in most cases 
the reporter expression would be driven at a higher rate under control of the native 
promoter.
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Although it is generally understood that enhancers and repressors function in a direction- 
independent manner, it would be worthwhile to prove this for the ECRs that have already 
been analysed. This would entail inserting the ECRs into the reporter vector in reverse 
orientation to their current direction and retesting. If any of the enhancers no longer give a 
signal or the ECRs that previously did not give a signal do so now, further investigation would 
be required to ascertain if they are direction-dependant. If this double-orientation testing 
was to become the norm it might be desirable to re-investigating the feasibility of using the 
directional, or non-directional "Gateway" method, to allow easier reporter vector 
generation.
6.5.1 Proposal to reduce infection in embryos 
Although the fertilized hens' eggs used in the work described in the previous chapters, were 
produced by specialist producers who maintain a high level of cleanliness, eggs by their 
nature are far from aseptic. Some of the eggs we received had visible faecal contamination 
on their shells and even on apparently clean eggs there is, presumably a myriad of fungal 
and bacteria coating the shell. Although eggs possess protection they are not totally immune 
from external infection, especially by fungus, particularly if incubation is delayed. This 
contamination can also reduce egg viability considerably (Cook et al., 2003). During the work 
described in this thesis it was found that the viability of the eggs deteriorated with time and 
also that whole experimental runs were ruined by what appeared to be a fungal infection. As 
this infection tended to occur during the autumn it was assumed that the fungus originated 
on dying leaves, however, upon reflection, it may be contamination on the eggshell. 
Furthermore, as it will be desirable to allow the embryos develop for longer periods this 
problem will no doubt become more significant.
Upon receipt of a batch of eggs, our procedure is to place them, in their papier-mache trays 
directly into a passively humidified fridge at 120C. In order to potentially reduce the risk of
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fungal infection and even possibly increase the viability of the stored eggs the procedure 
should be changed, at least for a trial period.
Under the proposed procedure, on receipt of the eggs, they should be washed in 70% 
ethanol, all evidence of faecal matter to be removed and they should be placed in the fridge 
in sterilised trays. The current washing in 70% ethanol prior to opening the egg should be 
continued. Following electroporation embryos should be covered in an antibiotic and 
fungicide solution in order to reduce infection (Croteau and Kania, 2011).
6.5.2 Expanding the tool's use into human ECRs
Whilst investigating how chick ECRs in chick moderate chick gene expression would be 
valuable in its own right one of the desirable uses for this tool would be to investigate 
human ECRs in the chick model. The first attempt at this would be just substituting the 
human equivalent ECRs for the chick ECRs shown to be enhancers and see if they still 
function as enhancers. By comparing the TFBSs in the two sequences extra data on the TFs 
that are involved in regulation may be obtained.
Following this it would be appropriate, by using site specific mutagenesis to investigate how 
mutations within the regulatory sequence affect expression. If this is shown to function, 
SNPs identified by GWAS surveys for diseases with specific genetic causes, such as the DeNT 
GWAS (Breen et al., 2011), should be used to establish if the SNPs can be shown to affect 
gene expression.
6.5.3 Transfection methods
Electroporation still appears to be an effective and preferred method transfecting chick cells 
and our general method i.e. electrode gap, voltage, pulse length and ~ one second interval is 
in line with other's methods used when electroporating the chick neural tube (Croteau and
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Kania, 2011) although platinum or platinum/iridium wire electrodes seem to be more 
commonly used than the gold-plated electrodes used for all but the earliest experiments 
previously described. Using the solid wire seems to allow more flexibility in cleaning and 
maintaining the electrodes in that the tips of the negative electrodes can be cut off, say, 
every dozen electroporations and the positive electrode can be cleaned using a forceps to 
scrape off any build-up. The gold-plated electrodes have the advantage of solidity but they 
are very expensive (£350 per set), have an estimated life of ~1,500 pulse and have to be 
cleaned gently to prevent ablation of the gold plating.
Electroporation has several disadvantages the first of which is that not all the expected cells 
are electroporated leading to a mosaic transfection pattern. Why this happens is not fully 
understood but it is possible that the shape of the cell and its orientation to the electric field 
prevents the cell reaching the transmembrane potential that triggers electroporation 
(Pucihar et al., 2006). To fully elucidate the expression pattern resultant from a particular 
enhancer requires the results from a number of transfected embryos to generate a 
composite view. A second problem is that generally the expression by the transgenes is 
transitory as the plasmids typically are not be integrated into the genome resulting in a 
diluted signal as the plasmids are distributed between a proliferating cell population. This 
problem would become more acute as the embryos are allowed to develop for longer with 
its concommitant increase in cell divisions. Cell divisions occur in a temporal (Fujita et al., 
1962, Wilson, 1973) and location dependant manner (Fujita, 1962, Smith and Schoenwolf, 
1988) making exact calculations difficult, however an estimate (Table 19) would indicate that 
increase in cells for an injection made after 48 hours incubation and stained a further 48 
hours later would be a power of 5.5 so a 100 cells would become 9,500 in that 48 hour 
period, resulting in a possible 95:1 dilution of the reporter vector.
Day 1 2 3 4 5 6
Cell-cycle/hours 5 7 8 9 13 15
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Divisions/day 4.5 3 | 3 2.5 2 1.5
Table 21. Frequency of cell cycles from embryonic day 1 to day 6 in chick.
The combination of a provirus vector, such as Replication-Competent ASLV long terminal 
repeat (LTR) with a Splice acceptor (RCAS) and virus-competent eggs (Federspiel and 
Hughes, 1997)1 facilitates the reporter's integration into the genome and the cross-infection 
of cells overcomes the short-term expression and mosaic problems. Therefore if loss of 
reporter vector expression diminished with increased development time an assessment of 
this system should be undertaken with a view to implementing it, if it appeared appropriate.
6.6 Overall conclusion
Evidence of LSAMP's position as a tumour suppression gene and its role in anxiety, and by 
implication in deviant social behaviour (Innos et al., 2011)is accumulating, as too is the 
indication of disease being related to polymorphisms associated with this gene.
This highlights the need for a diagnostic method to rapidly identify the effect of 
polymorphisms on this or any other gene.
This thesis has demonstrated that the ECR Browser can be used to identify chick ECRs that 
act as enhancers of gene expression and gives a starting point for further development.
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7.1 Reagents
Name/Function Source Catalogue or 
model number
Notes/comments
Agarose for Sigma A5304
Electrophoresis
Agarose for routine use Sigma A9539
Ampidllin stock 100 ng/pl
BlueJuice Invitrogen 10816-015 10X gel loading buffer
BSA Bovine serum albumin
Cloned AMV Invitrogen 12328-032
DARI Sigma D8417 4'6-Diamidino-2-
Fluorescent nucleic acid phenylindole
stain dihydrochloride.
DNA ladder Ikb Invitrogen 15628-019
DNA ladder Ikb plus Invitrogen 10787-018
DNA, whole-chick, 
genomic
Merck-Novagen 69233-3 249 ng/pl
dNTP 10 mM Invitrogen 12328-032
Dulbecco's PBS Sigma D8662
EDTA 0.5 M Gibco 155 75-038 - •; V/
Eggs, Fertilised chicken's Lea's Lane Farm White Leghorn
The Pinfold Centre
Farmfresh, Preston
Glycerol BDH 44448
HBSS Sigma H9394
HBSS {-) Gibco 14170 No Ca2t No Mg
HBSS (+) Gibco 24020
Ink Pelikan Fount Ink Used at 7% in PBS
IPTG Invitrogen 15529-019
LB Broth Sigma L3022
loading buffer Invitrogen Tracklt™ Cyan/Orange 6X 
10482-028
10bp-lkbp
loading buffer Invitrogen BlueJuice 10X Cat.
No.10816-015 —
loading buffer Invitrogen 10482-035 lOObp-lOkbp
Tracklt™ Cyan/Yellow 6X
MNR2 University of Iowa 81.5C10 Monoclonal Ab with a 
pan MNR2/HB9 
immunohistology 
pattern
molecular-weight marker Invitrogen Tracklt™ 100 bp DNA Ladder
10488-058
100 -1500 bp
molecular-weight marker Invitrogen Tracklt™ Tracklt™ 50 bp
DNA Ladder
10488-043
50 to 800 bp
NBT (Nitro blue 
trizoleum)
Roche G2451025
NP40IGEPAL Sigma 1-3021CA630
OCT medium Bright Cryo-M-Bed medium Mounting medium
pCRII vector Invitrogen 45-0641
Phase-lock gel Heavy Eppendorf 0032 007.953
Plasmid midi-prep Qiagen Plasmid midi-prep 12143
Plasmid midi-prep Sigma Aldrich GenElute plasmid mini-prep 
PLN-70
Endotoxin-free
Plasmid mini-prep Promega Pure Yield mini-prep A1223 BH
Plasmid mini-prep Sigma Aldrich GenElute plasmid mini-prep 
PLN-70
Potassium ferricyanide
Potassium ferrocyanide
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S.O.C. medium
Sodium deoxycholate
Invitrogen 46-0700
SyBR Green 1 Sigma S-9430 - - ' • -Vv :
TORO Cloning kit Invitrogen 46-0800
Wizard SV gel and PCR 
clean-up system
Promega A9281
|3-D-galactopyranoside Sigma B4252 X-gal
Table 22 Reagents used with suppliers name and catalogue number.
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7.2 Equipment
Name/Function Source Catalogue or model 
number
Notes/comments
Capillary glass tubing Warner instruments Mod G150TF-3 OD 1.5mm
ID 1.17mm
Length 7.5cm
Centrifuge Sanyo MSE Mistral 3000i Swinging bucket
Centrifuge Sanyo MSE Micro Centaur Bench
Centrifuge Heraeus Instruments Biofuge Stratus High speed
Centrifuge Heraeus Instruments Biofuge Pico Bench
Cloned AMV Invitrogen 12328-032
Electrodes, 3mm bent Harvard Apparatus, Inc. BIX Model 514, #45-0116
gold-plated
Electrodes, 5mm bent Harvard Apparatus, Inc. BTX Model 512, #45-0115
gold-plated
Electroporator Ovodyne electroporator TSS20
Electroporator, battery- 
powered
Digitimer Ltd Isolated stimulator
Model DS2
Hot block Techne DriBlock DB-2A : wr;4
Incubator - shaking New Brunswick Scientific, Edison, NJ. Controlled Environment
Shaker Incubator
Model G25
Incubator - cell/tissue Heraeus BB6060 CU . : .o-
Micropipette puller Sutter Instruments Model P-87 Flaming/Brown
Egg fridge (storage) Fison Temperature/Humidity 
12°C /Passive Humidity
Incubator; Egg incubator Brinsea Products, Multihatch Mkll Temperature/Humidity
(pre-injection) Sandford, BS25 5RA 38.5°C / Passive
Incubator; Cell Heraeus BB6060 CU Temperature/Humidity 
37°C/ Passive humidity 
C02 @ 5%
Incubator; Cell Sanyo C02 Incubator MCO-15AC Temperature/Humidity 
37°C/ Passive humidity 
C02 @ 5%
Incubator; Cell - used for
eggs
R S Biotech Galaxy Standard Temperature/Humidity 
37°C/ Passive humidity
Incubator; Egg Brinsea Products, OvaEasy 380A Temperature/Humidity
and
Humidity Management
Sandford, BS25 5RA 37.8 °C-38.0 °C/RH 
35%.
Module H22 Note: Rocking
mechanism in
incubator has been
disabled.
Microscope Leica Leica Leitz DMRB Fluorescent
microscope
Metamorph™
software.
LAS software V2 & V3
Camera: DFC420C
Microscope - Inverted Leica Leica Leitz DMIRB Fluorescent
microscope.
LAS software V3
Camera: DFC420C
Microscope - Dissecting Leica Leica Leitz LB M165FC Fluorescent
microscope.
LAS software V2,V3,V4
Camera: DFC420C 
Transmitted Light Base 
External halogen 
goose-neck illuminator
Microscope - Dissecting Motic Motic Stereo Dissecting Motic transilluminated
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base
External halogen 
goose-neck illuminator
Table 23 Equipment used during work on thesis.
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7.3 Solutions and Buffer Recipes
7.3,1 Millonig's Phosphate Buffer
Sodium Phosphate, monobasic Nat^PCVHaO 12.68g/l
Sodium Phosphate, dibasic Salt NaH2P04 43.80g/l
NaHaPO/t.h^Oand NaH2P04were dissolved in 900ml of de-ionized water (DIW) and pH 
adjusted with HCI or NaOH to pH7.4 at room temperature. Volume made up to 1 litre with 
DIW.
7.3.2 Millonig's Phosphate Buffer pH 7.4 (0.125M)
0.4M Phosphate Buffer diluted 3:7.
7.3.3 4% Paraformaldehyde
ddH20 35 ml
Paraformaldehyde 2g
NaOH 4-5 drops
Phosphate Buffer 0.4M 10ml
35 ml of distilled H20 was added to 2g paraformaldehyde and stirred constantly whilst being 
heated gently to 65°C. 5M NaOH was added dropwise until solution cleared. When solution 
had cooled to room temperature the volume was brought up to 50ml using ~10ml 0.4M 
Phosphate Buffer. pH was assayed and adjusted to pH 7.10 ml aliquots were stored at - 
20°C.
7.3.4 Luduena'sFix
100ml volume
Glutaraldehyde 8% (v/v)
Sucrose 0.12 M
CaCI2 0.5 mM
Phosphate buffer pH 7.4 75 mM
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7.4 Bacteriological Media
7.4.1 Luria Broth
25g of Luria Broth base added per litre of DIW H20 and autoclaved at 121°C for 15 minutes
7.4.2 Luria Agar
37g of LB Agar base added to 1 litre of DIW H20 and autoclaved at 121°C for 15 minutes
7.5 Antibiotics
Stock Working concentration
Ampicillin 100 mg/ml 50 pg/ml
Kanamycin 30 mg/ml 50 pg/ml
Antibiotics were dissolved in DIW and sterilized through 0.2 pm filter and aliquoted and 
stored at -20°C.
7.6 Tris-HCL 1M
121.lg Iris base dissolved in 800 ml ddH20 at room temperature and pH adjusted to 
required value. Volume topped up to 1 litre and sterilised by autoclaving 121 °C/15 minutes.
7.7 Electrophoresis Buffer for Agarose Gel Electrophoresis
Buffer was prepared as a SOX concentrate stock solution and stored at room temperature. 
For use it is diluted to IX in de-ionized water.
7.7.1 SOX Tris-Acetate (TAB) Buffer Stock.
Iris (TRIZMA base) 242g
0.5M EDTA pH8 8.0 ml
Glacial Acetic acid 57.1ml
H20 make up to 1 litre.
7.7.2 Agarose-gel running buffer - IX TAB
50XTAE 100 ml
H20 make up to 5 litres.
pH and adjusted to pH 8 if required.
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7.8 Embryo Staining
7.8.1 Sodium Azide 10% stock solution
lOgof sodium azide in 100 ml of distilled H20. this is stored at room temperature.
7.8.2 Embryo Staining Solution
Phosphate Buffer 0.1 mM pH7.3 
MgC!2 2mM
Sodium deoxycholate 1%
Potassium ferrocyanide 5mM 
Potassium ferricyanide 5mM 
NP-40 0.02%
X-gai Img/ml (added prior to use).
7.8.3 Detergent Rinse
Phosphate buffer 0.1M
MgCI2 2mM
Sodium Deoxycholate 0.01%
NP-40 0.02%
7.8.4 Diluent solution
1% BSA,
0.12M Pi (Diluted Millonig's)
0.1% Triton,
0.1% NaN3
Table 24 Solution mixes used in the work carried out for this thesis.
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7.9 Primers used for generating ECR1, ECR2 and ECR3 in LSAMP
Primer
name
Primer sequences as ordered Total
Primer
length
Total
Tm/°C
PrimerS
Primer
length
PrimerS
Product
Size/bp
PrimerS
Tm/°C
upLSAMP
ECR1fwd ci ci ci t g c gg c c g
32 84.8 20
486
60
upLSAMP
ECR1rev
ii i i'ii i in 11 "i1 1 31 66.4 21 59
upLSAMP
ECR2fwd
aggaGCGGCCGC^^^mjjHimmjllljy^
Due to strong hairpin, changed 
from this:
agctGCGGCCGCagtccagctgccaacagaat
32 85.8 20
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60
upLSAMP
ECR2
rev
ctgcACTAGTfBHHHHH^HHH
Chenged due to very strong 
dimer:
) ; gcagaaggcctgaaggaaat
30 74.7 20 61
upLSAMP
ECR3fwd
cl ti 3. cl GCGGC CGC^Hm^j 32 83.8 20
380
59.76
upLSAMP
ECR3rev
ggaa ggaggaacaaaggaggaacjg 30 72.6 20
Table 25 Primers used to amplify ECR1-LSAMP, ECR2-LSAMP and ECR3-LSAMP from whole- 
chick genomic DNA.
The PrimerB-generated forward primers are highlighted in green, the reverse primer 
highlighted in red. The Notl (green capital letters) and Spel (red capital letters) sequences 
were inserted to allow directional cloning. The short sequences distal to the main 
sequence were appended to allow the restriction enzymes to function.
The full length of the primer, and the total length, Tm of the total primer as calculated by 
the oligonucleotide manufacturer (Sigma), the primer length, product size and melting 
temperature of the highlighted sequences generated by PrimerB are also shown.
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7.10 Primers ordered for to PCR-amplify second tranche ECRs
A (ECRU
GC | GGCCGcBHH^^^^^HflllHac99a9gcaca9cacaa9gttgcagcaggccctggataagaaagcactgaggaatggg 
aagttggctactcacCTGTAGTGCAAAACAACCTCATTGATACGCAGGAGACTTCAGTCTCGGTGACTTTCAATGTCTTCCACAGC 
ATCAAACTGATATTTCAAAGAGATTAAGAACTGAAGGGAACATATGATATCCATTTAAAGCCAAGACTTCAGATTTAATGAAGGCT 
GTATCAGAATGAGATATGATTCAGATATCAAATTACATTTGTTTAGCCCAACACAGCTTAATAAATCACAGCAACATTTAATAAAT 
ATTTATCTTCTTTTAATCACCAGTTAGTGCTTTTTCTGATCTCTCCATTCCCTTAATGGCTCACTCCTGTATTTATTAAATGTGAT
TTCCATTTCTctaataatcaatacatctttttattttttataaHBHHBBBHIHBBBBA I CTAGT
B (ECRl)
GGTGGC | GGCCGC^mmmm^m|||acggaggcacagcacaaggttgcagcaggccctggataagaaagcactgaggaa 
tgggaagttggctactcacCTGTAGTGCAAAACAACCTCATTGATACGCAGGAGACTTCAGTCTCGGTGACTTTCAATGTCTTCCA 
CAGCATCAAACTGATATTTCAAAGAGATTAAGAACTGAAGGGAACATATGATATCCATTTAAAGCCAAGACTTCAGATTTAATGAA 
GGCTGTATCAGAATGAGATATGATTCAGATATCAAATTACATTTGTTTAGCCCAACACAGCTTAATAAATCACAGCAACATTTAAT 
AAATATTTATCTTCTTTTAATCACCAGTTAGTGCTTTTTCTGATCTCTCCATTCCCTTAATGGCTCACTCCTGTATTTATTAAATG
TGATTTCCATTTCTctaataatcaatacatctttttattttttataaHBHBBBHBBBBBBM c:rAG!:rGGATCCCCCGG:
GCTGGGCA TAAAAGTCAGGGCAGAGCCA TCTATTGCTTACATTTGCTTCTAGCCTGCAGGTCGAGGAGCGCAGCCTTCCAGAAGCA 
GAGCGCGGCGCCATGGGGA
C(ECR2)
GC I GGCCGCHBH^^^^HHBHH99TACCAATGATAAAATGTTATTGTTGTCACTGTCAGGCATTTGGTCTTTATCGGTC 
TACTCATGACAGCCCTTGTTAGTCAGGCAGGTCCTGGGACAACTTCAAAGGGAGACCTTCTCATCCAATGACAaacatagcaacct  
acttgacttctctgatcctctt|^Hmmmm^ | CTAGT
D(ECR2)
AGTGACTATGCGGGTGGC | GGCCGc|^^j^J^JJ^^UjggTACCAATGATAAAATGTTATTGTTGTCACTGTCAGGCAT 
TTGGTCTTTATCGGTCTACTCATGACAGCCCTTGTTAGTCAGGCAGGTCCTGGGACAACTTCAAAGGGAGACCTTCTCATCCAATG
ACAaacatagcaacctacttgacttctctgatcctctt^HBBBB^^^H^BB  ^I CTAGTGGATCCCCCGGGCTGGGCATA
AAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTAGCCTGCAGGTCGAGGAGCGCAGCCTTCCAGAAGCAGAGCGCGGCG
E(ECR3)
GC| GGCCGcmmmmU^magggggtatggtgtaagggtgggtctttcccgctatagtttttggtTGGAAGGAGAC 
TCTGAGAGGGGTGTAGAAAAGGAAGGAGATAACCCCCAGGAAAGTCAAACTATCTATTTATTTAGTTATGTGTTTTGGGTTGCGTT 
TTGCATTAATCGCTGCCACACACAGGAGCCCTGTAATTTATTATTGGTGATAAGTGTGGACAGTAGCTATTATTTTTGCTCCCTGT 
TCTAAAACGTGGCAAGCAGGGACACTTAGATTTATGGAACATGCATTATTCAAATCTCAAGGCCCGATGGCTCAGCATGAACAACC
CCAGCTATTTCCAGAACCTCTcagtBHHHHHHHH7^ I CTAGT
F (ECR3)
GACGGGGACTCCTCGTCGGGTGGC GGCCGC^mU^H^^^^dagggggtatggtgtaagggtgggtctttcccgcta 
tagtttttggtTG§AAGGAGACTCTGAGAGGGGTGTAGAAAAGGAAGGAGATAACCCCCAGGAAAGTCAAACTATCTATTTATTTA 
GTTATGTGTTTTGGGTTGCGTTTTGCATTAATCGCTGCCACACACAGGAGCCCTGTAATTTATTATTGGTGATAAGTGTGGACAGT 
AGCTATTATTTTTGCTCCCTGTTCTAAAACGTGGCAAGCAGGGACACTTAGATTTATGGAACATGCATTATTCAAATCTCAAGGCC 
CGATGGCTCAGCATGAACAACCCCAGCTATTTCCAGAACCTCTcagtBBBBBiB^HHBH^ I CTAGTGGATCCCCCGGG 
CTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTAGCCTGCAGGTCGAGGAGCGCAGCCTTCCAGAAGCAG 
AGCGCGGCGCCATGGGGGATCCCGTCGTTT
Figure 78. Sequencing results showing ECRs have been cloned into pl229.
(A) ECRl insert bracketed by Not! and Spel sequences.
(B) Results of the sequencing of clone ABM6 from the T7 promoter showing the ECRl sequence cloned into p!229 in the 
forward direction.
(C) ECR2 insert bracketed by Not) and Spel sequences.
(D) Results of the sequencing of clone 5 from the T7 promoter showing the ECR2 sequence cloned into p!229 in the forward 
direction.
E) ECR3 insert bracketed by Notl and Spel sequences.
(F) Results of the sequencing of clone F from the T7 promoter showing the ECR3 sequence cloned into p!229 in the forward 
direction. There Is one G:A substitution (pink highlight) which could be a sequencing error.
KEY:
Yellow highlight; PCR-amplified sequence within primer regions. Upper case; ECR sequence. Lower case; regions flanking 
ECR.
Green highlight; Forward primer's annealing sequence. Red highlight; Reverse primer's annealing sequence.
Notl cutting sequence; GCjGGCCGC, cuts at |. Spel cutting sequence; A | CTAGT, cuts at |.
Un-highlighted italics; p!229 reporter vector sequence.
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7.11 Alignment between predicted and sequenced LSAMP ECR1#2,3 
inserts
A
>lcl119999 
Length=619
Score = 922 bits (499), Expect = 0.0
Identities = 499/499 (100%), Gaps = 0/499 (0%) 
Strand=Plus/Plus
Query 1
Sbjct 5
Query 61
Sbjct 65
Query 121
Sbjct 125
Query 181
Sbjct 185
Query 241
Sbjct 245
Query 301
Sbjct 305
Query 361
Sbjct 365
Query 421
Sbjct 425
Query 481
Sbjct 485
GCGGCCGCATCTGAACGTTGCCCTGTCACGGAGGCACAGCACAAGGTTGCAGCAGGCCCT
i1111111!11II11111111111111! i i i 1111111111!! 11111111111111111
GCGGCCGCATCTGAACGTTGCCCTGTCACGGAGGCACAGCACAAGGTTGCAGCAGGCCCT
GGATAAGAAAGCACTGAGGAATGGGAAGTTGGCTACTCACCTGTAGTGCAAAACAACCTC
111111111111111111111II1111IIII111 M 1111 M I M 11111111 M 11111
GGATAAGAAAGCACTGAGGAATGGGAAGTTGGCTACTCACCTGTAGTGCAAAACAACCTC
ATTGATACGCAGGAGACTTCAGTCTCGGTGACTTTCAATGTCTTCCACAGCATCAAACTG
MMMIMMMMMMMMMMIIIIimMMMMMMMMMMIMM
ATTGATACGCAGGAGACTTCAGTCTCGGTGACTTTCAATGTCTTCCACAGCATCAAACTG
ATATTTCAAAGAGATTAAGAACTGAAGGGAACATATGATATCCATTTAAAGCCAAGACTT
I I I I I I I I 1 I I I I I I I I I I I I I I I I I I I M I II I I I I I I I I I I I I I I I I I M I I I I I I I I
ATATTTCAAAGAGATTAAGAACTGAAGGGAACATATGATATCCATTTAAAGCCAAGACTT
CAGATTTAATGAAGGCTGTATCAGAATGAGATATGATTCAGATATCAAATTACATTTGTT
M I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I II
CAGATTTAATGAAGGCTGTATCAGAATGAGATATGATTCAGATATCAAATTACATTTGTT
TAGGCCAACACAGCTTAATAAATCACAGCAACATTTAATAAATATTTATCTTCTTTTAAT
iiiiiiiiiiiiiiiiiiiiiiiniiiiiiiiiiiiiiiiiiiiiiiimiiiiiiii
TAGCCCAACACAGCTTAATAAATCACAGCAACATTTAATAAATATTTATCTTCTTTTAAT
CACCAGTTAGTGCTTTTTCTGATCTCTCCATTCCCTTAATGGCTCACTCCTGTATTTATT
MIIIMIMIMIIIIIIMIIIIIIIIIIIIIIIIIIIIIIIIIIIi Mllllll
CACCAGTTAGTGCTTTTTCTGATCTCTCCATTCCCTTAATGGCTCACTCCTGTATTTATT 
AAATGTGATTTCCATTTCTCTAATAATCAATACATCt ttttattttt tATAATTTGGGCA
I I I I I I I I I I II I I I I I I I I I I I I I I II I M I I II I I I I I I I I I I I I I I I I I I I I I I I II
AAATGTGATTTCCATTTCTCTAATAATCAATACATCTTTTTATTTTTTATAATTTGGGCA 
GGTTTACTGAACTACTAGT 499
lllllllllllllllllll
GGTTTACTGAACTACTAGT 503
60
64
120
124
180
184
240
244
300
304
360
364
420
424
480
484
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B
>lclI 54795
Length=342
Score = 405 bits (219), Expect = 6e-118
Identities = 219/219 (100%), Gaps = 0/219 (0%) 
Strand=Plus/Plus
Query 1
Sbjct 17
Query 61
Sbjct 77
Query 121
Sbjct 137
Query 181
Sbjct 197
GCGGCCGCAGTCCAGCTGCCAACAGAATGGTACCAATGATAAAATGTTATTGTTGTCACT
I I I I I I I I I I I I I I I I I! 1 M I I I !! I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
GCGGCCGCAGTCCAGCTGCCAACAGAATGGTACCAATGATAAAATGTTATTGTTGTCACT
GTCAGGCATTTGGTCTTTATCGGTCTACTCATGACAGCCCTTGTTAGTCAGGCAGGTCCT
I I I I I I I I I I I I I I I I I I [ M I I III I I I I I I I I I I I I I I I I I I I I I I I I I I I I ! i I I I I
GTCAGGCATTTGGTCTTTATCGGTCTACTCATGACAGCCCTTGTTAGTCAGGCAGGTCCT
GGGACAACTTCAAAGGGAGACCTTCTCATCCAATGACAAACATAGCAACCTACTTGACTT
I I I I I I I I I I I I I I I I I I M I I I I I I I I I I ! I I I I I I I I I I I I I I I I I I 1 I I I I I I I I I I
GGGACAACTTCAAAGGGAGACCTTCTCATCCAATGACAAACATAGCAACCTACTTGACTT 
CTCTGATCCTCTTATTTCCTTCAGGCCTTCTGCACTAGT 219
IIMIIIMIIIIIIIII[MIIIIIIIIIIMIIIIM
CTCTGATCCTCTTATTTCCTTCAGGCCTTCTGCACTAGT 235
c
>lcl|27485 
Length=543
Score = 719 bits (389), Expect = 0.0
Identities = 391/392 (99%), Gaps = 0/392 (0%) 
Strand=Plus/Plus
Query 3 GGCCGCCTGTCTGCCTGTCTGTCTGCAGGGGGTATGGTGTAAGGGTGGGTCTTTCCCGCT
iiiiiMiiiiiiiiiiiiiiiiiiiiimmiiiiiiiiiiiiiiiiiiiiiiiiii
Sbj ct 24 GGCCGCCTGTCTGCCTGTCTGTCTGCAGGGGGTATGGTGTAAGGGTGGGTCTTTCCCGCT 
Query 63 ATAGTTTTTGGTTGGAAGGAGACTCTGAGAGGGGTGTAGAAAAGGAAGGAGATAACCCCC
111111! 1111111 IIIIIIIIMMliMIMMIIIIIimmilimilllll
Sbjct 84 ATAGTTTTTGGTTGAAAGGAGACTCTGAGAGGGGTGTAGAAAAGGAAGGAGATAACCCCC 
Query 123 AGGAAAGTCAAACTATCTATTTATTTAGTTATGTGTTTTGGGTTGCGTTTTGCATTAATC
iMiiiMiiiiiiiiiiiiiiiiiiiMiimiiiiiiiimmiiiiiiiiiiii
Sbjct 144 AGGAAAGTCAAACTATCTATTTATTTAGTTATGTGTTTTGGGTTGCGTTTTGCATTAATC 
Query 183 GCTGCCACACACAGGAGCCCTGTAATTTATTATTGGTGATAAGTGTGGACAGTAGCTATT
MllliltllllllllllllllllllllllllllllllllimMMIIIIIIIIIIII
Sbjct 204 GCTGCCACACACAGGAGCCCTGTAATTTATTATTGGTGATAAGTGTGGACAGTAGCTATT 
Query 243 ATTTTTGCTCCCTGTTCTAAAACGTGGCAAGCAGGGACACTTAGATTTATGGAACATGCA
M h iMIMIMIM I llllllll I MMIMIMMI11 MIMIM MII Ml!
Sbj ct 264 ATTTTTGCTCCCTGTTCTAAAAGGTGGCAAGCAGGGACACTTAGATTTATGGAACATGCA 
Query 303 TTATTCAAATCTCAAGGCCCGATGGCTCAGCATGAACAACCCCAGCTATTTCCAGAACCT
11 M 1111111 M 11 M 111111111 M I M 111111111 M 11111 M I M I M 11111
sbjct 324 TTATTCAAATCTCAAGGCCCGATGGCTCAGCATGAACAACCCCAGCTATTTCCAGAACCT 
Query 363 CTCAGTCCTTCCTCCTTTGTTCCTCCACTAGT 394
I I M I I M I I I I I I I I I I I I M I i I I I M I I I
Sbjct 384 CTCAGTCCTTCCTCCTTTGTTCCTCCACTAGT 415
76
120
136
180
196
60
62
83
122
143
182
203
242
263
302
323
362
383
Figure 79 Alignments between predicted and sequenced (from T7 promoter) of (A) ECR1
(clone ABM6) (B) ECR2 (clone 5) (C) ECR3 (clone F) sequences cloned into the pl229
construct.
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7.12 PCR sequences ordered to amplify second tranche of ECRs
ECR Name Direction Sequence ordered
GrplEcr2 F TGAGACTGACCAGACACAAAGG
R CCATGGTGAGACAGGGTTTT
GrplEcr3 F CCT CATT AACACACCG CT CA
R TGCTGAGTTGCAAAGGACAG
Grp2Ecr4 F TTTGTTGTGAGAGGCTGTGC
R TCCCTT AAT CT GTT GT GTTCCA
Grp2Ecr5 F TT CT CCCAT ACATCCTTGTTGTT
R CCAGACAGGAGGAAAGAAGC
Grp2Ecr6 F TGACAAACTCAAACCTGAAGC
R GCGTTTGTCCAAGGAAGAAG
Grp3Ecr3 F CAGGGAATGTGAGGAAGAGG
R ACCAGCCTCTACCCCTTTGT
Grp3Ecr4 F CAGAGACTTTGGGGATCACTG
R A AAC CAG ACA AG G G G CA AC
Grp3Ecr5 F CGTGTGGAAAGAGAGGGATG
R GCTGTCAGCTAGGGACAAATG
Table 26 Primers ordered for second tranche of ECRs. As directional cloning was not being 
performed for these ECRs the Notl and Spel sites were not required.
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TF Class E B N
ARID 0 0 1
GRAINY 0 0 1
P53 0 0 1
RFX 0 0 1
TBX 0 0 1
PolyA 0 0 3
HMG 0 0 4
GCM 1 0 0
PLZF 1 0 0
SAND 1 0 0
Unclassified 1 0 0
ZFRING 1 0 0
D-Type LTRs 1 0 1
ZFPHD 1 0 1
E2 2 0 0
TBP 2 1 1
MYB 2 0 2
MADS 2 0 6
IRF 3 0 0
SMAD 3 0 1
GENINI 3 0 2
STAT 3 0 2
ZFC2H2 3 2 5
ZFC4-NR 5 5 2
BHLH 6 0 3
HISTONE 7 0 0
FORKHEAD 9 1 2
ZFGATA 9 0 2
E2F 12 0 0
BZIP 19 3 7
HOX 20 15 18
Totals 117 27 67
Table 28 TFBSs within all LSAMP-re\ated ECRs tested in this thesis.
Key: E = TFBSs located in ECRs shown to have only enhancer activity
B = TFBSs located in ECRs that had both enhancer and no enhancer activity in this 
tissue and at this stage of development
N = TFBSs located in ECRs that only showed no enhancer activity in this tissue and at 
this stage of development
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